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Summary
Understanding the evolutionary basis for human-specific phenotypes such as com-
plex speech and language, advanced cognition or the unique preparation of their
food is a topic of broad interest. Approaches focusing on comparisons of the ge-
nomic DNA (deoxyribonucleic acid) or RNA (ribonucleic acid) sequence between
species, individuals or tissues allow for the identification of evolutionary sequence
changes, some of these changes may underlie differences in phenotypes. In ad-
dition, differences in when, where and how much of a particular gene is present
may also contribute to functional changes and therefore also to phenotypic dif-
ferences.
The resources to make such comparisons using genetic data are now available.
The genome sequences of a number of outgroups: all living great apes, as well
two archaic humans, are now publically available. Studying gene expression on
the RNA level - a precursor of the protein expression - is considerably easier
and cheaper than the measurement of expression of the protein itself. It has
been shown that the RNA and protein expression levels are well correlated and
therefore measuring RNA levels provides a good proxy for the expression of the
protein. Using high-throughput sequencing techniques, relatively unbiased ex-
pression comparison is now possible because the RNA from any species can be
sequenced directly, rather than being captured on arrays which are designed based
on a particular reference sequence.
The aim of this research was to use gene expression as a molecular phenotype
to identify changes relevant to human-specific biology and study the difference
between humans and their closest living relatives to understand patterns and
differences in the gene expression and in gene expression regulation in multiple
tissues in primates using high-throughput sequencing techniques. In my thesis,
I describe two analyses to address open questions in the field of gene expression
and genes expression regulation in humans.
In the first part I will analyze how the effect of different diets impact gene expres-
sion using a mouse model. Two key components of the human diet that differ
substantially from the diet of other primates, the frequent use of meat of many
humans and the cooking of their food which is common for almost all human
populations, are modeled in the experiment. I tested for their impact on liver
gene expression. I found that both the differences in food substrates - meat and
iii
tuber - as well as in their preparation affect gene expression in mice significantly.
The effect is bigger between food substrates than between methods of prepara-
tion. Differentially expressed genes between food substrates and food preparation
were predominantly related to metabolic functions. In addition, immune-genes
showed differential expression between the comparisons of raw meat to both, raw
tuber and cooked meat, respectively. The results indicate that different food
substrates and food preparations activate different metabolic pathways and that
the cooking of food and particularly of meat has an influence on the immune
also changes immune-reactions of the body. I showed that expression differences
in these mice are correlated with the differences observed between humans and
other primates, and that there is evidence that adaptation to these diets dates
to more than 300.000 years. Finally, I showed that transcription factors play
in important role in regulation of gene expression with respect to different food
preparation.
In the second part I analyzed the expression of one key regulator of gene ex-
pression: microRNAs (miRNAs). Using miRNA expression data from multiple
primate species and for multiple tissues I found that expression differences vary
between tissues. While heart and brain show only few expression differences be-
tween primates, other tissues are more variable in expression. The most extreme
expression differences in all three primate species were found in the brain, which
may reflect the importance of miRNAs in the regulation of gene expression in the
brain. Expression differences in testis were significantly larger between humans
and macaques than between chimpanzees and macaques, indicating that miRNAs
evolved differently in human compared to chimpanzees. MiRNA expression dif-
ferences were correlated with expression differences of their target genes genome-
wide which underlines the regulatory importance of miRNAs. I also showed that
differentially expressed miRNAs between species/tissues preferentially targeted
transcription factors, which are important gene expression regulators as well.
This finding that suggests complex regulatory pathways involving both miRNAs
and transcription factors in the control of gene expression. Finally, I used the
miRNA sequencing data to annotate new miRNAs in primates and was able to
increase the number of annotated miRNAs substantially, especially for the non-
human primates which were previously not extensively annotated. The overlap
of miRNAs annotated in multiple primate species thereby also increased which
will support future studies to investigate the evolutionary changes of miRNAs
between these primates.
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1. Introduction
Understanding the evolutionary basis for human-specific phenotypes like speech,
advanced cognition or the unique preparation of their food is a topic of broad
interest (Lehner, 2013; Rzhetsky et al., 2007).
Approaches focussing on comparisons of the genomic DNA (deoxyribonucleic
acid)/RNA (ribonucleic acid) sequence between species, individuals or tissues al-
low for the identification of sequence changes between the samples. Such changes
reflect sequence evolution, and some of these changes have effects on the phe-
notype (Herlyn and Zischler, 2006; Wagner, 2011; Zerbino, Paten and Haussler,
2012). For example: changes in sequence that occur in protein coding sequence
regions may affect the structure of the encoded protein and may lead to change
in function (Lindquist, 2009). The identification of these phenotypically relevant
changes is a challenge currently being undertaken by researchers.
Further, differences in when, where and how much of a particular gene is present
may also contribute to functional changes and to phenotypic differences. De-
spite a relatively small number of differences in genomic sequence between hu-
mans and their closest living relatives the chimpanzees (∼2.6 percent) humans
and chimpanzees differ quiet substantially in behavior and anatomy (Creely and
Khaitovich, 2006; Olson and Varki, 2003; Tomasello and Vaish, 2013). This rather
low genetic difference compared to the major phenotypic discrepancies suggests
that not only differences on the nucleotide level, but also differences on the level
of transcription and translation of the genomic code may play an important role
(King and Wilson, 1975).
The resources to make such comparisons using genetic data are now available.
The genome sequences of all living great apes as well as a number of outgroups are
now publically available (Gibbs et al., 2007; Lander et al., 2001; Locke et al., 2011;
Mikkelsen et al., 2005; Pru¨fer et al., 2012; Scally et al., 2012). For addressing
questions relating to human-specific traits the availability of two archaic human
genomes allow very recent sequence changes on the human lineage to be identified
(Meyer et al., 2012; Pru¨fer et al.). Studying expression on the RNA level - a pre-
product of the protein expression - is considerably easier and cheaper than the
measurement of expression of the protein itself. It has been shown that the RNA
and protein expression levels are well correlated and therefor measuring RNA
levels provides a good proxy for the expression of the protein (Nagaraj et al.,
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2011). Using high-throughput sequencing techniques, expression comparison is
now possible in an unbiased way because it is possible to sequence directly the
RNA from any species, rather than being dependent on arrays which are designed
based on a reference sequence (Chu and Corey, 2012).
1.1. Objectives
The aim of this research was to use gene expression as a molecular phenotype
to identify changes relevant to human-specific biology and study the difference
between humans and their closest living relatives to understand patterns and
differences in the gene expression and in gene expression regulation in multiple
tissues in primates.
In this thesis, I will describe two analyses to address open questions in the field
of gene expression and genes expression regulation in humans. In the first part
(chapter 4) I will analyze how the effect of different diets impact gene expres-
sion using a mouse model. Two key components of the human diet that differ
substantially from the diet of other primates, the frequent use of meat of many
humans and the cooking of their food, which is common for almost all human
populations are modelled in the experiment I tested for their their impact on
liver gene expression. I will link expression differences in mouse in response to
the human-specific diets to human-specific expression differences and test the
evolutionary importance of the expression changes.
In the second part (chapter 5) I will analyze expression data of one key regulator
of gene expression: microRNAs in great apes and rhesus macaques. I will test for
differences in expression between humans and primates in multiple tissues, link
the effect of these expression changes to the microRNA target genes, and use the
expression data to annotate new microRNAs in all primate species.
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2. Background
2.1. From DNA to protein
Proteins are virtually involved in all cell functions. Changes in the amino acid
sequence of a protein might have a direct impact on its structure and therefore
its function. While amino acid changes are not the only reasons for functional
changes of a protein they are the ones that - given the available technology -
are the easiest to study. The effort of sequencing and annotating genomes and
transcriptomes in the field of genomics has one of its motivations in the detection
of such changes.
Two main stages of the protein biosythesis can be studied. The typical processing
of a protein coding gene starts with the transcription. In this step the messen-
gerRNA (mRNA) - which is a single stranded copy of the DNA - is created.
Transcription is therefore the first step to gene expression. The more copies are
created the higher the expression for a given gene. In the second stage - the
translation - the mRNA is decoded by the ribosome. An amino acid chain is
produced and is folded into a protein. Amino acids are composed of three nu-
cleotides, and the DNA code is redundant, multiple different nucleotide triplets
can produce the same amino acid. One therefore has to differentiate between the
so-called synonymous changes, which don’t alter the encoded amino acid, and
non-synonymous changes which do.
Changes in the expression of a gene, i.e. the amount of RNA generated by
transcription from the DNA sequence may alter the amount of protein that is
produced. Changes in RNA and protein quantities may also have an important
functional impact. So even entirely identical proteins in different organisms can
lead to phenotypic changes when available in different amounts.
Already small changes in expression can result in strong phenotypic changes. Un-
derstanding the mechanisms of gene expression regulation is therefore of major
importance. Hence, regulatory elements like transcription factors (TFs) or mi-
croRNAs (miRNAs) are focus of many experiments in order to understand gene
expression mechanisms. TFs are themselves protein coding genes and are di-
rectly involved in the transcription process by promoting or repressing transcrip-
tion (Latchman, 1997). MiRNAs on the other hand interact with the complete
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mRNA product and have their major function in degrading their target mRNAs
(Figure 2.1) among other functions (Wu, Shen and Tang, 2009).
2.2. Aim of comparative expression studies
Though relatively new, large-scale transcript sequencing has been applied to
study gene expression in tissues, different species/populations, different devel-
opmental stages or to disease studies (Chesler et al., 2004; Dermitzakis, 2008;
Liscovitch and Chechik, 2013; Pavey et al., 2010; Schwanha¨usser et al., 2011;
Stranger et al., 2007). The samples reveal information about variation in ex-
pression levels between the different genetic conditions help understanding the
involvement of genes in existing biological pathways. Databases containing such
information of genes with similar functions and genes involved in pathways are
for example the gene ontology (GO) (Ashburner et al., 2000), the human and the
mammalian phenotype ontologies (Robinson et al., 2008; Smith, Goldsmith and
Eppig, 2004), the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway
database (Kanehisa, 2004) and the REACTOME pathway database (Matthews
et al., 2009) among many others. The databases provide annotations of genes to
specific pathways and functions. The annotation is carried out by manual assig-
ment of genes to pathways from the scientific literature and updated frequenctly.
Expression information helps to reveal which genes are active in a sample, and the
application of prior knowledge, captured in the form of ontologies like the GO or
other pathway databases allow to deduce which pathways are present/modified.
Gene expression studies also enable to directly investigate the impact of expres-
sion regulators like miRNAs and transcription factors and their effect on differ-
ential gene expression. For example since miRNAs may regulated the expression
of sets of genes by binding to the 3’UTR of the transcribed RNA, it is possible to
determine the relationship between transcript and regulator. The target predic-
tion is still mainly carried out computationally with a high error rate (Alexiou
et al., 2009) and multiple target prediction tools are available (Kertesz et al.,
2007; Lewis et al., 2003) which enable to study the relationship between miRNAs
and their targets’ gene expression. Similarly, databases for transcription factor
binding site are available (Boyle et al., 2012; Matys et al., 2006), that mostly
computationally predict target genes for transcription factors and equivalently to
miRNA databases enable to study the relationship between transcription factors
and their target genes.
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DNA
transcription
RNA
translation
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Figure 2.1.: Simplified illustration of the biogenesis of a protein. The protein
produced by making an RNA copy of the DNA in a step called tran-
scription and the resulting RNA modified to the final protein - called
translation. Regulators like microRNAs and transcription factor in-
teract at different stages and affect the biogenesis.
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2.3. Techniques for quantifying gene expression
The aim of gene expression experiments changed over time. With the first genome
sequences of the human genome the annotation of expressed parts of the genome
was of major importance. With more and more functionally annotated genomes
available and the emergence of more advanced techniques the focus shifted to-
wards the quantification. The direct measurement of multiple proteins at a time
- using for example protein mass spectrometry - is still difficult and time consum-
ing even with the rapid inprovement in the last years (Aebersold and Mann, 2003;
Mallick and Kuster, 2010). An indirect approach is the quantification of interme-
diate products in the biogenesis, i.e. mRNA levels that are proportional to the
expression of the final and functional product - the protein, i.e. mRNA expres-
sion levels are correlated with the expression levels of the protein (Nagaraj et al.,
2011) and therefor a good proxy for the expression estimate of the functional en-
tity - the protein. It has been recently shown that due to their different half-lifes
period expression of mRNA and protein are not necessarily perfectly correlated
compared to quantitative proteomics approaches (Schwanha¨usser et al., 2011).
However, the lower cost and higher throughput of modern technologies measur-
ing mRNA expression is still a major focus when studying gene expression.
But not only protein coding genes are in the focus when studying gene expres-
sion. More and more experiments put their emphasis on non-coding RNAs like
microRNAs, piRNAs, lincRNAs, snoRNAs, tRNAs, rRNAs, snRNAs, siRNAs
among others (Eddy, 2001; Hu¨ttenhofer, Schattner and Polacek, 2005). They are
involved in essential biological processes like translation, gene regulation, genome
defense or splicing (Eddy, 2001). Among them are miRNAs which are an interest-
ing group of small non coding RNAs that are directly involved in gene expression
regulation (Chen and Rajewsky, 2007).
In this section I will introduce mutiple techniques for measuring gene expression
on the mRNA level that have been widely used over the past 20 years, that
partially can also be used to study other genomic features like for example non-
coding RNAs.
2.3.1. Expressed sequence tags (EST)
Expression sequence tags (ESTs) are short fragments sequenced from cDNA
copies of transcripts, and have been used to identify expressed genes. This
technique was one of the first approaches to identify expressed and therefore
potentially functional parts of the genome, and were used to generate estimates
of gene number prior to the availability of whole genome sequences (Adams et al.,
1991). More than 70 million ESTs from multiple species are available in public
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databases - such as dbEST (Boguski, Tolstoshev and Bassett, 1994). Traditional
EST sequencing is rarely carried out these days since the SAGE and other high
throughput sequencing approaches, that I will present in the following sections,
result in similar results with a higher throughput compared to the low costs.
An EST results from single-pass sequencing of a cloned cDNA. The cDNAs used
for EST generation are typically individual clones from a cDNA library. The
resulting sequence is a relatively low quality fragment whose length is limited by
current technology to approximately 500 to 800 nucleotides. Because these clones
consist of DNA that is complementary to mRNA, the ESTs represent portions
of expressed genes.
2.3.2. Microarrays
History and design In this section I will focus on DNA microarrays (Maskos
and Southern, 1992). These arrays are chips with many thousand probes designed
to determine DNA and RNA abundance. A probe is a specific DNA sequence
also called oligo which is ∼25 nucloetides long. Once DNA or RNA with the same
sequence binds to it a fluorescence signal can be measured. However, also partial
matching can lead to binding and a fluorescence signal. The more DNA/RNA
binds to the probe the higher the more intense the signal becomes. In order
to measure relative gene or transcript expression the probes have to be designed
specifically for the target molecules. Highly polymorphic and repetitive sequences
should not be included in the probes to minimize the effect of external factors
(Draghici et al., 2006; Murphy, 2002). One of the most frequent applications
of microarrays is the quantification of gene/transcript abundance or detecting
single nucleotide polymorphisms. Depending on the application, different ar-
rays are available, gene arrays for gene expression quantification, exon arrays
for expression on exon level and SNP arrays for the detection single nucleotide
polymorphisms.
2.3.3. Serial analysis of gene expression (SAGE)
The serial analysis of gene expression (SAGE) is a technique that uses sequence
tags of ∼20-30 nucleotides from desired mRNA populations to quantify their
expression (Velculescu et al., 1995). mRNA is isolated from a sample. Restriction
enzymes cut the mRNA at a specific base motif and remaining tags of a similar
length are then sequenced, nowadays by high throughput sequencing techniques,
which I will discuss a bit more in detail in the next section. The sequenced
reads can be assigned to known genes by mapping them to annotated genomes
or transcriptome datasets. The accuracy of this procedure, i.e. the precision of
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the gene expression estimate is highly dependent on whether reads can be clearly
assigned to genes. Excluding reads that can be assigned to multiple genes or
assigning these reads to all genes is not optimal because it either over, or under
estimates expression levels, particularly in cases where expression of the affected
genes is very different. The longer the read sequences are the more likely they
are to be mapped uniquely and accurately, leading to more relaiable expression
estimates. implementations of the SAGE protocol often tend towards sequencing
longer tags, like LongSAGE (Saha et al., 2002), RL-SAGE (Gowda et al., 2004)
and SuperSAGE (Matsumura et al., 2005).
2.3.4. RNA-Seq
History Recently developed next generation sequencing (NGS) platforms, for
instance 454 (Margulies et al., 2005), Illumina (Bentley et al., 2008) and SOLiD
(Valouev et al., 2008) have revolutionized the field of DNA sequencing by enabling
the generation of several million reads in parallel at a much lower cost than was
previously possible. As a result it is now feasible to consider whole transcriptome
sequencing and quantitation in a relatively unbiased manner that is able to survey
even rather rare transcripts - given sufficient sequencing depth (Mardis, 2008;
Metzker, 2010). The most widely used approach to studying transcript expression
levels using NGS is called RNA-Seq or Whole Transcriptome Shotgun Sequencing
(Wang, Gerstein and Snyder, 2009).
Sequencing The 454 technology is based on the pyrosequencing approach which
iteratively complements single strands. One nucleotide at a time is incorporated
and washed over several copies of the desired sequence. In Illumina and SOLiD
sequencing DNA is fragmented and adapters are ligated to both ends before
the molecules are clonally amplified by polymerase chain reaction (PCR). The
amplification is performed by either a technique call emulsion PCR (Dressman
et al., 2003) or solid-phase amplification (Fedurco et al., 2006). The sequencing
reaction can be performed by single-nucleotide addition and real-time sequencing
or by ligation (Metzker, 2010). Molecules can be sequenced from only one end
(single-end sequencing) or from both ends (paired-end). Cameras read out the
light intensities which will be translated in the following base-calling step.
Base-calling and mapping Images carrying the fluorescence signal - produced
on the sequencer - which encode for the obtained nucleotides have to be trans-
lated in computer-readable sequences. This step is realized by using base calling
software (Ledergerber and Dessimoz, 2011), such as BayesCall (Kao, Stevens and
Song, 2009) or IBIS (Kircher, Stenzel and Kelso, 2009). In the base-calling step
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chromatogram intensities are modelled and likelihoods for all possible bases at
each position are computed. Reads with low genotype quality, i.e. multiple posi-
tions in the read with low likelihoods for the observed and called bases should be
excluded from further analyses. In a next step reads have to be mapped to the
genome in order to find the gene from which they originate. As cDNA libraries
have been sequenced the mapper has to be able to align reads to the genome
taking into consideration that introns might have to be ignored. The so-called
splice mappers like TopHat (Trapnell, Pachter and Salzberg, 2009), GSNAP (Wu
and Nacu, 2010) or splicmap (Au et al., 2010) are able to either take into account
known splice sites and map reads accordingly to the transcripts or find likely
splice form that are not annotated. NGS technologies have a estimated error
rate of 10−3-10−2, which is higher than for example PCR, were the error rate is
∼10−5. Therefor, mappers have to be mismatch tolerant to avoid the unnecessary
exclusion of reads. Additionally, reads with low mapping quality, that is reads
mapping to multiple regions, should be excluded from further analyses.
Other applications for RNA-Seq experiments RNA-specific features can be
studied, such as RNA editing which is a post-transcriptional modification of the
RNA (Gott and Emeson, 2000). The most widespread type of RNA editing is the
modification of adenosine to inosine (A-to-I). This modification will be recognized
as A-to-G in RNA-Seq experiments. A recent study in primates shows that these
editing events were located in Alu-repeat elements inside the 3’ UTRs of the
transcripts, similar to other studies of higher eukaryotes, and that events are
highly conserved between primates (Li et al., 2013). Multiple other applications
using the RNA-Seq approach are commonly used. The transcriptome annotation
(Garber et al., 2011; Mortazavi et al., 2008) of newly annotated genomes are
frequenctly based on RNA-Seq experiments. Especially in medical studies the
discovery of new isoforms and translocations are a major focus (Maher et al.,
2009). And just like in sequencing DNA, RNA-Seq experiments enable to perform
Nucleotide variant calling (Dressman et al., 2003), even though the RNA-Seq data
is not optimal due to highly variable coverage between different genes.
2.4. Comparative gene expression
In comparative genome studies gene expression experiments have been used to
determine species-specific expression differences (Chu and Corey, 2012). The
technologies that have been used for such experiments have different advantages
and disadvantages that should be considered when performing such experiments.
In this section I will introduce methods for comparative expression studies and
discuss their advantages and shortcomings.
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2.4.1. Microarrays
Gene/transcript expression quantification Many software tools for analyzing
microarray data have been provided by Bioconductor (Gentleman et al., 2004)
which hosts multiple packages for expression analyis using the R programming
language. In this paragraph I will focus on methods implemented in the Biocon-
ductor environment.
In order to increase the accuracy of the expression estimate for the desired tran-
script probesets made up of multiple different probes are designed to measure
the abundance of a particular molecule. These probe sets have to be normalized
to obtain an expression value for the whole set. To increase the accuracy of the
normalization procedure some array types also included for each probe a second
matching probe carrying a single mismatch nucleotide in the middle position.
Whether or not a probe or probe set is expressed can then be determined by
comparing its expression to the estimation of background expression provided by
these probes. This is especially important when multiple arrays are compared
to each other. One frequently applied method to quantify expression based on
arrays designed with these mismatch probes is called robust multi-array average
(RMA) (Irizarry et al., 2003). In this approach signal intensities between differ-
ent arrays are normalized by probe specific correction of the perfectly matching
probes using a model based on observed intensity being the sum of signal and
noise; the normalization of those probes using a quantile normalization and fi-
nally the expression calculation using the median polish algorithm. In a later
approach the RMA algorithm was susbtituted by the GCRMA algorithm which
additionally corrects intensities based on their GC content (Wu et al., 2004).
Comparative gene expression The design of the array becomes more and more
relevant the larger the sequence divergence between the compared samples. Es-
pecially in species comparisons the array design could cause a species bias if
probes are designed based on one species and then used to measure expression
in another. In an ideal case probes have the same primary and secondary - e.g.
partially matching - targets. Due to for example missing genomic information it
is not always possible to obtain unbiased results. One approach to minimize the
effect of different binding affinities to the probes between groups is to use only
probes with the same target sequence in all compared groups (Gilad et al., 2005)
or to use longer target sequences to increase the uniqueness of the sequence in
the genome (Walker et al., 2006). A second approach is to use the expression
result to remove probes from the analysis that show binding affinity differences.
If the genome sequence for all species/samples is available, this can be done by
removing all probes that show sequence differences between species or by identi-
fying and removing probes based on their expression signal (Dannemann et al.,
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2009; Greenhall et al., 2007). Probes measuring the aboundance of the same
transcript should be highly correlated between species. Probes measuring the
same molecule that do not correlate between species are likely to show binding
affinity differences between species and should be removed from the analysis to
avoid biases in expression estimation. In one of the algorithms used to remove
probes, I have shown the effect of badly designed probes for between species
comparisons (Dannemann et al., 2009) and developed a Bioconductor R package
to detect and remove these probes (Dannemann, Lachmann and Lorenc, 2012)1.
Microarrays are also used for medical studies and I showed that for comparisons
between different tissues, in this case healthy and disease tissues from the same
patient, probes should be removed due to different binding affinities (Dannemann,
Lachmann and Lorenc, 2012).
In comparative analyses the obtained expression estimates for each species are
tested for differences between groups using models based on a normal distribution
assumption, like a t-test or an ANOVA. Since the emergence of next generation
sequencing techniques microarrays are less and less frequenctly used to quantify
gene expression. Nevertheless, they opened a a completely new approach to
study expression for many genes or transcripts where the reference sequence is
available.
2.4.2. Next generation sequencing techniques
This section mainly focuses on the analysis of RNA-Seq data. However, SAGE
experiments that are performed with next generation sequencing technologies
would follow a similar processing to that described in this section.
Gene/transcript expression quantification Sequence reads obtained from the
base-calling and mapping to a reference genome as described in section 2.3.4 are
usually assigned to known genes/transcripts in order to perform expression anal-
yses. One approach is to assign reads that are aligned to regions overlapping
with known gene annotations to the annotated genes. This is appropriate when
the reference genome and gene annotation used is the same for all sequenced
individuals. Another approach should be considered once reference genomes and
gene annotations differ between samples, for instance when comparing different
species. A concern is that the base content and length of genes may influence
expression quantification if counts between samples with different transcriptomes
are used. For example if a gene in one species is longer than in the other this
gene would have more reads assigned even if the relative expression level of the
orthologous gene between the species is the same. The Cuﬄinks algorithm has
1This work was part of my Diploma thesis.
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been proposed as a potential solution to the problem of different transcriptome
composition between samples (Trapnell et al., 2010). Cuﬄinks assignes reads
to existing transcripts or if no transcript information is available it creates so-
called bundles that sum reads that seem to form a connected set similar to a
transcript. Cuﬄinks constructs a parsimonious set of transcripts by combining
reads obtained by an RNA-Seq experiment by reducing the comparative assem-
bly problem to a problem in maximum matching in bipartite graphs. Cuﬄinks
constructs a covering relation on the read alignments, and finds a minimum path
cover on the directed acyclic graph for the relation (Trapnell et al., 2010). After
reads are assigned to transcripts, they are normalized by the total number of
mapped reads and the length of the transcript or gene. This approach results
in so called RPKM (Reads Per Kilobase per Million mapped reads) (Mortazavi
et al., 2008) or FPKM (Fragments Per Kilobase per Million mapped reads) es-
timates. Alternatively, R packages DESeq and edgeR (Anders and Huber, 2010;
Robinson, McCarthy and Smyth, 2010) are designed to model count data based
on a negative binomial distribution and enable to normalize between groups using
of ’offset’ terms that correct for gene length.
Comparative gene expression Depending on the amount of sequence gener-
ated the expression of tens of thousands of genes can be quantified and com-
pared. While comparative expression analyses with microarray can be performed
by standard statistical tests, like t-tests or ANOVAs (analysis of variance) for two
or more factors respectively due to normally distributed data, statistical tests for
NGS experiments had to be designed in order to deal with non-normally dis-
tributed count data. Such data is common to RNA-Seq, SAGE experiments or
miRNA experiments when using NGS techniques. First approaches treated count
data experiments like multinomial processes with each gene having a certain prob-
ability to be measured which should be equivalent to its relative expression to all
other genes, resulting in the use of a Poisson distribution to fit the data (Marioni
et al., 2008; Wang et al., 2010). The Poisson distribution has only one parameter
which models thee mean and the variance at the same time. Later studies have
shown that the variance is not independent of the mean in NGS experiments and
a sum of the so-called shot noise, which is the variance obtained from a multi-
nomial experiment and biological and technical noise (Anders and Huber, 2010;
Robinson, McCarthy and Smyth, 2010). The DESeq package and the edgeR
R packages (Anders and Huber, 2010; Robinson, McCarthy and Smyth, 2010)
propose a fit of the data with a negative binomial distribution, which has two
parameters - mean and dispersion - that are not independent. The variance is
connected to the mean via the dipersion parameter. The use of point estimates
for both parameters for each gene showed a high false positive rate, especially
for genes expressed at low levels i.e. genes with low read counts. In order to
correct for that bias the dispersion parameter is computed by fitting a function
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to the mean-dispersion relation using all genes. Differential expression can then
be obtained by applying a likelihood ratio test for each gene comparing (i) a fit
treating the data as one group and (ii) fitting the parameters for ach group sep-
aratly. Once a fit for each group is statistically significantly better then fitting
the data for a gene as one group a gene is called differentially expressed with a
certain P value. In order to compare more groups or multiple factors one either
has to perform pair-wise tests or use the multinomial test provided by both -
DESeq and edgeR. One shortcoming is that both approaches allow only two lev-
els per factor which limits the analyses between multiple groups. In the case of
multiple groups either pair-wise test have to be performed or all combinations
of groups have to be included in the multinomial approach. Another problem is
the comparison between groups with different transcriptomes. Different counts
for genes might be due to gene length differences. While an obvious solution
for that problem is the use of normalized expression estimates like those from
cuﬄinks, the authors of DESeq and edgeR (Anders and Huber, 2010; Robinson,
McCarthy and Smyth, 2010) claim that these normalized counts violate the dis-
tribution assumption of their tests. An alternative is approach uses ’offset’ terms
that correct for gene length. However, gene length might not be the only factor
that might bias comparisons between groups with different genetic backgrounds.
Differences in genome quality, base composition or gene annotation quality are
among multiple factors that complicate the comparison. When interpreting the
significance of differential expression one has to consider the problem of multi-
ple testing. The most established approach to obtain a false discovery rate is
the correction proposed by Benjamini and Hochberg (Benjamini and Hochberg,
1995). A recent comparison of software tools for computing differential expres-
sion based on RNA-Seq experiments showed that modelling RNA-Seq data with
distributions applicable for count data are superior to tools that model the data
based on a log-normal distribution (Rapaport et al., 2013). The authors also
show that improving the accuracy of the differential expression results depends
on a high number of samples than on higher sequencing depth (Busby et al., 2013;
Rapaport et al., 2013).
Advantages and disadvantages of different methods Different techniques for
performing expression experiments feature various advantages and disadvantages.
Depending on the goal of the experiment each of the technologies might be suit-
able to apply. Analyzing whole transcriptomes is possible with SAGE, microar-
rays and RNA-Seq experiments. Microarrays need a reference for probe design
and are therefore prone to biases in comparisons between groups of different ge-
netic background such as different species. EST experiments are not suitable for
whole transcriptome analyses due to their low throughput. As already discussed
in the last section, the confidence in measuring a transcript will increase the con-
fidence in expression estimates. Microarray experiments will lack this precision
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once probes are or cannot be well designed, which is a challenge due to their
short length of ∼25 nucleotides. The same lack of precision will affect SAGE ex-
periments since SAGE tags are short enough that they can often not be uniquely
mapped to transcripts. The need for a reference is another shortcoming of mi-
croarrays. While not only comparative studies are complicated also the option of
annotating new transcripts is not possible. Over the last years RNA-Seq exper-
iments have established themselves as the standard way of analyzing expression
as they feature important points like enabling whole transcriptome expression
analyses, annotating transcriptomes and high throughput at low costs. However,
there is still a discrepancy in cost between RNA-Seq and microaray experiments.
Even though high-throughput sequencing became considerably cheaper, microar-
ray experiments are still significantly less expensive. For example, when studying
many individuals with low genetic variation at the same time microarrays might
still perform similarly compared to RNA-Seq at lower cost.
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3. Open questions in the field of
human-specific gene expression
and gene expression regulation
In the following two chapters of the thesis, I will address two specific questions
related to primate gene expression and gene expression regulation.
3.1. Human-specific changes of gene expression in
response to nutrition
In the first part of the thesis (chapter 4) I will present a study that uses a model
system to measure gene expression in the liver and relates this to changes induced
by different diets. In particular, I explore expression changes in response to cook-
ing and choice dietary substrate - both factors that changed during human evo-
lution. I show how transient changes in gene expression in the model system can
be used to identify those genes underlying expression differences between human
and chimpanzees. To determine the effect of food substrate and food preparation
on metabolism I used high throughput transcript sequencing (RNASeq) to study
liver gene expression in mice fed diets of meat or tubers served either raw or
cooked. I will show that expression differences between humans and chimpanzees
and between mice fed the analogous diets of the two species are highly correlated.
I will also present how transcription factors act as key regulators in regulating
these expression changes. I identified the functions and pathways in which the
genes that are differentially expressed participate as these provide insights into
the potential functional impacts of these changes. I also investigated the selec-
tive pressures on the DNA sequence of genes that show expression changes with
respect to the different substrates and preparations of food types as this also
provides insight into potential targets of recent adaptation.
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3.2. Expression changes of microRNAs in primates
and their regulatory importance
In the second part of the thesis (chapter 5) I will investigate the expression
evolution of microRNAs (miRNAs) in primates. MiRNAs play an important
role in gene regulation and their functional importance is reflected in their high
sequence conservation, which indicates strong purifying selection. I used miRNAs
sequenced from humans and four other primate species (chimpanzee, gorialla,
orang-utan, and rhesus macaque) for five different tissues (brain, heart, kidney,
liver, and testis) to show how expression of this class of non-coding RNAs differes
between species and tissues. I also investigated the regulatory importance of these
changes, by testing for correlation between expression changes of miRNAs and
their target genes. Finally, I used the expression data to identify new miRNAs and
contributed these to the public database, miRBase. This extended the annotation
of primate miRNAs available for these five primate species.
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4. Human dietary response in gene
expression using mouse models
4.1. Motivation and Introduction
The evolutionary role of cooking in broadening the human diet (Alperson-Afil
et al., 2009; Ungar et al., 2006) and increasing nutrient digestibility (Aiello and
Wheeler, 1995) has long been acknowledged. However, only recently has cooking
been proposed as an important driver of evolution in the genus Homo (Lucas,
2004; Wrangham et al., 1999, 2009; Wrangham and Conklin-Brittain, 2003). In-
creases in energy budget and reductions in molar and gut size indicate a transi-
tion toward higher dietary quality beginning ∼2 mya, consistent not only with
increased reliance on animal foods (Blumenschine, 1991; Lee and DeVore, 1969;
Milton, 1999; Shipman and Walker, 1989) but also with the positive effects of
cooking on food toughness, digestibility and energy value (Carmody and Wrang-
ham, 2009). Wrangham and Conklin-Brittain (2003) observed that the modern
human gut has too little volume and too rapid a passage rate to extract sufficient
energy from a diet of raw wild foods. Their model-based conclusion is supported
by reports of low body mass index and reproductive dysfunction among modern
raw foodists, an outcome not improved by the incorporation of raw animal foods
into the diet (Fontana et al., 2005; Koebnick et al., 1999). Such data have led to
the suggestion that the diet to which modern humans are biologically adapted
is obliged to include cooked items (Wrangham and Conklin-Brittain, 2003). If
this is the case, one should expect to find signals of human genetic adaptation to
a cooked diet. Dietary differences have previously been shown to cause genetic
adaptations. For example, several populations with a history of dairying exhibit
the ability to digest lactose into adulthood, through persistence of the lactase en-
zyme (Bersaglieri et al., 2004). Lactase persistence has evolved at least twice in
the last ∼7,000 years; in Europeans the trait is associated with a single nucleotide
polymorphism (SNP) in the lactase gene coding sequence, whereas in Africans
the trait is associated with three SNPs that enhance transcription from the lac-
tase promoter (Tishkoff et al., 2007). In addition, populations with a history of
consuming starch-rich foods exhibit higher copy numbers of the gene encoding
salivary amylase, the enzyme responsible for starch digestion in the mouth (Perry
et al., 2007). That diet-induced genetic adaptations exist even among modern
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human populations suggests that dietary differences with longer evolutionary
histories may produce more widespread genetic change. Although the origin of
cooking is presently unclear, fire was certainly controlled by 250 kya (James et al.,
1989). Older dates for the control of fire are also widely acknowledged at sites
such as Beeches Pit (Preece et al., 2006), Scho¨ningen (Gamble and Porr, 2005),
and Me´nez-Dre´gan (Monnier et al.), all dated to ∼400 kya, and at Wonderw-
erk Cave, dated to ∼1 mya (Berna et al., 2012). Although control of fire does
not necessarily imply cooking, a strong preference for cooked items among great
apes suggests that cooking would likely have followed shortly thereafter (Wob-
ber, Hare and Wrangham, 2008). Notably, dates for the control of fire overlap
with those proposed for the split between modern humans and the last common
ancestor of Neandertals and Denisovans (Scally and Durbin, 2012), making it un-
clear whether control of fire and cooking was present in the last common ancestor
of our clade. Heat-gelatinized starch granules embedded in the dental calculus
of Neandertals suggests they were consuming cooked plant items by ∼50 kya
(Henry, 2012). However evidence of highly sporadic fire use in cold-weather cli-
mates has some to suggest that early Neandertals used fire opportunistically but
did not control it (Sandgathe et al., 2011), developing robust pyrotechnic skills
only in the Late Pleistocene (Roebroeks and Villa, 2011). If cooking was shared
among the last common ancestor of our clade, genetic signals of adaptation to a
cooked diet could reasonably be expected to precede the split between modern
humans and Neandertals and Denisovans, roughly 500 kya (Scally and Durbin,
2012). One first step to search for evidence of genetic adaptation to cooking is
to analyze gene expression on cooked versus raw diets, to identify genes whose
expression is affected by cooking of food. These genes are likely to have been
among the targets of positive selection during adaptation to a cooked diet, and
can be tested for signals of such selection. However, studies requiring functional
manipulations of diet followed by tissue harvest cannot generally be performed
in humans or our close genetic relatives. A model organism is therefore required;
ideally a species for which the genome has been sequenced, orthologous genes
have been mapped between the model organism and humans and chimpanzees,
and research animals are bred under strict genetic control to maximize homo-
geneity. Recent work by Somel et al. (Somel et al., 2008) has demonstrated that
laboratory mice can be effectively used to study aspects of human-chimpanzee
dietary divergence. The team reared groups of mice for two weeks on rodent
chow, chimpanzee food (raw/vegetarian), human cafeteria food (cooked/mixed),
or human fast food (cooked/mixed). This short period of dietary divergence led
to differences in liver gene expression between groups of mice that recapitulated
10% of the differences in liver gene expression observed between chimpanzees and
humans. Since no differences were observed between mice eating the two human
diets, despite large differences in caloric and macronutrient content, (Somel et al.,
2008) reasoned that the expression differences were caused by features that unite
the two human diets while simultaneously distinguishing them from both the
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mouse diet and the chimpanzee diet. (Somel et al., 2008) speculated that meat
or cooking might have been responsible. The study build upon (Somel et al.,
2008) and use a mouse model to examine whether individuals fed raw versus
cooked diets exhibit differences in gene expression. We assessed the impact of a
cooked diet on gene expression for two important classes of hominin foods, meat
(Milton, 1999; Stanford and Bunn, 1999) and tubers (Hatley and Kappelman,
1980; Laden and Wrangham, 2005; Ragir, 2000), and we fed cooked diets in both
free and restricted rations to evaluate the effects of differential energy balance
(Koza et al., 2006). The study was restricted to liver, a tissue with a precedent of
diet-altered gene expression (Somel et al., 2008) and for which human-chimpanzee
gene expression differences have been catalogued (Blekhman et al., 2010; Gilad
et al., 2006; Khaitovich et al., 2005). Where differences in gene expression were
found to exist between raw-fed and cooked-fed mice, I use published compara-
tive data on gene expression in liver to investigate whether the genes affected
by cooking in mice also exhibit corresponding differences between humans and
non-human primates. Finally, I use published data on positive selection in the
human and chimpanzee genomes (Kosiol et al., 2008) to examine whether genes
affected by cooking have been positively selected in the human lineage and, if
so, when. Jointly, these methods enable to test and explore the hypothesis that
humans are biologically adapted to the consumption of cooked food.
4.2. Experimental design
To assess the impacts of a cooked diet on liver gene expression, adult male
BALB/c mice have been reared for 5 days on one of the following homogeneous
diets: raw tuber / free-fed (TRF; n = 4), cooked tuber / free-fed (TCF; n = 4),
cooked tuber / restricted ration (TCR; n = 4), raw meat / free-fed (MRF; n = 4),
cooked meat / free-fed (MCR; n = 4), or cooked meat / restricted ration (MCR;
n = 4) (4.1 a)). Diets consisted of organic sweet potato tubers (Ipomoea batatas)
or organic lean beef eye round roast (Bos taurus), served either raw, cooked, or
cooked but in a restricted ration that allowed to evaluate the effects of a cooked
diet given negative energy status. Domesticated species have been used to avoid
freezing, which is known to affect material and nutritive properties in both meat
(Ballin and Lametsch, 2008) and tubers (Mondy and Chandra, 1979).
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Figure 4.1.: (a) The three treatments explored in the study are illustrated: food
type, food preparation and caloric consumption. For each combina-
tion of treatments the number of mice used in expression analysis
is represented. (b) Table showing the number of differentially ex-
pressed genes for each of the three treatments (FDR < 0.05 and p-
value < 0.05). (c) Direction of expression change for genes that are
differentially expressed for each of the combination of factors (black
squares). The x-axis gives the expression difference between either
raw and cooked (confidence intervals in blue; p < 0.001) or meat and
tuber (confidence intervals in orange; p < 0.001) Pie chart showing
the functionally enriched categories in the Biological Process domain
of the GO for all differentially expressed genes (FWER < 0.05) be-
tween the tuber and meat diets (d) and the raw and cooked diets (e).
Figure taken from Carmody et al.
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4.3. Results
4.3.1. Tissue harvest, Library Preparation, Sequencing, and
Base Calling
Liver tissues have been harvested from mice 2 h following their final meal and
within 1 min of death. Total RNA was used to prepare barcoded sequencing
libraries, which were pooled and run across 3 lanes of an Illumina HiSeq, resulting
in ∼265 million 75 bp paired-end reads. Base-calling from the Illumina intensities
was carried out using freeIbis (Renaud et al. (2013),version 65773c3).
4.3.2. Energy balance
These diets had predictable effects on body mass, with mice fed unrestricted
cooked diets (TCF and MCF) maintaining their weight, and mice fed cooked
restricted (TCR and MCR) or raw (TRF and MRF) diets losing weight. One
mouse from the TRF group died unexpectedly 4 days into the experiment, and
was therefore excluded from analysis. Mean daily food intake (dry-weight basis)
differed between treatments in both tuber and meat (one-way ANOVA; tuber: p
= 0.000; meat: p = 0.039). Despite their better ability to sustain body mass,
cooked diets were associated with lower rather than higher intakes (unpaired t-
test; TCF < TRF, p = 0.000; MCF < MRF, p = 0.039). This suggests that
cooking increased net energy gain per gram of food, a result consistent with prior
reports (Carmody, Weintraub and Wrangham, 2011).
4.3.3. Differential expression analysis
Computing expression I mapped all reads to the mouse genome
(NCBI37/mm9) using the TopHat mapper (Trapnell, Pachter and Salzberg,
2009) using default parameters. All mapped reads above a minimum mapping
quality of 30 were kept and assigned to genes defined by the mouse ENSEMBL
gene annotation (version 65). All genes with a read count greater than zero in
at least two individuals were defined as expressed/detected. Based on the mouse
genome annotation I found expression evidence for 26375 genes.
Computing differential expression To identify expression changes driven by
differences in “food type” (meat versus tuber), “food preparation” (cooked versus
raw) and “calorie consumption” I computed differential expression (FDR < 0.05,
correction based on the Benjamini-Hochberg procedure Benjamini and Hochberg
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(1995)) between each of the groups of mice using the multifactor model provided
by the R package DESeq (Anders and Huber, 2010). As might be expected given
that digestive demands vary for protein, fat and carbohydrate, differences in food
type account for the largest number of differentially expressed genes (2946 genes),
with the effect being greater when the food was cooked (1402) than when the food
was served raw (478) (4.1 b)). 123 genes were differentially expressed between
animals fed the raw and the cooked diets regardless of food substrate. A larger
number of genes were differentially expressed between animals fed cooked and raw
tubers (444) than for cooked and raw meat (112) (4.1 b)), consistent with the
more dramatic effects of cooking on nutrient digestibility in tuber compared with
meat (Carmody and Wrangham, 2009). Surprisingly, I found no differentially
expressed genes across animals with different levels of calorie consumption or
energy statuses (absolute weight gain or loss; weight gain or loss relative to the
treatment mean). I therefore treated these factors as non-explanatory for the
model and excluded them from all further analyses, combining the cooked free-
fed and cooked restricted groups into a single “cooked” group. Interestingly, 110
of the 112 (98%) differentially expressed genes between the cooked and the raw
meat diet show higher expression in the raw diet, which might be caused either
by an up-regulation in response to the raw meat diet or a down-regulation in the
cooked diet (4.1 c)). Also genes differentially expressed between meat and tuber
show a bias to be more often higher expressed in the meat diet compared to the
tuber diet (4.1 c)). Genes differentially expressed between the raw and cooked
tuber diet are significantly more often highly expressed in the cooked tuber diet
(4.1 c)).
4.3.4. Functional enrichment of differentially expressed
genes
To determine whether genes affected by changes in diet carry out particular
functions or are involved in particular biochemical pathways I assessed func-
tional enrichment of each of the sets of differentially expressed genes using the
gene ontology (GO) (Ashburner et al., 2000) and Kyoto Encyclopedia of Genes
and Genomes (KEGG) pathway database (Kanehisa, 2004). Sets of differen-
tially expressed genes were tested for enrichment by comparing them to all ex-
pressed genes using a hypergeometric test. For the GO I used the FUNC pack-
age (Pru¨fer et al., 2007) and defined functional categories to be significantly
over-represented if the corresponding family-wise error rate (FWER) was smaller
than 0.05. Over-representation of differentially expressed genes in a KEGG path-
way was computed by running the GOstats R package (Falcon and Gentleman,
2007). Pathways with a p-value smaller than 0.05 were defined to be signif-
icantly enriched. The differentially expressed genes in the comparisons of all
22
factors were largely related to GO and KEGG metabolic functions/pathways.
In addition, the genes that were differentially expressed between animals fed
raw and cooked meat were enriched for immune-related functions (4.1 d) and
e), A.3,A.2) among other non-melabolic pathways. Based on differences in
macronutrient content between the tuber and meat diets, as well as prior expec-
tations that cooking would increase nutrient bioavailability and reduce digestive
effort by denaturing proteins in meat and gelatinizing starch in tubers (Car-
mody, Weintraub and Wrangham, 2011), I tested four specific upper-level cate-
gories (carbohydrate metabolic process, cellular amino acid metabolic
process, protein metabolic process, lipid metabolic process) that I ex-
pected to be affected differently by the different food types given to the mice. I
used the GO to determine whether genes that show expression differences between
the food types and food preparation methods were enriched in these categories.
I found that patterns of functional enrichment largely conformed to a priori ex-
pectations. Firstly, I found that genes associated with carbohydrate metabolic
processes were more highly expressed in the tuber diet compared to the meat diet
regardless of cooking, which is consistent with the higher carbohydrate contents of
the tuber diets (4.2). In addition, genes associated with carbohydrate metabolism
were significantly more highly expressed in the raw tuber diet compared to the
cooked tuber diet, likely reflecting the additional physiological investment nec-
essary to digest raw sweet potato. Secondly, protein metabolic processes and
lipid metabolic processes more highly expressed in the meat diets compared to
the tuber diet, consistent with the higher protein and fat contents of the meat
diets (4.2). In addition, I found higher expression of lipid metabolic processes
in the raw meat diet compared with the cooked meat diet, consistent with the
marginally higher lipid content of the raw meat diet compared to the cooked meat
diets that resulted from lipids adhering to tool surfaces during processing (4.2),
Finally, expression of genes in the cellular amino acid metabolism category was
significantly higher in the tuber diets compared with the meat diet, and higher
in the raw tuber diet compared with the cooked tuber diet. Notably, the tuber
diets were very low in protein (4.2) , and the raw tuber diet especially so due to
the lower bioavailability of non-denatured protein (Evenepoel et al., 1999), I pro-
pose that the upregulation of cellular amino acid metabolism on low protein diets
reflects an increased need to synthesize certain amino acids relative to diets that
provide plenty of amino acids through catalysis of plant or animal proteins.
4.3.5. Correlation with human-specific expression patterns
I sought to investigate the correlation between expression differences in the
dataset and datasets from related studies. To do this, it was necessary to draw
parallels between this experiments’ factors and the experimental factors used in
other studies, a process generally informed by matching humans with cooking and
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increased carnivory and matching other primates with raw plant-eating (A.1). In
each case, I found a high degree of overlap among studies. I correlated expression
differences for the different factors’ candidate genes in this study with expression
differences in the three datasets described subsequently. In order to correlate
expression changes I (i) assigned the factors in our study with corresponding fac-
tors of the other experiments (A.1) and (ii) computed the percentage of genes
with the same fold change in the compared experiments. I then tested whether
the percentages of fold change agreement is significantly higher for the differen-
tially expressed genes compared to all other expressed genes using the one-sided
Fisher’s exact test with the alternative hypothesis that I find a greater proportion
of genes overlapping than expected. In the case of the primate dataset I only con-
sidered genes which showed human specific expression, i.e. a genes is consistently
either up- or down-regulated in human compared to both chimpanzee and rhesus
macaque.
Liver gene expression in mice fed human and chimpanzee diets Somel et al.
assessed the effects of typical human and chimpanzee diets on gene expression in
the mouse liver (Somel et al., 2008). I used the microarray expression data from
mouse individuals fed different diets provided by the Somel et al. study (Somel
et al. (2008), ArrayExpress accession numbers GSE6285 and GSE6297). I ex-
cluded all individuals fed the pellet diet. Using the R affy and gcrma packages
(Wu et al., 2004) I computed expression estimates for all individuals. I com-
pared the expression differences observed across diets in their experiment with
the expression differences observed in this study, matching the factors meat and
cooked to their human diets and the factors tuber and raw to their chimpanzee
diet (A.1). With regard to both food substrate and food preparation, there was
a significant correlation in expression differences between studies (4.3).
Liver gene expression in humans, chimpanzees and rhesus macaques
Blekhman et al. studied liver gene expression in multiple human, chimpanzee
and rhesus macaque individuals (Blekhman et al., 2010). I used liver RNA-Seq
data of multiple human, chimpanzee and rhesus macaque individuals provided
by the Blekhman et al. study (Arrayexpress series accession no. GSE17274). I
mapped reads to the corresponding genomes hg19, pantro2 and rhemac2 using
the TopHat splice mapper (Trapnell, Pachter and Salzberg, 2009) with standard
parameters and all mapped reads with a minimum mapping quality of 30 were
kept. I obtained expression values for each individual by running the cuﬄinks
algorithm (Trapnell et al., 2010) on all mapped reads. The required gene an-
notation was build by using the human gene annotation (version 59) and using
liftover (Hinrichs et al., 2006) in order to find orthologous regions in chimpanzee
and rhesus macaque. Only exons that could have been identified by liftover in all
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three species were used. I compared the expression differences observed across
species in their experiment with the expression differences observed in this study,
matching the factors meat and cooked to their human subjects and the factors
tuber and raw to their chimpanzee and macaque subjects (A.1). Differences in
gene expression between the humans and non-human primates in the Blekhman
et al. study (Blekhman et al., 2010) showed a significant overlap with the direc-
tion of fold-change that I observed between food substrates and food preparations
in this study. However, there was no significant overlap by food type when only
raw foods were considered or by food preparation when meat and tuber were con-
sidered individually (4.3) . This may in part be due to imperfect matching, as the
majority of primates used in the Blekhman study were consuming primate chow,
which is both cooked and incorporates a substantial amount of animal protein.
Blood gene expression of patients consuming high protein and high carbo-
hydrate diets Van Erk et al. measured blood gene expression of patients after
eating either a protein-rich breakfast or a high-carbohydrate breakfast (Erk et al.,
2006). As there was no description how the food was processed I only tested the
correlation with the food type. I used the microarray dataset measuring blood
cell gene expression provided by this study (ArrayExpress accession number E-
TABM-271). Using the R affy and gcrma packages (Wu et al., 2004) I computed
expression estimates for all individuals. I assigned the protein-rich breakfast to
the meat diet and the high-carbohydrate breakfast to the tuber diet (A.1) and
found a significant overlap in fold change direction with the genes differentially
expressed between meat and tuber (A.4).
Overlap of differentially expressed genes with genes showing human-specific
expression patterns A study by Brawand et al. (Brawand et al., 2011) re-
ported genes with species-specific expression pattern in ten mammalian genomes
and six organs including multiple primate species. I tested whether the sets of
differentially expressed genes between either meat and tuber or cooked and raw
food were significantly enriched in genes that showed human-specific expression
pattern in liver reported by Brawand et al. using a Fisher exact test and a sigif-
icance level of 0.05. I found no significant enrichment and therefore no evidence
that genes that are differentially expressed with respect to the food substrate and
its preparation still show strong human-specific expression pattern compared to
other mammalian species (A.5).
Regulation of differentially expressed genes by key transcription factors
Promoter regions of genes involved in metabolic pathways have been reported to
be targets of positive selection in humans (Haygood et al., 2007). These regions
are targeted by transcription factors that play a major role in gene expression
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Figure 4.3.: For the sets of differentially expressed genes identified for each com-
bination of treatments I calculated the proportion of genes that show
the same expression change seen in the data in Somel et al (Somel
et al., 2008) (orange) and in Blekhman et al (Blekhman et al., 2010)
(blue). I compute the odds ratio (y-axis in log scale, 95% CI; *** <
0.001, ** < 0.01) of this proportion with the proportion of overlap
for all genes that are not differentially expressed. The black squares
provide the odds ratios for all combinations of treatments. Figure
taken from Carmody et al.
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regulation. I investigated whether groups of genes that are targeted by particular
transcription factors (Wingender et al., 1996), and that are up- or down-regulated
in response to a meat diet in mice, also show the same direction of expression
difference in humans compared to other primates. Similarly, I investigated the
direction of expression change of transcription factor target genes in mice be-
tween cooked and raw diets, and identified those sets of genes for which there is
a corresponding human-specific difference to other primates.
Using a set of transcription factors and their predicted target genes (Wingender
et al., 1996) I explored whether expression changes in target genes tend to agree
more often between the mouse expression data and the Blekhman primate ex-
pression data (Blekhman et al. (2010), as before matching “meat” and “cooked”
treatments to human subjects and “tuber” and “raw” treatments to non-human
primate subjects,A.1). I tested whether the overlap is greater than expected by
chance using a Fisher exact test and comparing the overlap of target genes for par-
ticular transcription factors to the overlap for all remaining genes. I found three
transcription factors (NR1H2, NR1H3, HIF1A) whose target genes show more
overlap between the raw versus cooked meat comparison, and the human versus
non-human comparison, than expected by chance (Fisher’s exact test, NR1H2:
p = 0.043; NR1H3: p = 0.043; HIF1A: p = 0.032). Only one transcription fac-
tor shows more overlap than expected by chance for the comparison of raw and
cooked diets with tuber and meat data lumped together (ZNF219, p = 0.047).
4.3.6. Evidence for positive selection on the seqence level in
humans for differentially expressed genes
To test whether genes affected by diet may have been selected during human
evolution, I investigated whether the genes that are differentially expressed in
mice fed different diets are enriched for genes bearing putative evidence of positive
selection in the human lineage.
Positive selection on the human lineage I used the study of positive selection
using six mammalian genome provided by Kosiol et al. (Kosiol et al., 2008). I
defined all genes to be positively selected that showed a p value smaller than 0.05
in the corresponding likelihood ratio test for humans and chimpanzees. For all
sets of differentially expressed genes I computed the overlap with the positively
selected genes in both species and compared the fraction of overlapping genes to
the overlap of all remaining expressed genes using the one-sided Fisher’s exact
test with the alternative hypothesis that I find a greater proportion of genes
overlapping than expected. Using the lists of positively selected genes on the
human and chimpanzee lineages published by Kosiol et al., I find that genes
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differentially expressed in response to cooked and raw food exhibit more overlap
with regions that are putatively positively selected in the human lineage than is
expected by chance (4.4). The overlap is even more pronounced for the genes
that are differentially expressed in the comparison of cooked versus raw meat,
hinting that the evolutionary benefits of cooking may have been especially strong
where meat was concerned, whether for reasons of energy gain or food safety . By
contrast, the overlap between genes that are positively selected on the chimpanzee
lineage and those differently expressed in the mice was not significant (4.4). Sets
of differentially expressed genes for all other contrasts, including meat versus
tuber, did not show a higher overlap than expected on the human or chimpanzee
lineage.
Recent positive selection of differentially expressed genes on the human
lineage Using the high quality genomes of the Neandertal and the Denisovan
(Meyer et al., 2012; Pru¨fer et al.) it is possible to determine whether those genes
that are differentially expressed in response to diet, and which also appear to
have been selected on the human lineage, changed before or after the split from
the common ancestor with the archaic individuals (∼300,000-600,000 years) .
Pru¨efer et al. presented a set of recently selected genes that overlap with regions
showing selection on the human lineage after the split from the two archaic groups
(Pru¨fer et al.). Again, I tested if the differentially expressed genes for food type
and food preparation show an excess of overlap with these genes and I found
no higher than expected overlap using the one-sided Fisher’s exact test with the
alternative hypothesis that there is a greater proportion of genes overlapping
than expected (4.4). In a second approach I used the positively selected genes
from Kosiol et al. that overlap with genes differentially expressed between (a)
the raw and the cooked diet and (b) the raw and the cooked meat diet and
tested whether human-specific non-synonymous mutations with high frequency
(frequency greater than 90%) in modern human populations pre- or postdate the
split from Neandertals and Denisovans. I found 25008 such mutations and all
of those happened before the split. Given the 3.3% for all genes in the human
genome, this is fewer, but not statistically significant. Both analyses indicate
that if cooking-related genes have been selected on the human lineage, this likely
happened before the split between modern humans and the common ancestor of
Neandertals and Denisovans.
Positively selected promoter regions of genes differentially expressed Hay-
good et al. reported that genes whose promoter regions have been under positive
selection on the human lineage functionally clustered in nutrition-related genes
(Haygood et al., 2007). I tested whether genes differentially expressed on the diets
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Figure 4.4.: (a) Schematic tree of the phylogeny of chimpanzees, modern human,
Neandertal and Denisovan. For ease of referral to specific lineages,
the chimpanzee lineage is shaded brown, the human lineage since the
split from the common ancestor with chimpanzees is red, and the
modern human lineage since the common ancestor with archaic hu-
mans is yellow. (b) Enrichment of differentially expressed genes for
each of the treatments within sets of genes for which there is evidence
of positive selection on the human lineage since the split from chim-
panzee (Kosiol et al., 2008) and the split from Neandertal-Denisovan
(Pru¨fer et al.), and on the chimpanzee lineage (Kosiol et al., 2008).
I identify the proportion of differentially expressed genes that over-
lap with the positively selected genes, and compute the odds ratio
(y-axis in log scale, 95% CI; *** < 0.001, ** < 0.01) and compared
this proportion to the proportion of differentially expressed genes
that overlap the selected genes and are not differentially expressed.
Figure taken from Carmody et al.
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in this experiment show a greater than expected overlap with the set of nutrition-
related genes whose promoter regions have been reported to be positively selected
using the one-sided Fisher’s exact test with the alternative hypothesis that I find
a greater proportion of genes overlapping than expected. I found enrichment for
neither food type nor food preparation (A.6).
Differentially expressed genes pseudogenized on the human lineage I next
sought to investigate whether differentially expressed genes might have lost their
function on the human lineage, since cooking may have reduced or removed the
need for their activity. I found a few candidate genes described as pseudogenised
on the human lineage that overlap with the lists of differentially expressed genes.
First, I found the set of major urinary protein (Mup) genes. In mouse the Mup set
consists of more than 20 functional genes and approximately the same number of
pseudogenes, while in humans only a single pseudogene is present, making humans
the only placental mammal without a functional Mup gene (Logan, Marton and
Stowers, 2008). I found specific expression for all copies in mouse that show a
consistently lower expression in the raw tuber diet. Other reported pseudogenes
that lost their function on the human lineage are the synthesizing enzyme, CMP-
sialic acid hydroxylase (Cmah) (Chou et al., 1998). Also this gene shows a lower
expression level for mice fed a raw tuber diet and differentially expressed between
food preparation in tuber. A whole group of genes that has been reported to be
affected by members turning into pseudogenes is the Cytochrome P450 gene group
(Nelson et al., 2004). I found differentially expressed Cytochrome P450 genes to
be enriched in the KEGG pathway analysis for the factors food type, food type
raw, food type cooked and food preparation in tuber.
4.4. Discussion
Differential Expression In this chapter, I have characterized the effect of dif-
ferent food substrates and different ways of preparing the food on liver gene
expression in mice using high throughput sequencing. Multiple mice per group
4.1 (a) have been fed either meat or tuber which was served either raw or cooked.
An additional factor was introduced in the experiment by feeding a subset of the
mice eating cooked food a calorie-restricted diet to match the calorie content of
the raw diet to investigate the effect of the energy gain as well in this experi-
ment. I found that the difference in food type and food preparation each had
a significant effect on gene expression in mice. The amount of calories did not
show a signal of differential expression (4.1 (b)). The amount of differentially
expressed genes (FDR < 0.05) between the different food types (2946) was con-
sideably larger than between food preparations (123), indicating a larger effect
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of different food types on genes expression than their way of preparation. Both
factors have been hypothesized to play a major role in the metabolism (Hatley
and Kappelman, 1980; Laden and Wrangham, 2005; Lucas, 2004; Milton, 1999;
Ragir, 2000; Stanford and Bunn, 1999; Wrangham et al., 1999, 2009; Wrangham
and Conklin-Brittain, 2003) and I showed that indeed both, the food sbstrate
as well as the preparation introduce expression changes. Surprisingly, the differ-
ence in calorie consumption did not yield in differential expression (4.1 (b)), as
also hypothesized by other studies (Koza et al., 2006). A former experiment by
Somel et al. (Somel et al., 2008) showed that human and chimpanzee diets differ
substantially in their effect on liver gene expression in mice. However, Somel
et al. were not able to assess which factor(s) different between the human and
chimpanzee diets was/were driving the differential expression. Using our the ex-
periment design I was able to address the question which factors contribute to
the differential expression.
Functional enrichment of differentially expressed genes I tested whether dif-
ferentially expressed genes between food types and food preparations were en-
riched in particular biological pathways in the gene ontology (Ashburner et al.,
2000) and KEGG pathway database (Kanehisa, 2004). I found that the ma-
jority of enriched categories and pathways were related to metabolic functions,
which indicate that different metabolic mechanisms are responsible for digest-
ing the different food types and differently processed food (4.1 (d,e)). When
testing particular high-level gene ontology categories (4.2), I found that a priori
expectations were largly conformed. For example I found that genes related to
carbohydrate metabolic processes were higher expressed in the tuber diets, which
can be explained by a higher carbohydrate content in that food type compared
to meat (4.2). Genes in this category were also higher expressed in the raw tu-
ber diet compared to the cooked tuber diet, which potentially reflects the higher
investment to digest raw tubers (4.2). Also for the meat I found that genes in
categories related to protein and lipid metabolism showed increased expression
levels in the meat diet compared to the tuber diet and higher expression levels
in genes related to lipid metabolism in raw meat compared to cooked meat (4.2).
These finding indicate that the higher protein and fat content in meat diets and
the slighly higher lipid content in the raw meat compared to the cooked meat lead
to the expected reaction of the metabolism, i.e. higher expression of genes for
diets with increased lipid and protein content. Interestingly, genes differentially
expressed between the raw and cooked food, particularly between raw and cooked
meat and differentially expressed genes between the raw and cooked food types
showed an additional enrichment for immune-related functions, among other cat-
egories (4.1 (d,e)). Immune genes in the raw meat diet had a significantly higher
expression which indicated an immune-response. The source for that response is
not entirely clear but could for example be caused by microbial contamination of
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the raw meat or a response to raw foreign protein among other unknown reasons.
The enrichment results in this study show to my knowledge the first time that
cooking changes both, the metabolic mechnisms when processing the food and
decreases immunological activities in the body by either removing pathogens or
decreasing unknown defense meachnisms while thermally processing the food.
Correlation with human-specific expression patterns The study used a mouse
model to investigate the effect of different food substrates and food preparations
on gene expression. One of the major goals of the study was to map the ob-
served expression differences in this controlled experiment to differences between
humans and other primates to help understanding human evolution with respect
to their unique diets, which includes a higher meat consumption than other close
living relatives and the thermal processing of their food. First, I used the data
provided by Somel et al (Somel et al., 2008) who fed mice human and chim-
panzee diets and measured the effect of liver gene expression. Experimental
factors in study (meat and tuber; cooked and raw) had to be assigned to the
human and chimpanzee diets used in the Somel et al. study. Based on the
present-day human diets I assigned meat and cooked food substrates to the hu-
man diet and tuber and raw food to the chimpanzee diet (A.1). I found that
differential expression between both, food substrates and food preparations were
highly correlated with expression differences between the mice fed a human and
chimpanzee diet (4.3). The high correlation between expression differences in
this experiment and the study by Somel at al. indicates that both experiments
capture the effects of different diets on liver gene expression in mice and that
I was able to assign expression differences to food substrate and food prepara-
tion, which was not possible with the experiment design used by Somel at al.
(Somel et al., 2008). Somel et al. reported that differentially expressed genes
between the human and the chimpanzee diets significantly overlap with genes
that were differentially expressed between humans and other primates (Somel
et al., 2008). However the direction of expression change in their experiment did
not correlate with the expression changes observed between humans and other
primates (Somel et al., 2008). A later study by Weng et al. (Weng et al., 2012)
that used the data provided by Somel et al. correlated the expression differ-
ences between the human and the chimpanzee diets with expression differences
between humans and chimpanzees/macaques (Blekhman et al., 2010) and found
that not only differentially expressed genes overlap between the mouse experi-
ments and humans and other primates but also direction of expression changes
were significantly correlated (Weng et al., 2012). I correlated expression changes
between food substrates and food preparations with expression differences be-
tween humans and other primates (Blekhman et al., 2010) and found that the
difference between both, food substrates and food preparations correlate signif-
icantly with expression changes between humans and other primates (4.3, A.1).
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Also expression changes between cooked food substrates correlate significantly
with human-specific expression changes 4.3 while the correlation between raw
food substrates did not correlate with human-specific expression 4.3. The pri-
mates used in the Blekhman et al. study were feed partially cooked food which
might explain this finding. Expression changes between the raw and cooked tu-
ber and meat diets did not correlate significantly with human-specific expression
differences 4.3. The result is not entirely surprising as the food substrates used
in the experiment (beef and sweet potato) might not be optimal to compare ex-
pression changes as they are under-represented in the non-human primate diet.
I found that expression changes between food types were also highly correlated
with expression changes of patients eating high corbohydrate and high protein
diets (Erk et al. (2006),A.4,A.1). Gene expression differences in the study by van
Erk et al. were measured in blood which shows that even in other tissues sim-
ilar expression changes are triggered by different diets. Differentially expressed
genes between food substrate and food preparation were not enriched in the list
of significant expression differences in liver on the human lineage (Brawand et al.
(2011),A.5). This result indicates that the diet and cooking are not the key
components that drive expression differences in modern humans in liver.
Regulation of differentially expressed genes I investigated whether expression
differences between the food types and the food preparations that are correlated
with human-specific expression changes are driven by specific transcription fac-
tors. I found four transcription factors (NR1H2, NR1H3, HIF1A, ZNF219) for
which target genes show a significantly increased overlap of expression changes
between raw and cooked diets and human-specific expression. Target genes for
one transcription factor (ZNF219) showed a stronger overlap between raw and
cooked food and human-specific expression while the three other transcription
factors targeted genes that showed significantly more often the same expression
changes between the raw and cooked meat and human-specific expression. These
results show that especially expression differences between raw and cooked food
might be driven by regulation via specific transcription factors. Weng eta al.
(Weng et al., 2012) reported that target genes of the transcription factor EGR1
were more often differentially expressed between the human and chimpanzee diet
the mice were fed in the Somel at al. experiment (Somel et al., 2008). I did not
find an enrichment of differentially expressed genes between food substrates or
food preparations for this transcription factor. I also did not find a significant
overlap between expression changes in different food types and food prepara-
tions with human-sepcific expression for EGR1. The lack of evidence that this
transcription is responsible for expression changes between food types or food
preparations indicates that the experiment does not capture all factors that drive
differential expression between human and chimpanzee diets.
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Evidence for selective pressures on differentially expressed genes I tested
whether differentially expressed genes between food substrates and food prepara-
tions in the mouse experiment show evidence for selection on the sequence level
in humans. I show that differentially expressed genes between raw and cooked
food - and even more pronounced between raw and cooked meat - are enriched
in the set of positively selected genes (Kosiol et al., 2008) in humans since their
split from chimpanzees (4.4). Using the high-voverage genomes of two archaic
humans - the Denisovan and Neandertal (Meyer et al., 2012; Pru¨fer et al.), I also
show that the selection events likely happened before the split from these archaic
humans (4.4). Differentially expressed genes between the raw and the cooked
food that showed enrichment in the set of positively selected genes (Kosiol et al.,
2008) did not show an enrichment in a set of recently positively selected genes
(Pru¨fer et al.,4.4). Also non-synonymous single nucleotide changes in these genes
that are present at high frequency in modern humans were shared with the two
archaic humans, which indicated that the changes happended before the split.
The results are consistent with the fact that for example Neandertals used fire
and cooked food (Henry, Brooks and Piperno, 2011), and therefore selection with
respect to the food preparation must have happened further back in time. I also
sought to investigate whether the regulatory units of genes that show differential
expression in the mouse experiment might have been under selection pressure.
Haygood et al. reported that genes which showed evidence for positive selection
in their promoter regions in humans were enriched for functions related to nu-
trition (Haygood et al., 2007). I tested for enrichment of differentially expressed
genes between food types and food preparations in the set of genes with signifi-
cantly selected promoter regions and found no significant overlap (A.6). I found
that genes that showed adaptation with respect to the diet rather changed their
protein coding sequence than their promoter regions. I also found several families
genes which show differential expression between food tyes and food preparations
that have been pseudogenized on the human lineage (Cmah, Mup, Cytochrome
P450) which might lost their function due to adaptation to different diets.
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5. MicroRNA expression and
annotation in primates
5.1. Motivation and Introduction
MicroRNAs (miRNAs) are small RNA molecules of around 22 nucleotides that
regulate gene expression posttranscriptionally via messenger RNA (mRNA)
destabilization or translational repression (Friedman et al., 2009; Lee, Feinbaum
and Ambros, 1993; Lim et al., 2005; Wightman, Ha and Ruvkun, 1993). MiRNAs
are characterized by high sequence conservation across highly divergent species
(Chen and Rajewsky, 2007; Hertel et al., 2006; Pasquinelli et al., 2000; Stark
et al., 2007), which reflects the effects of purifying selection due to their evolu-
tionary importance as regulatory molecules. While the majority of efforts have
focused on the annotation of protein-coding genes, the discovery of large-scale
transcription outside of protein-coding genes (Altuvia et al., 2005; Ohler et al.,
2004) has led to the identification of a great diversity of non-protein-coding RNA
genes (Hertel et al., 2006). Among these are the miRNAs. The official repos-
itory of miRNAs miRBase (v.19) (Brameier and Wiuf, 2007; Yue, Sheng and
Orwig, 2008) contained 1,424 human miRNAs, whereas fewer miRNAs were an-
notated in other primate genomes (chimpanzee: 600; bonobo: 88; gorilla: 85;
orangutan: 581; rhesus macaque: 479), a fact that is explained by the larger
number of human studies. MiRNAs have been annotated in humans using a mix-
ture of bioinformatics prediction and cDNA sequencing (Baev, Daskalova and
Minkov, 2009a). The identification of miRNAs in non-human primates has made
use of a number of comparative methodologies such as sequence homology be-
tween closely related organisms (Altschul et al., 1990; Griffiths-Jones et al., 2006;
Hofacker, 2003; Raaum et al., 2005), the genomic search for RNA secondary
structure patterns characteristic of miRNAs (Gusfield, 1997) and by direct se-
quencing of small RNA libraries (Nahvi, Shoemaker and Green, 2009; Saunders,
Liang and Li, 2007)). However, direct characterization of small RNA libraries by
high throughput sequencing has been performed for a limited number of tissues
in only chimpanzees and rhesus macaques (Nahvi, Shoemaker and Green, 2009;
Saunders, Liang and Li, 2007). As a result the majority of non-human primate
miRNAs in miRBase have no evidence for their expression and their existence
is only supported by computational prediction. Expression profiling of miRNAs
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has been performed using cloning and Sanger sequencing (Landgraf et al., 2007a),
microarrays (Lim et al., 2005), and, most recently, by direct high-throughput se-
quencing (Creighton, Reid and Gunaratne, 2009). High-throughput sequencing
technologies have facilitated both the identification and the large-scale expres-
sion profiling of miRNAs in different tissues and cells. MiRNA profiling was also
used to study expression across various developmental stages (Somel et al., 2010,
2011) and in comparison between healthy and diseased tissue (Erson and Petty,
2008). The destabilization of target mRNAs is the predominant mechanism of
expression regulation by miRNAs (Guo et al., 2010). It is therefore possible to
assess the extent to which miRNAs shape gene expression by quantifying both
miRNA and mRNA expression in the same samples. The correlation between the
expression of single miRNAs and their target genes has previously been studied
in cell culture by knocking out/down endogenously expressed miRNAs or by in-
troducing miRNAs into a specific target cell (Baek et al., 2008; Guo et al., 2010;
Selbach et al., 2008). Genome-wide patterns of correlation between expression of
miRNAs and their target genes in multiple tissues have been less widely explored.
In primates, the main focus has been on discovery and annotation of miRNAs
(Baev, Daskalova and Minkov, 2009b; Berezikov, Cuppen and Plasterk, 2006;
Berezikov et al., 2005, 2006b; Brameier, 2010; Kawaji et al., 2008; Yue, Sheng
and Orwig, 2008), but much less is known about expression variation within and
between species, and how these patterns vary in different cell types and tissues.
Three studies have correlated the expression of miRNA, mRNA, and proteins in
prefrontal cortex comparing humans and rhesus macaques (Somel et al., 2010,
2011) and between humans, chimpanzees, and rhesus macaques (Hu et al., 2011;
Somel et al., 2011). These studies showed that miRNAs play a role in primate
development and aging (Somel et al., 2010, 2011) and that miRNAs with human-
specific expression patterns target genes involved in neuronal functions (Hu et al.,
2011). However, an understanding of the evolution of gene expression regulation
in primates across multiple tissues has not yet emerged. This is of particular
interest given that it has been hypothesized that the phenotypic differences be-
tween species may be better explained by changes in gene expression than by
changes in DNA sequence (King and Wilson, 1975). Studies exploring differences
in gene expression in multiple primate tissues have yielded lists of genes, which
are differentially expressed in closely related species (Khaitovich et al., 2005),
but it is less clear which regulatory changes drive these differences. In this chap-
ter I used a primate miRNA dataset to ascertain expression differences between
miRNAs, their regulatary role and annotate new miRNAs.
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5.2. Data
MiRNAs have characterized from multiple individuals in five primate species
(humans, chimpanzees, gorillas, oranutans and rhesus macaques) for five differ-
ent tissues (brain, heart, kidney, liver, and testis) in humans, chimpanzees and
rhesus macaques and two tissues (brain and liver) for gorillas and oranutans by
Illumina sequencing (Table 5.1). For the expression comparison, I analyzed only
the human, chimpanzee and rhesus macaque samples. For the annotation of new
miRNAs all species were included.
Human Chimpanzee Rhesus
macaque
Gorilla Orangutan
Brain 5 5 5 2 2
Heart 5 5 5 - -
Kidney 5 4 5 - -
Liver 5 5 5 2 2
Testis 5 5 4 2 2
Table 5.1.: Individuals sequenced for each species and tissue.
5.3. Results
5.3.1. Expression
I quantified expression of previously annotated miRNAs from miRBase (Griffiths-
Jones et al. (2008), www.mirbase.org, release 15) for human, chimpanzee, and
rhesus macaque. I mapped the sequenced reads to the official miRNA repository
and the corresponding species’ annotated miRNAs using PatMaN (Pru¨fer et al.,
2008) allowing zero mismatches. Only reads with a length greater than 18 nt were
used. The mature sequences were used as reference sequences for each miRNA.
If a read was a substring of a miRNA sequence or vice versa, this read was
assigned to this miRNA. If a read mapped to multiple miRNA sequences, the
counts of this read were equally distributed to all matched miRNAs. To classify
reads that did not map to miRNAs in miRBase, I mapped the remaining reads
to multiple databases in order to distinguish alternative read sources. I used the
gene database provided by Biomart (ensembl.org/biomart) using all ENSEMBL
genes (version 59) with their untranscripted sequence for human. To identify
different structural RNAs, I used sequence annotation from UCSC of RNA genes
based on the NCBI 36.1 (hg18) human reference genome. I obtained the sequences
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of piwiRNAs (piRNAs) for human from RNAdb (http://jsm-research.imb.
uq.edu.au/rnadb/). Sequences not mapping to any of these databases were
aligned to the corresponding species genomes (hg19, panTro2, rheMac2). The
reads were distributed to the different categories in the following hierarchical
order: miRNA, piRNA, rnaGenes, genes, unknown but mapped to the genome
and not mapped to the genome. The majority of reads matched known miRNAs
(median 59%). However, testis yielded a consistently smaller fraction of matches
for all species (median 9%). A considerable proportion of reads in testis were
assigned to piRNAs, which are a different class of small RNAs that are mainly
found expressed in the germ line (Aravin, Hannon and Brennecke, 2007; Girard
et al., 2006) (Figure 5.1 a and b) but also play a role in the central nervous
system (Lee et al., 2011). Indeed, I found in all brain samples of human a small
fraction, that I was able to map to piRNAs. The fraction was bigger than for all
other tissues except testis. An excess of 5’ uridine (U) residues is a signature of
the piRNA family (Malone and Hannon, 2009). This 5’ uridine (U) enrichment
in piRNAs is clearly visible in testis-derived molecules (55% U in first position)
compared with molecules from other tissues (Figure 5.2).
In addition, I found that in testis a higher fraction of reads failed to be assigned
to small RNAs, structural RNAs, or mRNAs. However, these reads could be
mapped to the respective genome and showed an even higher fraction of uridine
in the first position than observed for the reads mapping to annotated piRNAs
suggesting that they represent unannotated piRNAs (Table A.7). I could not find
these pattern in brain. Combining the data of all five tissues, I identified 585 of
the 718 (81%) known miRNAs in human, 431 of the 530 (81%) known miRNAs in
chimpanzee, and 399 of the 502 (79%) known miRNAs in rhesus macaque (table
1). Although the number of different miRNAs detected is similar between tissues,
brain and testis showed consistently more expressed miRNAs than other tissues
(5.1). The majority of expressed miRNA in the three species were expressed in
all five tissues (368 out of 585 in human, 258 out of 431 and 270 out of 399 in
rhesus macaque, Figure 5.3).
5.3.2. Differential expression between species and between
tissues
For the analyses presented in this chapter, I used only the set of all miRBase-
annotated miRNAs detected in our sequencing data. For the between-species
comparisons, I used miRNAs expressed in all three species and for the between-
tissues comparisons, I used miRNAs expressed in all compared tissues in a given
species. I defined a miRNA as expressed if more than one transcript was se-
quenced in one species and one tissue. The fraction of variance explained by
tissues and species was calculated by computing the fractions of sum of squares
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Figure 5.1.: Small RNA libraries composition and variance distribution for
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ple of human brain and human testis, respectively. (c) Percentage of
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and their interaction. (d) Percentage of miRNA expression variance
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Figure 5.3.: Expression of miRNAs shared between tissues in human.
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explained by the factor tissue and the factor species in a linear model. I found an
approximately six times higher divergence in expression between tissues than be-
tween species. Divergence between tissues explained 65% of the miRNA expres-
sion variance, whereas differences between species explained around 11% (Fig-
ure 5.1 c). Expression differences in brain explained the highest fraction of the
tissue variance (41%) followed by differences in heart (20%), liver (16%), kidney
(14%,) and testis (9%) (Figure 5.1 d).
I compared expression levels between species and tissues using the R package
DESeq (Anders and Huber, 2010). To determine the effect of species and tissues
in our data set, I used the set of miRNAs with at least ten transcripts in each
species for the analyzed tissue. Additionally, only miRNAs annotated in all three
species were included. I compared the number of miRNAs with a significant
expression difference between any two species (Figure 5.4). When comparing
the fraction of miRNAs with significant difference in expression, I found that
brain and heart show consistently fewer differences between species than other
tissues. Between humans and chimpanzees, 4% of all detected miRNAs differ
significantly in expression in brain and 11% in heart. In contrast, liver and testis
had the most differentially expressed miRNAs (52% for both tissues). When
comparing the fractions of differentially expressed miRNAs between 1) human
and rhesus macaque and 2) chimpanzee and rhesus macaque, I found a signifi-
cant difference between the two proportions for testis (45% and 25% for human-
macaque and chimpanzee-macaque, respectively; P = 0.006, Fisher’s exact test)
but no other tissue (P > 0.05). When I summed the number of differently ex-
pressed miRNAs over all three pairwise species comparisons, I observed a higher
number of differently expressed miRNAs between human-macaque and between
chimpanzee-macaque as compared with human-chimpanzee. The same pattern
was consistently observed in all individual tissue comparisons except in testis,
which departed significantly from this trend. In testis, 38 miRNAs showed dif-
ferent expression between human and chimpanzee, 39 between chimpanzee and
macaque, and 74 between human and macaque.
Interestingly, miRNAs with expression differences between tissues show often
tissue-specific patterns, that is, these miRNAs differ in expression in only one
tissue while expression is unchanged in the other four tissues. In humans, 50% of
these tissue-specific differentially expressed miRNAs were found in brain (chim-
panzee 73%, rhesus macaque 43%). In total, I found that nine of the ten miR-
NAs with a consistent tissue-specific expression in all three species were brain
specific.
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(2012b)
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5.3.3. MiRNA Expression and Sequence Evolution
To calculate the correlation between miRNA expression and sequence evolution,
I used two measures: sequence conservation among vertebrates and sequence
variation within humans. I found positive Spearman correlations between average
miRNA hairpin conservation score and miRNA expression for all species and
tissues (Figure 5.5).
All but one (chimpanzee testis) were statistically significant (alpha = 0.05,
TableA.10). Conversely, I found negative Spearman correlations between the
miRNA hairpin SNP number and miRNA expression though only in brain was
the correlation statistically significant (Figure 5.5).
5.3.4. Regulation of mRNA levels
To evaluate the effect of miRNA expression on the transcriptome, I used mRNA
sequence tags quantified using sequencing using the Illumina NG III Digital Gene
Expression approach (Kircher, 2011; Velculescu et al., 1995). Of the 73 samples,
64 were common to both the mRNA and the miRNA studies (supplementary table
S2, Supplementary Material online). mRNA targets of our expressed miRNAs
were identified using TargetScanS (Lewis et al., 2003). As for miRNAs I used only
expressed genes. A gene was considered to be expressed as defined in Kircher et
al. (2011), that is, all used samples had to have of at least three mapped reads.
To determine the functional relationship between miRNAs and their predicted
target genes, I correlated the expression values of miRNAs and genes. For each
miRNA-mRNA target pair, I required that both the miRNA and the mRNA
were expressed in all species or tissues. I then carried out two tests to determine
the level of correlation at different levels of granularity. Each test calculates the
Pearson correlation coefficient (r) for each pair. Significance levels for the fol-
lowing tests were computed by calculating a random distribution and comparing
the observed values to this distribution. The random distribution is computed
by randomly assigning expressed miRNAs to expressed genes from the prediction
list. Each miRNA and gene had the same chance of assignment. For the cor-
relation between tissues dependent on the number of binding sites for expressed
miRNAs, we randomly permuted the number of binding sites between the miRNA
and the mRNA pairs. The random assignments were performed 1,000 times.
For the first test, I correlated miRNA and mRNA expression between tissues
in each species. I averaged the miRNA and mRNA expression values over all
individuals per tissue and species. I then calculated the Pearson correlation
coefficient between miRNA expression and mRNA expression levels for the five
tissues. The fraction of negative correlations observed was not different from the
46
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l l l
l
l
ll
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
ll l
l
ll
l
l l
l
l
ll
l
l
l
l
l l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
lll
l
l
l
l
0.0 0.2 0.4 0.6 0.8 1.0
0
2
4
6
8
10
12
14
conservation
m
iR
N
A 
ex
pr
es
sio
n
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll l
l l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
0 1 2 3 4
0
2
4
6
8
10
12
14
#SNPs in miRNA hairpin
m
iR
N
A 
ex
pr
es
sio
n
Figure 5.5.: Correlation between human brain miRNA expression and (i) hair-
pin conservation among vertebrates (upper panel) and (ii) variation
across humans (lower panel). The x-axes show the average conserva-
tion (i) and number of SNP (ii) for miRNA hairpin sequences. Figure
taken from Dannemann et al. (2012b)
47
fraction obtained by randomly assigning miRNAs and mRNAs. When comparing
genes with one miRNA binding site to genes with more than one miRNA binding
site, I found a significant signal in all species (to obtain significance, I randomly
permuted the number of binding sites in genes, Phu < 0.01, Pch < 0.01, Prh <
0.01; 5.6). However, when I restricted the analysis to genes with only one miRNA-
binding site, I found that the fraction of negative correlations was significantly
higher than by randomly assigning miRNAs and mRNAs in human but none of
the other species (Phu = 0.02, Pch = 0.26, Prh = 0.65).
For the second test, I sought to test the correlation of miRNA to target mRNA
between species. For each tissue and miRNA-mRNA pair, I arrived at three data-
points that are used as input for the individual correlations. The correlations were
calculated for each pair, and the resulting fraction of negative correlations was
tested against random target assignments. I also tested the fraction of negative
correlations dependent on the number of miRNA-binding sites in the genes. None
of the tissues gave a significant excess of negative correlations, and the amount
of negative correlation was not different from the amount obtained from random
assignments of genes to miRNAs (all P values > 0.05). The excess of negative
correlation also did not differ depending on the number of miRNA-binding sites
in the genes.
It has been proposed that miRNAs exert their effect by setting the mean and
reducing the variance of the genes that they regulate, and in this way, they
stabilize phenotypes a process called canalization (Wu, Shen and Tang, 2009).
These results are consistent with miRNAs setting the mean expression of the
genes they regulate. For technical reasons, I am not able to test where there
is also a reduction in the variance of mRNA expression. I found a correlation
between the mean expression level of the genes and the relative variance to the
mean in the mRNA data set, that is, miRNAs tend to target highly expressed
genes, and these genes also show a higher variance due to the fact that their
expression level and their variance are not independent. Unfortunately, I found
no general normalization that eliminated the correlation between the variance
estimate and the expression of a given gene.
5.3.5. Functional enrichments of targeted genes
I tested for functional enrichment of target genes in two of the GO (Ashburner
et al., 2000) domains (molecular function and biological process) using FUNC
(Pru¨fer et al., 2007). The multitissue/species comparisons allow to distinguish
two groups of differentially expressed miRNAs. The first group is the tissue-
specific miRNAs, which were identified in the within-species comparisons (a total
of 15 pairwise tests: 3 species × 5 tissues). For a given species, I required that
all miRNAs were expressed in all five tissues and filtered for miRNAs that were
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Figure 5.6.: Relation amid the fraction of negative correlations between the ex-
pression of miRNA–mRNA pairs (in the between-tissue correlation)
and the number of miRNA-binding sites in 3’ UTRs of genes for hu-
man (a), chimpanzee (b), and rhesus macaque (c). The black points
and lines show the observed fraction of negative correlations. The
green-shaded area shows the 95% confidence intervals (CIs) obtained
by randomly permuting miRNA-binding sites across genes. Fraction
of negative correlations between the expression of miRNA–mRNA
pairs (in the between-tissue correlation) for genes with only one
3’ UTR miRNA-binding site in human, chimpanzee, and rhesus
macaque. (d) The red points show the observed fraction of nega-
tive correlations and in black the 95% CIs obtained by randomly
assigning miRNAs and mRNAs from the original miRNA–mRNA
set. Figure taken from Dannemann et al. (2012b)
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differentially expressed in one tissue compared with all others. The second group
is the species-specific miRNAs, which were identified in the between-species com-
parisons (a total of 15 pairwise tests: 3 pairwise species comparisons × 5 tissues).
For a given tissue, I required all miRNAs to be expressed in all species and filtered
for those miRNAs that are differentially expressed in a species comparison.
I found 93 GO categories to be significantly enriched in at least one test for tissue-
specific miRNA targets and 103 categories in at least one test for species-specific
miRNA targets. The significantly enriched categories overlapped substantially
(62 categories) between the species- and the tissue-specific tests. I identified
several highly connected clusters in the directed acyclic graph representation
of the GO, which were related to development, cell communication, gene and
transcript expression, cell movement, regulation of metabolic, and biosynthetic
processes and DNA/protein/transcription binding (Figure 5.7).
I found that transcription factor-binding categories were significantly enriched in
23 of the total 30 GO tests performed. The signal was even more pronounced
in the species-specific tests, where 13 of 15 tests were significant. Additionally,
all tissue-specific tests in human were significant. In categories related to devel-
opment, most of the significant enrichments were found in brain for both tissue-
specific tests (16 of 25 significant tests in these categories were brain specific)
and species-specific comparisons (15 of 21 significant tests in these categories
were brain specific). Another cluster that showed enrichment for brain-related
categories was cell communication in the species-specific test (of 22 significant
tests, 13 were brain specific and 8 were testis specific). Additionally, I found that
categories related to regulation of metabolic and biosynthetic processes (a total
of 101 significant tests) were preferentially enriched in kidney (35) and liver (32)
compared with brain (8), heart (6), and testis (10).
5.3.6. Annotation of new miRNAs
While human miRNAs are intensively studies and highly annotated, other pri-
mate species lack that efford of annotation (Figure 5.8).
I used the primate miRNA data to identify miRNAs independently of their
miRBase annotation and applied the miRDeep and miRDeep2 algorithms
(Friedla¨nder et al., 2011, 2008). For a first approach I used the original miRD-
eep algorithm (Friedla¨nder et al., 2008) to indentify novel miRNAs in human,
chimapzee and rhesus macaque. miRDeep takes as input the position and fre-
quency of reads aligned to the genome (“signature”) with respect to a putative
RNA hairpin and scores the miRNA candidate employing a probabilistic model
based on miRNA biogenesis. The algorithm provides a combined score indicating
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mann et al. (2012b)
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the reliability of the prediction. The score produced by miRDeep takes into ac-
count the energetic stability of the putative hairpin and the compatibility of the
observed read distribution with miRNA cleavage. The more positive the score
the more reliable the prediction. To reduce the false positive prediction rate, I
applied a score cutoff of zero. That is, I required a higher likelihood for a true
miRNA than random background. This resulted in the prediction of 649 miR-
NAs in human (2,993 total predictions, 331 known), 377 (3,063 total, 239 known)
in chimpanzee, and 859 (3,538 total, 249 known) in rhesus macaque. Of these,
17 miRNAs were located in orthologous genomic regions in all three species and
had a positive miRDeep score. One miRNA was predicted to be functional for
both strands of the mature/star duplex in human. Seven miRNAs were inde-
pendently described by others and were added to miRBase during the abalysis
of this dataset (Berezikov et al., 2006a; Creighton et al., 2010; Goff et al., 2009;
Jima et al., 2010; Liao et al., 2010; Persson et al., 2011; Schotte et al., 2011;
Stark et al., 2010). Twelve of the newly predicted miRNA candidates were tissue
specific and eight of them were brain specific (Figure 5.9, Table A.8).
In a second approach I took advantage of the publication of an improved miRDeep
algorithm, called miRDeep2 (Friedla¨nder et al., 2011). Analogously to the first
version, miRDeep2 computes a combined score, which is similar to the one from
miRDeep. Additionally, miRDeep2 calculates false-positive rates by running the
algorithm on a set of “signatures” and secondary structures that are paired by
random permutation. Using predictions with a positive score and a significant
folding p-value I identified from our sequences 47 (22 with expression evidence for
star sequence) new miRNAs in chimpanzee, 240 (166 with expression evidence
for star sequence) in gorilla, 55 (13 with expression evidence for star sequence)
in orangutan and 47 (24 with expression evidence for star sequence) in rhesus
macaque. miRDeep2 was able to predict 338 (64% of all annotated) known
miRNAs (312 with a positive score) in chimpanzee, 75 (94% of all annotated, 73
with a positive score) in gorilla, 364 (61% of all annotated, 325 with a positive
score) in orangutan and 348 (71% of all annotated, 312 with a positive score) in
rhesus macaque 5.10. miRDeep2 performance statistics were similar to the ones
reported in other species (Friedla¨nder et al., 2011) (Figure 5.10, Table A.9).
I tested the newly predicted miRNAs for tissue specificty. MiRNAs were defined
to be tissue specific when less than 5% of reads map to each of the other tissues.
This means that at least 80% of the perfectly aligned reads in chimpanzee and
rhesus macaque (where I have reads from 4 tissues), and 95% of the perfectly
aligned reads in gorilla and orangutan (where I have reads from 2 tissues) that
were used for the prediction of the miRNA came from one tissue. I was able
to identify 11 tissue-specific miRNAs in chimpanzee (7 in brain, 1 in heart, 2 in
kidney, 1 in testis), 110 in gorilla (100 in brain, 10 in liver), 28 in orangutan (25
in brain, 3 in liver) and 21 in rhesus macaque (11 in brain, 10 in testis). To iden-
tify miRNAs which are shared between all the primates studied here I examined
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Figure 5.9.: Read distribution of newly predicted miRNAs. Different colors indi-
cate samples from different tissues. Figure taken from Dannemann
et al. (2012b)
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miRNAs that are encoded in orthologous locations in all four primate species and
in human. I identified orthologous regions starting from human hg19-based miR-
Base (version 17) hairpin locations (Griffiths-Jones et al., 2008; Kozomara and
Griffiths-Jones, 2011). The genome coordinates were transferred to hg18 coordi-
nates using liftOver (Hinrichs et al., 2006) with the 95% identity cutoff. Human
mature sequences from miRBase were aligned to the human genome (hg18) and
their corresponding hairpin sequences were assigned by overlapping genome co-
ordinates using intersectBed from Bedtools (Quinlan and Hall, 2010). All other
primate miRNA mature sequences (known and predicted) were aligned against
the corresponding genome and their genome locations were transferred to hg18
coordinates. The mature miRNA sequences found in the other primates that over-
lapped with human coordinates were defined as orthologous. The corresponding
primate hairpin sequence was obtained by transferring the human genome hair-
pin coordinates to the corresponding primate genome. I excluded regions where
liftOver was unable to identify an orthologous region.For the miRNAs present in
miRBase (version 17). I found 60 miRNAs that are located in orthologous regions
in human and the four non-human primate species. When I included the set of
miRNAs predicted in this study the number increased to 175 miRNAs. This
set of miRNAs can be considered prediction of high confidence since they were
known in human and either known or predicted by us in all other four primate
species.
5.3.6.1. Sequence similarity between species for newly predicted miRNAs
One important aspect to study evolutionary pattern is to look at sequence differ-
ences. Sequence identity of miRNAs (mature/hairpin) in orthologous regions was
computed using the multiple sequence alignment tool MUSCLE (Edgar, 2004)
and the identity function of the R package bio3d (Grant et al., 2006). All 60 of
the known miRNAs present in all four species and human showed a high sequence
identity i.e. the sequence is completely identical between the mature sequences
for all of them. Using the set of 175 miRNAs I was able to reconstruct the ex-
pected phylogenetic relationships between the species studied for both the hairpin
and the mature sequence. A principle component analysis on the sequence iden-
tity between hairpin sequences shows a close relationship between chimpanzee
and gorilla while both species are distant from orangutan and even more afar to
rhesus macaque (5.11).
5.3.6.2. Secondary structure comparison for newly predicted miRNAs
For some stages during their biogenesis miRNAs form a secondary structure that
resembles a hairpin (Winter et al., 2009). Since the endonuclease that processes
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miRNAs recognizes them based on their three-dimensional structure (Winter
et al., 2009), the stability of the secondary structure can be considered a proxy
for miRNA functionality and therefore for the reliability of miRNAs predictions.
I used the minimum free energy (MFE) as a measure of structure stability. I
calculated the minimum free energy (MFE) of known and predicted hairpin se-
quences by using RNAfold algorithm with default parameters (Hofacker, 2003).
The MFE for each group of annotated/predicted miRNAs was computed by av-
eraging the MFEs. I found that the hairpins of predicted miRNAs are as stable
as hairpins from known miRNAs (p > 0.05, Wilcoxon Rnak Sum Test), which is
not unexpected given that the score calculated by miRDeep2 takes into account
the stability of the miRNA hairpin secondary structure.
5.4. Discussion
Expression and miRNA annotation In this chapter, I have characterized gene
expression in five tissues of humans, chimpanzees, and rhesus macaques using
high-throughput sequencing and using additional individuals from orangutan and
gorilla I was able to annotate many new miRNAs in all five primate species. In
the gene expression part I showed for four of the five tissues, that the majority of
the sequencing reads mapped to known miRNAs. In contrast, testis showed only
a small percentage (9%) of reads matching known miRNAs. A larger fraction
mapped to piRNAs (17%) while about one-third mapped to the genome but did
not overlap any known RNA annotation. PiRNAs are known to be expressed
specifically in germ line and gonadal somatic cells (Siomi et al. 2011) and are
associated with the PIWI proteins, which are indispensable proteins for germ line
development (Siomi et al. 2011) in many animals (Ghildiyal and Zamore 2009).
It was also reported that they play a role in in the central nervous system (Lee
et al., 2011). They are divided in two classes: the first class is involved in silencing
transposons, whereas the function of the second class remains unknown (Aravin et
al. 2007). PiRNAs have a length distribution of between 25 and 35 nt (Aravin et
al. 2001). I was able to detect the typical bias for 5’ uridine (U) residue (Malone
and Hannon 2009) and an excess of adenosine at position 10 (Friedla¨nder et al.
2009) that characterize piRNAs. Interestingly, testis reads that mapped to each
species’ corresponding genome but did not overlap any known RNA annotation
showed the same patterns, suggesting that a large fraction of piRNAs remain to
be characterized, as they are not among the ∼32,000 human piRNAs reported
in the database I used for mapping (Pang et al. 2007). However, the missing
characteristics of a U 5’ bias could not be found in the brain samples despite the
fact that I see a higher fraction of reads mapping to piRNAs in brain than in
heart, kidney and liver.
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Summing over all tissues, I was able to detect approximately 80% of all known
miRNAs for each of the three species. When counting the number of miRNAs
expressed, I observed a difference between tissues. In all three species, brain and
testis show the most diverse miRNA repertoire. For testis, this result is sur-
prising given the reduced power that I had to detect lowly expressed miRNAs
because of the large fraction of reads representing other small RNAs that may
or may not be transcribed from unannotated parts of the genome. In contrast,
the miRNA repertoires of heart and liver are less diverse. Given that miRNAs
have been shown to regulate mRNA abundance it is to be expected that the
diversity of expressed miRNAs is linked to the number of different mRNAs ex-
pressed in each tissue. MRNA expression diversity was shown in previous studies
to be highest in testis (Khaitovich et al., 2005; Kircher, 2011). However, gene
expression diversity in brain was similar to the diversity seen in liver, kidney,
and heart, and not more diverse, as observed for miRNA expression in the brain.
This discrepancy between mRNA and miRNA diversity is further supported by
my observation that a large fraction of the newly predicted miRNAs were brain
specific (Figure 5.9 and Figure 5.10). The data thus suggest that a larger frac-
tion of genes may be regulated by miRNAs in brain as compared with other
tissues. If true, this would lend further support to the central role attributed
to regulatory RNAs in brain function (Mattick, 2011). However, I want to also
note that brain is an intensively studied tissue and that miRNAs annotated in
miRBase could be potentially biased toward brain-specific miRNAs. A bias in
annotation cannot, however, explain why newly discovered miRNAs in human
are often brain specific. Additionally, I was able to annotate many new miRNAs
in the second study, where I annotated miRNAs in non-human primates using
miRDeep2 (Friedla¨nder et al., 2011). I found 47 new miRNAs in chimpanzee, 240
in gorilla, 55 in orangutan and 47 in rhesus macaque (Figure 5.10). Secondary
structures for those miRNAs were as stable as the ones for prior existing miR-
NAs. The number of miRNAs which are located in orthologous regions in the
four non-human primate genomes studied here and in human increased from 60
to 175. This is a set of high confidence miRNAs based on homology, expression
and miRNA biogenesis signatures.
Differential expression MiRNAs show high sequence conservation between
species (Chen and Rajewsky, 2007; Hertel et al., 2006; Pasquinelli et al., 2000;
Stark et al., 2007). In this study, I found a similar high conservation in their
expression between primate species. In agreement with previous gene expression
studies, the divergence between tissues is higher than the divergence between
species. This is reflected in the high amount of variance (65%) explained by the
factor “tissue” in the linear model that I applied (Figure 5.1 c). The high con-
servation of miRNA expression levels and tissue-specific expression patterns were
previously observed in a comparative study of 26 tissues in humans and rodents
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(Landgraf et al., 2007b). In my study, miRNAs expressed in brain explained the
highest fraction of tissue variance (Figure 5.1 d). It has been shown that brain
has the smallest mRNA expression differences between species, and it was con-
cluded that purifying selection is extremely efficient at eliminating mutations that
modify gene expression in this tissue (Khaitovich et al., 2005, 2006). I found that
many miRNAs are specifically expressed in brain. I therefore hypothesize that
miRNAs, in addition to purifying selection, may explain the highly conserved
mRNA expression patterns for this tissue.
Although the expression differences in miRNAs between species are small, they
are sufficient to pinpoint miRNAs with a difference in expression between the pri-
mate species studied. Humans and chimpanzees show more similarity than either
shows to rhesus macaques. The differences between species are particularly small
in brain and heart and much bigger in liver and testis. It has been previously
shown that mRNA expression is subjected to different levels of constraint in dif-
ferent tissues (Khaitovich et al., 2005, 2006). Using rhesus macaque as outgroup
to assign differences, I found no excess of differential expression on the human
or chimpanzee lineage for the tissues brain, kidney, liver, and heart. In testis,
however, I observed that chimpanzees and rhesus macaques are much closer to
one another than either is to humans (Figure 5.4). Reproductive pressures such
as sperm competition may be similar for chimpanzees and rhesus macaques (Dix-
son, 1999), and it has been hypothesized that selection may have shaped both the
protein sequence evolution and the mRNA expression of male reproductive genes
(Khaitovich et al., 2005, 2006; Wyckoff, Li and Wu, 2002). The data suggest that
adaptive changes may have shaped the expression patterns of miRNAs in testis
on the human lineage.
Sequence evolution I sought to study the relation between expression and
sequence evolution. I found a positive correlation between miRNA sequence
conservation and expression level. It has previously been shown in humans and
Drosophila that purifying selection is weaker in lowly expressed miRNAs and that
they therefore have less constraint in sequence evolution than highly expressed
miRNAs (Liang and Li, 2009; Lu et al., 2008). Highly expressed miRNAs are
important regulators of gene expression, and their sequence conservation is there-
fore accordingly higher. The levels of purifying selection can be also assessed by
the within species diversity. I took advantage of the extensive human diversity
databases and found negative correlations between miRNA expression and the
number of miRNA polymorphisms. A similar effect has been reported in humans
(Liang and Li, 2009). However, the effect was not as strong as the correlation
between expression and conservation. The lack of polymorphism data available
for other primate species meant that I was not able to perform the same analysis
on these.
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In addition to known miRNAs, I used the 17 new miRNAs predicted the first an-
notation study using miRDeep for human, chimpanzee and rhesus macaque. It
has been debated whether newly predicted miRNAs are functional or not, espe-
cially because they tend to have lower expression and more sequence divergence
than known miRNAs (Liang and Li, 2009; Lu et al., 2008). The comparison
of the expression levels of those newly predicted miRNAs with known miRNAs
showed that the former group tended to have lower expression values. This is in
agreement with previous studies and supports the hypothesis that newly emerged
miRNAs are raw material for evolution that only have weak or negligible impact
on gene expression after their emergence (Liang and Li, 2009).
Functional relation between miRNA expression and gene expression Mam-
malian miRNAs exert their regulatory action by decreasing target mRNA levels
(Guo et al., 2010). I therefore expected to find a negative correlation between ex-
pression levels of miRNAs and their target genes. I used miRNA targets that were
computed based on genome-wide prediction algorithms that take sequence com-
plementarity into account. For these predicted targets, I performed the analysis
at tissue and species level. I did not find an excess of negative correlation be-
tween miRNA and mRNA expression in the between tissues and between species
comparisons. However, when I restricted the set of targets to genes with only
one binding site for expressed miRNAs, I did find an excess of negative correla-
tion in the between tissues comparison, whereas the between species comparison
gave no signal. This difference in results may be due to a difference in power;
tissue divergence exceeds species divergence, with tissue differences explaining
the majority of variance in miRNA expression (Figure 5.1 c). It is possible that
technical variation exceeds the effect exerted by miRNAs at the gene level in
the between species comparisons, whereas the comparison between tissues yields
significant results due to more pronounced differences in expression. The lack
of power in the between-species comparison may be further exacerbated by the
use of human-based target prediction databases that could potentially obscure
species-specific effects. However, a substantial source of error may lie in the
high false positive rate of computational miRNA target prediction, which poses a
challenge for understanding the impact of miRNAs on gene expression regulation
(Alexiou et al., 2009). Another source of noise for finding the regulatory rela-
tion between the expression of miRNA–mRNA pairs is the involvement of other
regulatory molecules that hinder a clear measurement of the effect of miRNAs
alone. Transcription factors, in particular, can regulate transcription positively
and negatively (Hobert, 2008) and their effect strength has been reported to be
larger than that of miRNAs: in Caenorhabditis elegans individual deletion of
miRNA loci only caused developmental and morphological defects in <10% of
the cases (Miska et al., 2007), whereas RNA interference experiments for tran-
scription factors resulted in observable effects in ∼30% of the cases reviewed in
61
Hobert (Hobert, 2008). The action of transcription factors may therefore lead to
false signals of apparent positive correlation between miRNA–mRNA pairs, and
mRNA expression differences have to be seen as the result of the sum of many
regulating factors impacting the expression level.
The pronounced excess of negative correlations, I observe when using only genes
with fewer binding sites for expressed miRNAs indicates that the power to mea-
sure the functional relation between miRNA–mRNA pairs is higher for this group
of genes. Genes regulated by multiple expressed miRNAs introduce more noise
and hinder the ability to measure the impact of each miRNA on mRNA expression
values. Two studies of development and aging in humans and macaque brains
(Somel et al., 2010), and humans, chimpanzee, and macaque brains (Somel et al.,
2011) have shown that age-related miRNA expression profiles are more nega-
tively correlated with their targets than random expectations. A similar effect
has been reported by comparing mRNAs, miRNAs, and proteins from human
and chimpanzees using two different brain regions (Hu et al., 2011).
Functional enrichment of miRNA target genes By comparing multiple species
and tissues, I found that genes targeted by differentially expressed miRNAs were
enriched in some GO categories, whereas genes targeted by miRNAs with uniform
expression showed no signal of enrichment. The significant categories formed
functionally related clusters in the GO graphs for the biological process and
molecular function domains (Figure 5.7). A significant enrichment for genes with
transcription factor–binding activity was found consistently in the majority of
tests both between species and between tissues. This suggests that miRNAs, as
downregulators of gene expression, preferentially modulate transcription factors,
which are themselves transacting regulatory molecules. It has been shown that
transcription factors that are differentially expressed between human and chim-
panzee brains preferentially regulate genes involved metabolism and transcription
among others (Nowick et al., 2009). Additionally, in plants, miRNAs prefer-
entially regulate transcription factors that are involved in development (Jones-
Rhoades and Bartel, 2004; Rhoades et al., 2002). I speculate that miRNAs may
therefore also have an indirect influence on the expression of these types of genes.
As a second line of evidence for the connection between miRNAs and transcrip-
tion factors, I measured the functional relationship between transcription factor
expression differences and miRNA regulation between tissues. To do that I used
as a proxy the number of binding sites for expressed miRNA present in transcrip-
tion factors 3’ UTRs. I found that differentially expressed transcription factors
contain fewer miRNA-binding sites than transcription factors that are not dif-
ferentially expressed. MiRNAs have been speculated to have the function of
stabilizing the expression of their targets (Kircher, Bock and Paulsen, 2008; Wu,
Shen and Tang, 2009). In the between-tissue comparison, this would mean that
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the miRNA expression level is adjusted to maintain homogeneous mRNA ex-
pression. Transcription factors that are differentially expressed show a depletion
in miRNA-binding sites. I hypothesize that these transcription factors achieve
differential expression by reducing the number of miRNA-binding sites and there-
fore avoiding the control by expressed miRNAs. Beside the transcription factor
activity involvement I also found several categories enriched for developmental
processes, preferentially in brain. Several other studies already reported the in-
volvement of miRNAs in developmental processes of miRNAs (Krichevsky et al.,
2003; Somel et al., 2010, 2011). A third group of enriched categories were related
to metabolic functions. I found those preferentially in liver and kidney. A re-
cent review discusses the impact of miRNAs in matabolism (Rottiers and Na¨a¨r,
2012).
Further studies integrating miRNA–mRNA profiles with data sets produced by
shotgun proteomics and ribosome profiling will further improve the understand-
ing of gene expression and gene expression regulation in primates and help to
disentangle the relative contributions of different gene expression regulatory ma-
chinery and their impact on phenotype in primate evolution.
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6. Conclusion
In my thesis I used next generation sequencing data to investigate evolutionary
changes in gene expression in primates.
The typical human diet differs substantially from that of other primates. The
fraction of humans eating meat as well as the proportion of meat within the daily
diet is higher than it is for any other primate species. An even more unique
feature is the way humans prepare their food. Practically all human populations
include cooked food, both meat and vegetable, in their diets. Using a mouse
model I explored the effect of changes in diet that are typical of humans - meat-
eating and cooking - on gene expression. I found that both the different food
substrated meat and tuber as well as their preparation change gene expression
in mice significantly. The effect is bigger between food types than between their
ways of preparation. While genes differentially expressed between food types
largly have metabolic functions genes differentially expressed between raw and
cooked food showed an additional immune-response signal. This observation
hints that cooking not only changes metabolic functions but also helps avoiding
immune reactions. I showed that expression differences in mice are correlated
with differences in modern humans compared to other primates, and that there
is there evidence of adaptation to these diets which dates to more than 300.000
years. Finally, I showed that transcription factors play in important role in
regulation of gene expression with respect to different food preparation.
Regulatory elements like transcription factors or miRNAs play a major role in the
process of gene expression. Using miRNA expression data from multiple primate
species and for multiple tissues I found that expression differences vary between
tissues. While heart and brain show only little expression differences between
primates other tissues are more variable in expression. Brain showed the strongest
expression differences compared to other tissues in all three primate species which
indicates that miRNAs have an important role in that tissue. I also showed
that miRNA expression differences are correlated with expression differences of
their target genes genome-wide which underlines the regulatory importance of
miRNAs. I tested for functional enrichment of target genes for miRNAs that
showed strong expression differences between both, species and tissues and found
that transcription factors are the target of these miRNAs with strong expression
differences. This result implies that the regulation of gene expession might be
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more complex than known before. Especially differentially miRNAs can regulate
gene expression more strongly via the targeted transcription factors, which puts
miRNAs and their role in a new perspective. Finally, I used the expression data
to annotate new miRNAs in primates and was able to increase the number of
annotated miRNAs substantially especially in the non-human primates. The
overlap of miRNAs annotated in mutiple primate species thereby also increased
which will help future studies to investigate the evolutionary changes of miRNAs
between these primates.
The results I present in my thesis have direct impact on the fields of nutrition
and gene regulation. It will help to design new studies that will for example be
able to investigate the effect of other food types on gene expression. Differentially
expressed genes between food substrates and food preparations can be used for
further functional studies. The results of my thesis also help to annotate the role
of transcription factors which were involved in regulating the gene expression
differences with respect to different food preparations. I also show that espe-
cially the transcription factors are targets of differentially miRNAs in primates.
Correlating miRNA expression with transcription factor activit and stding the
binding of miRNAs to 3’UTRs of transcription factors will help understanding
the mechanisms of the interaction between these two classes of gene regulators.
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Meat vs. Tuber
(Cooked and Raw
combined)
molecular function structural constituent of ribosome 0
molecular function catalytic activity 0
molecular function monooxygenase activity 0
molecular function iron ion binding 0
molecular function transaminase activity 0
molecular function electron carrier activity 0
molecular function oxidoreductase activity 0
molecular function oxidoreductase activity, acting on CH-
OH group of donors
0
molecular function oxidoreductase activity, acting on the
CH-OH group of donors, NAD or
NADP as acceptor
0
molecular function oxidoreductase activity, acting on
paired donors, with incorporation or re-
duction of molecular oxygen
0
molecular function transferase activity, transferring alkyl
or aryl (other than methyl) groups
0
molecular function transferase activity, transferring ni-
trogenous groups
0
molecular function lyase activity 0
molecular function vitamin binding 0
molecular function heme binding 0
molecular function carboxylic acid binding 0
molecular function tetrapyrrole binding 0
molecular function cofactor binding 0
molecular function coenzyme binding 0
biological process monosaccharide metabolic process 0
biological process glucose metabolic process 0
biological process alcohol metabolic process 0
biological process organic acid metabolic process 0
biological process cellular amino acid metabolic process 0
biological process lipid metabolic process 0
biological process fatty acid metabolic process 0
biological process fatty acid beta-oxidation 0
biological process steroid biosynthetic process 0
biological process coenzyme metabolic process 0
biological process response to stress 0
biological process metabolic process 0
biological process steroid metabolic process 0
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biological process cholesterol metabolic process 0
biological process lipid biosynthetic process 0
biological process catabolic process 0
biological process biosynthetic process 0
biological process fatty acid catabolic process 0
biological process cellular amino acid catabolic process 0
biological process glutamine family amino acid metabolic
process
0
biological process response to endogenous stimulus 0
biological process response to hormone stimulus 0
biological process cellular process 0
biological process response to organic substance 0
biological process regulation of cellular ketone metabolic
process
0
biological process lipid catabolic process 0
biological process organic acid biosynthetic process 0
biological process organic acid catabolic process 0
biological process sterol metabolic process 0
biological process sterol biosynthetic process 0
biological process regulation of fatty acid metabolic pro-
cess
0
biological process hexose metabolic process 0
biological process fatty acid oxidation 0
biological process carboxylic acid metabolic process 0
biological process lipid modification 0
biological process monocarboxylic acid metabolic process 0
biological process lipid oxidation 0
biological process cellular ketone metabolic process 0
biological process response to chemical stimulus 0
biological process oxoacid metabolic process 0
biological process cellular metabolic process 0
biological process primary metabolic process 0
biological process cellular lipid catabolic process 0
biological process cellular catabolic process 0
biological process cellular lipid metabolic process 0
biological process small molecule metabolic process 0
biological process small molecule catabolic process 0
biological process small molecule biosynthetic process 0
biological process regulation of fatty acid oxidation 0
biological process carboxylic acid biosynthetic process 0
biological process carboxylic acid catabolic process 0
biological process glycerolipid metabolic process 0
biological process cofactor metabolic process 0
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biological process response to glucocorticoid stimulus 0
biological process oxidation-reduction process 0
biological process organic substance transport 0
biological process monocarboxylic acid catabolic process 0
cellular component cell fraction 0
cellular component intracellular 0
cellular component cell 0
cellular component soluble fraction 0
cellular component cytoplasm 0
cellular component mitochondrion 0
cellular component peroxisome 0
cellular component endoplasmic reticulum 0
cellular component cytosol 0
cellular component cytosolic ribosome 0
cellular component microbody 0
cellular component organelle 0
cellular component membrane-bounded organelle 0
cellular component intracellular organelle 0
cellular component intracellular membrane-bounded or-
ganelle
0
cellular component intracellular part 0
cellular component endoplasmic reticulum part 0
cellular component cytoplasmic part 0
cellular component cell part 0
biological process aromatic compound catabolic process 0.001
cellular component mitochondrial envelope 0.001
cellular component cytosolic large ribosomal subunit 0.001
cellular component vesicular fraction 0.001
cellular component ribosomal subunit 0.001
cellular component mitochondrial part 0.001
biological process acylglycerol metabolic process 0.002
biological process isoprenoid biosynthetic process 0.002
biological process response to metal ion 0.002
biological process response to corticosteroid stimulus 0.002
cellular component microsome 0.002
cellular component mitochondrial membrane 0.002
molecular function palmitoyl-CoA hydrolase activity 0.003
molecular function oxidoreductase activity, acting on
paired donors, with incorporation or re-
duction of molecular oxygen, NADH or
NADPH as one donor, and incorpora-
tion of one atom of oxygen
0.003
molecular function pyridoxal phosphate binding 0.003
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molecular function vitamin B6 binding 0.003
cellular component endoplasmic reticulum lumen 0.003
molecular function serine-type endopeptidase inhibitor ac-
tivity
0.004
biological process neutral lipid metabolic process 0.004
cellular component ribosome 0.006
cellular component organelle membrane 0.006
cellular component intracellular organelle part 0.006
cellular component mitochondrial matrix 0.008
molecular function acetyl-CoA C-acyltransferase activity 0.009
biological process response to xenobiotic stimulus 0.009
biological process phosphatidylcholine metabolic process 0.009
cellular component endoplasmic reticulum membrane 0.009
biological process very long-chain fatty acid metabolic
process
0.011
biological process carbohydrate metabolic process 0.011
biological process triglyceride metabolic process 0.011
biological process cholesterol biosynthetic process 0.011
biological process isoprenoid metabolic process 0.011
biological process cellular amino acid biosynthetic process 0.011
biological process glutamine family amino acid biosyn-
thetic process
0.011
biological process response to extracellular stimulus 0.011
biological process organophosphate metabolic process 0.011
biological process response to nutrient levels 0.011
biological process ethanolamine-containing compound
metabolic process
0.011
biological process response to peptide hormone stimulus 0.011
biological process glycerolipid catabolic process 0.011
cellular component cytosolic small ribosomal subunit 0.012
biological process cellular modified amino acid metabolic
process
0.013
biological process cellular aromatic compound metabolic
process
0.015
cellular component nuclear outer membrane-endoplasmic
reticulum membrane network
0.015
molecular function glutathione transferase activity 0.017
molecular function oxidoreductase activity, acting on the
CH-NH group of donors
0.017
biological process response to inorganic substance 0.017
biological process energy derivation by oxidation of or-
ganic compounds
0.017
biological process cellular amine metabolic process 0.017
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biological process regulation of glycogen metabolic pro-
cess
0.019
biological process cellular biogenic amine metabolic pro-
cess
0.02
biological process regulation of polysaccharide metabolic
process
0.021
biological process glycogen biosynthetic process 0.022
biological process generation of precursor metabolites
and energy
0.022
biological process glucan biosynthetic process 0.022
molecular function fatty-acyl-CoA binding 0.023
cellular component extracellular space 0.029
cellular component organelle part 0.029
biological process response to topologically incorrect pro-
tein
0.03
biological process cellular biosynthetic process 0.032
biological process xenobiotic metabolic process 0.035
biological process positive regulation of fatty acid
metabolic process
0.035
biological process cellular response to xenobiotic stimulus 0.035
molecular function carbon-carbon lyase activity 0.041
biological process porphyrin-containing compound
metabolic process
0.043
molecular function enzyme inhibitor activity 0.049
Meat vs. Tuber
(Cooked)
molecular function catalytic activity 0
molecular function glutathione transferase activity 0
molecular function monooxygenase activity 0
molecular function iron ion binding 0
molecular function electron carrier activity 0
molecular function oxidoreductase activity 0
molecular function oxidoreductase activity, acting on CH-
OH group of donors
0
molecular function oxidoreductase activity, acting on the
CH-OH group of donors, NAD or
NADP as acceptor
0
molecular function oxidoreductase activity, acting on
paired donors, with incorporation or re-
duction of molecular oxygen
0
molecular function lyase activity 0
molecular function vitamin binding 0
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molecular function heme binding 0
molecular function tetrapyrrole binding 0
molecular function cofactor binding 0
molecular function coenzyme binding 0
biological process carbohydrate metabolic process 0
biological process monosaccharide metabolic process 0
biological process glucose metabolic process 0
biological process alcohol metabolic process 0
biological process organic acid metabolic process 0
biological process generation of precursor metabolites
and energy
0
biological process cellular amino acid metabolic process 0
biological process cellular modified amino acid metabolic
process
0
biological process lipid metabolic process 0
biological process fatty acid metabolic process 0
biological process fatty acid beta-oxidation 0
biological process neutral lipid metabolic process 0
biological process acylglycerol metabolic process 0
biological process triglyceride metabolic process 0
biological process steroid biosynthetic process 0
biological process cholesterol biosynthetic process 0
biological process coenzyme metabolic process 0
biological process response to stress 0
biological process metabolic process 0
biological process steroid metabolic process 0
biological process cholesterol metabolic process 0
biological process isoprenoid biosynthetic process 0
biological process lipid biosynthetic process 0
biological process catabolic process 0
biological process fatty acid catabolic process 0
biological process cellular amino acid catabolic process 0
biological process glutamine family amino acid metabolic
process
0
biological process response to endogenous stimulus 0
biological process response to hormone stimulus 0
biological process response to organic substance 0
biological process regulation of cellular ketone metabolic
process
0
biological process regulation of glucose metabolic process 0
biological process energy derivation by oxidation of or-
ganic compounds
0
biological process lipid catabolic process 0
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biological process carbohydrate biosynthetic process 0
biological process organic acid biosynthetic process 0
biological process organic acid catabolic process 0
biological process sterol metabolic process 0
biological process sterol biosynthetic process 0
biological process hexose metabolic process 0
biological process fatty acid oxidation 0
biological process aromatic compound catabolic process 0
biological process carboxylic acid metabolic process 0
biological process lipid modification 0
biological process monocarboxylic acid metabolic process 0
biological process lipid oxidation 0
biological process cellular ketone metabolic process 0
biological process response to chemical stimulus 0
biological process response to peptide hormone stimulus 0
biological process oxoacid metabolic process 0
biological process cellular metabolic process 0
biological process primary metabolic process 0
biological process cellular lipid catabolic process 0
biological process cellular catabolic process 0
biological process cellular lipid metabolic process 0
biological process cellular carbohydrate metabolic pro-
cess
0
biological process small molecule metabolic process 0
biological process small molecule catabolic process 0
biological process small molecule biosynthetic process 0
biological process carboxylic acid biosynthetic process 0
biological process carboxylic acid catabolic process 0
biological process cofactor metabolic process 0
biological process oxidation-reduction process 0
biological process monocarboxylic acid catabolic process 0
cellular component cell fraction 0
cellular component extracellular region 0
cellular component soluble fraction 0
cellular component insoluble fraction 0
cellular component cytoplasm 0
cellular component mitochondrion 0
cellular component mitochondrial envelope 0
cellular component peroxisome 0
cellular component endoplasmic reticulum 0
cellular component endoplasmic reticulum lumen 0
cellular component endoplasmic reticulum membrane 0
cellular component microsome 0
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cellular component organelle membrane 0
cellular component mitochondrial membrane 0
cellular component nuclear outer membrane-endoplasmic
reticulum membrane network
0
cellular component microbody 0
cellular component vesicular fraction 0
cellular component membrane-bounded organelle 0
cellular component intracellular membrane-bounded or-
ganelle
0
cellular component intracellular part 0
cellular component mitochondrial part 0
cellular component endoplasmic reticulum part 0
cellular component cytoplasmic part 0
molecular function transaminase activity 0.001
molecular function transferase activity, transferring alkyl
or aryl (other than methyl) groups
0.001
molecular function pyridoxal phosphate binding 0.001
molecular function carboxylic acid binding 0.001
molecular function vitamin B6 binding 0.001
biological process energy reserve metabolic process 0.001
biological process acyl-CoA metabolic process 0.001
biological process isoprenoid metabolic process 0.001
biological process aromatic amino acid family catabolic
process
0.001
biological process regulation of cellular carbohydrate
metabolic process
0.001
biological process regulation of lipid metabolic process 0.001
biological process response to insulin stimulus 0.001
biological process thioester metabolic process 0.001
biological process regulation of carbohydrate biosynthetic
process
0.001
biological process dicarboxylic acid metabolic process 0.001
biological process monosaccharide biosynthetic process 0.001
biological process glycerolipid metabolic process 0.001
cellular component mitochondrial inner membrane 0.001
molecular function transferase activity, transferring ni-
trogenous groups
0.002
biological process regulation of carbohydrate metabolic
process
0.002
biological process glutathione metabolic process 0.002
biological process regulation of fatty acid metabolic pro-
cess
0.002
biological process response to lipid 0.002
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cellular component membrane fraction 0.002
cellular component organelle inner membrane 0.002
biological process peptide metabolic process 0.003
biological process glutamine family amino acid biosyn-
thetic process
0.003
biological process amine metabolic process 0.003
biological process carbohydrate catabolic process 0.003
biological process hexose biosynthetic process 0.003
biological process cellular respiration 0.003
biological process positive regulation of lipid metabolic
process
0.003
biological process regulation of lipid biosynthetic process 0.003
biological process cellular response to chemical stimulus 0.003
biological process organic substance transport 0.003
cellular component extracellular space 0.004
cellular component intracellular 0.004
molecular function oxidoreductase activity, acting on the
CH-CH group of donors
0.005
molecular function oxidoreductase activity, acting on
paired donors, with incorporation or re-
duction of molecular oxygen, reduced
flavin or flavoprotein as one donor, and
incorporation of one atom of oxygen
0.005
biological process gluconeogenesis 0.005
biological process cellular response to lipid 0.005
molecular function palmitoyl-CoA hydrolase activity 0.006
molecular function L-amino acid transmembrane trans-
porter activity
0.007
cellular component melanosome 0.011
cellular component pigment granule 0.011
biological process glutamate metabolic process 0.012
biological process response to oxidative stress 0.012
biological process response to inorganic substance 0.012
biological process response to metal ion 0.012
biological process organophosphate metabolic process 0.012
biological process negative regulation of cellular carbohy-
drate metabolic process
0.013
biological process response to stilbenoid 0.013
biological process cellular amine metabolic process 0.013
molecular function carboxy-lyase activity 0.014
biological process regulation of fatty acid oxidation 0.015
cellular component organelle envelope 0.015
cellular component extracellular region part 0.015
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molecular function acetyl-CoA C-acyltransferase activity 0.016
molecular function misfolded protein binding 0.016
biological process response to carbohydrate stimulus 0.018
biological process response to monosaccharide stimulus 0.018
biological process cellular response to peptide hormone
stimulus
0.018
molecular function carbon-carbon lyase activity 0.02
biological process cellular response to organic substance 0.02
biological process response to glucose stimulus 0.021
biological process negative regulation of carbohydrate
metabolic process
0.021
biological process acetyl-CoA metabolic process 0.022
cellular component envelope 0.023
molecular function transferase activity, transferring acyl
groups other than amino-acyl groups
0.024
molecular function small molecule binding 0.024
molecular function transferase activity 0.028
biological process regulation of gluconeogenesis 0.029
biological process cellular biogenic amine metabolic pro-
cess
0.033
biological process vitamin metabolic process 0.033
cellular component intracellular organelle 0.036
molecular function ammonia-lyase activity 0.038
molecular function carboxylesterase activity 0.04
biological process negative regulation of lipid biosynthetic
process
0.041
cellular component organelle 0.041
molecular function oxidoreductase activity, acting on
paired donors, with incorporation or re-
duction of molecular oxygen, NADH or
NADPH as one donor, and incorpora-
tion of one atom of oxygen
0.042
biological process positive regulation of fatty acid
metabolic process
0.042
biological process phosphatidylcholine metabolic process 0.042
biological process negative regulation of gluconeogenesis 0.046
biological process positive regulation of fatty acid oxida-
tion
0.046
Meat vs. Tuber
(Raw)
molecular function catalytic activity 0
molecular function glutathione transferase activity 0
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molecular function monooxygenase activity 0
molecular function iron ion binding 0
molecular function electron carrier activity 0
molecular function oxidoreductase activity 0
molecular function oxidoreductase activity, acting on
paired donors, with incorporation or re-
duction of molecular oxygen
0
molecular function heme binding 0
molecular function tetrapyrrole binding 0
molecular function methyl indole-3-acetate esterase activ-
ity
0
molecular function methyl salicylate esterase activity 0
molecular function methyl jasmonate esterase activity 0
biological process organic acid metabolic process 0
biological process cellular amino acid metabolic process 0
biological process lipid metabolic process 0
biological process fatty acid metabolic process 0
biological process organic acid catabolic process 0
biological process carboxylic acid metabolic process 0
biological process monocarboxylic acid metabolic process 0
biological process cellular ketone metabolic process 0
biological process oxoacid metabolic process 0
biological process cellular lipid metabolic process 0
biological process small molecule metabolic process 0
biological process small molecule catabolic process 0
biological process carboxylic acid catabolic process 0
biological process oxidation-reduction process 0
cellular component cytoplasm 0
cellular component peroxisome 0
cellular component endoplasmic reticulum 0
cellular component microbody 0
cellular component endoplasmic reticulum part 0
cellular component cytoplasmic part 0
molecular function carboxylesterase activity 0.001
molecular function cofactor binding 0.001
biological process lipid catabolic process 0.001
biological process cellular lipid catabolic process 0.001
biological process cofactor metabolic process 0.001
biological process monocarboxylic acid catabolic process 0.001
cellular component endoplasmic reticulum membrane 0.001
biological process metabolic process 0.002
biological process response to organic substance 0.002
cellular component membrane attack complex 0.002
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cellular component nuclear outer membrane-endoplasmic
reticulum membrane network
0.002
biological process acyl-CoA metabolic process 0.003
biological process coenzyme metabolic process 0.003
biological process fatty acid catabolic process 0.003
biological process lipid modification 0.003
biological process thioester metabolic process 0.003
cellular component microsome 0.005
molecular function alkane 1-monooxygenase activity 0.006
biological process response to chemical stimulus 0.006
cellular component cell fraction 0.006
cellular component mitochondrial inner membrane 0.006
cellular component vesicular fraction 0.006
biological process response to stress 0.008
biological process fatty acid beta-oxidation 0.009
molecular function vitamin binding 0.01
biological process response to stilbenoid 0.012
molecular function pyridoxal phosphate binding 0.014
molecular function vitamin B6 binding 0.014
biological process fatty acid oxidation 0.014
cellular component endoplasmic reticulum lumen 0.016
cellular component organelle inner membrane 0.016
biological process saturated monocarboxylic acid
metabolic process
0.022
biological process unsaturated monocarboxylic acid
metabolic process
0.022
cellular component cytosol 0.022
biological process lipid oxidation 0.025
molecular function carboxylic acid binding 0.027
molecular function retinyl-palmitate esterase activity 0.033
biological process cellular modified amino acid metabolic
process
0.036
biological process response to other organism 0.042
biological process response to biotic stimulus 0.044
Cooked vs. Raw
(Meat and Tuber
combined)
biological process organic acid metabolic process 0.009
biological process carboxylic acid metabolic process 0.009
biological process response to chemical stimulus 0.009
biological process oxoacid metabolic process 0.009
biological process cellular ketone metabolic process 0.017
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biological process positive regulation of fatty acid oxida-
tion
0.032
molecular function carbonate dehydratase activity 0.045
Cooked vs. Raw
(Tuber)
molecular function structural constituent of ribosome 0
molecular function catalytic activity 0
molecular function monooxygenase activity 0
molecular function stearoyl-CoA 9-desaturase activity 0
molecular function insulin-activated receptor activity 0
molecular function iron ion binding 0
molecular function odorant binding 0
molecular function pheromone binding 0
molecular function electron carrier activity 0
molecular function acyl-CoA desaturase activity 0
molecular function oxidoreductase activity 0
molecular function oxidoreductase activity, acting on CH-
OH group of donors
0
molecular function oxidoreductase activity, acting on the
CH-OH group of donors, NAD or
NADP as acceptor
0
molecular function oxidoreductase activity, acting on
paired donors, with incorporation or re-
duction of molecular oxygen
0
molecular function oxidoreductase activity, acting on
paired donors, with incorporation or re-
duction of molecular oxygen, reduced
flavin or flavoprotein as one donor, and
incorporation of one atom of oxygen
0
molecular function heme binding 0
molecular function tetrapyrrole binding 0
molecular function cofactor binding 0
molecular function coenzyme binding 0
biological process negative regulation of peptide secretion 0
biological process organic acid metabolic process 0
biological process lipid metabolic process 0
biological process fatty acid metabolic process 0
biological process insulin receptor signaling pathway 0
biological process lipid biosynthetic process 0
biological process response to hexose stimulus 0
biological process response to glucose stimulus 0
biological process response to organic substance 0
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biological process regulation of cellular ketone metabolic
process
0
biological process positive regulation of cellular carbohy-
drate metabolic process
0
biological process negative regulation of cellular carbohy-
drate metabolic process
0
biological process negative regulation of lipid storage 0
biological process positive regulation of glucose metabolic
process
0
biological process regulation of lipid metabolic process 0
biological process carboxylic acid metabolic process 0
biological process monocarboxylic acid metabolic process 0
biological process cellular response to insulin stimulus 0
biological process response to monosaccharide stimulus 0
biological process insulin secretion involved in cellular re-
sponse to glucose stimulus
0
biological process cellular ketone metabolic process 0
biological process response to chemical stimulus 0
biological process oxoacid metabolic process 0
biological process cellular lipid metabolic process 0
biological process small molecule metabolic process 0
biological process small molecule biosynthetic process 0
biological process locomotor rhythm 0
biological process negative regulation of gluconeogenesis 0
biological process positive regulation of lipid metabolic
process
0
biological process negative regulation of carbohydrate
metabolic process
0
biological process positive regulation of carbohydrate
metabolic process
0
biological process negative regulation of insulin secretion 0
biological process oxidation-reduction process 0
biological process regulation of insulin secretion involved
in cellular response to glucose stimulus
0
biological process negative regulation of insulin secretion
involved in cellular response to glucose
stimulus
0
biological process mitochondrion morphogenesis 0
biological process cellular response to chemical stimulus 0
biological process cellular response to monosaccharide
stimulus
0
biological process cellular response to hexose stimulus 0
biological process cellular response to glucose stimulus 0
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biological process negative regulation of peptide hormone
secretion
0
cellular component cell fraction 0
cellular component extracellular region 0
cellular component membrane attack complex 0
cellular component membrane fraction 0
cellular component insoluble fraction 0
cellular component cytoplasm 0
cellular component endoplasmic reticulum 0
cellular component endoplasmic reticulum membrane 0
cellular component microsome 0
cellular component cytosol 0
cellular component ribosome 0
cellular component small ribosomal subunit 0
cellular component cytosolic small ribosomal subunit 0
cellular component vesicular fraction 0
cellular component ribosomal subunit 0
cellular component endoplasmic reticulum part 0
cellular component cytoplasmic part 0
molecular function transporter activity 0.001
biological process cellular glucose homeostasis 0.001
biological process regulation of gluconeogenesis 0.001
biological process transmembrane receptor protein tyro-
sine kinase signaling pathway
0.001
biological process steroid metabolic process 0.001
biological process negative regulation of hormone secre-
tion
0.001
biological process cellular response to carbohydrate stim-
ulus
0.001
biological process cellular response to peptide hormone
stimulus
0.001
cellular component hemoglobin complex 0.001
cellular component cytosolic ribosome 0.001
cellular component nuclear outer membrane-endoplasmic
reticulum membrane network
0.001
cellular component cytosolic part 0.001
biological process regulation of insulin secretion 0.002
biological process cellular response to lipid 0.002
biological process regulation of hormone levels 0.003
biological process response to hormone stimulus 0.004
biological process regulation of lipid biosynthetic process 0.004
biological process insulin secretion 0.005
biological process response to stilbenoid 0.005
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biological process response to carbohydrate stimulus 0.007
biological process heat generation 0.007
biological process regulation of carbohydrate biosynthetic
process
0.007
biological process positive regulation of protein kinase B
signaling cascade
0.007
biological process regulation of peptide hormone secretion 0.007
molecular function structural molecule activity 0.008
molecular function oxidoreductase activity, acting on
paired donors, with oxidation of a pair
of donors resulting in the reduction of
molecular oxygen to two molecules of
water
0.009
biological process regulation of peptide secretion 0.01
biological process regulation of peptide transport 0.01
biological process circadian behavior 0.011
biological process aerobic respiration 0.013
biological process response to endogenous stimulus 0.013
cellular component organelle inner membrane 0.017
biological process organic acid biosynthetic process 0.018
biological process carboxylic acid biosynthetic process 0.018
biological process rhythmic behavior 0.019
biological process regulation of lipid storage 0.019
biological process peptide transport 0.019
molecular function oxygen binding 0.02
biological process regulation of cellular carbohydrate
metabolic process
0.022
cellular component mitochondrial inner membrane 0.024
biological process enzyme linked receptor protein signal-
ing pathway
0.027
biological process peptide hormone secretion 0.028
biological process cellular response to hormone stimulus 0.028
biological process cellular response to organic substance 0.028
biological process negative regulation of lipid metabolic
process
0.029
biological process regulation of carbohydrate metabolic
process
0.031
biological process negative regulation of lipid biosynthetic
process
0.031
molecular function N-acyltransferase activity 0.032
biological process peptide secretion 0.032
molecular function oxygen transporter activity 0.034
biological process cellular respiration 0.035
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molecular function aromatase activity 0.043
biological process gastrulation with mouth forming sec-
ond
0.046
biological process regulation of glucose metabolic process 0.046
biological process response to insulin stimulus 0.046
biological process negative regulation of secretion 0.046
cellular component 90S preribosome 0.047
biological process response to lipid 0.049
Cooked vs. Raw
(Meat)
molecular function receptor activity 0
biological process cell activation 0
biological process type III hypersensitivity 0
biological process regulation of type III hypersensitivity 0
biological process positive regulation of type III hypersen-
sitivity
0
biological process adaptive immune response 0
biological process immune effector process 0
biological process myeloid leukocyte activation 0
biological process neutrophil activation involved in im-
mune response
0
biological process immune system process 0
biological process leukocyte mediated immunity 0
biological process myeloid leukocyte mediated immunity 0
biological process antigen processing and presentation of
peptide antigen via MHC class I
0
biological process antigen processing and presentation of
exogenous peptide antigen
0
biological process antigen processing and presentation of
peptide antigen via MHC class II
0
biological process antigen processing and presentation of
peptide or polysaccharide antigen via
MHC class II
0
biological process positive regulation of acute inflamma-
tory response
0
biological process regulation of immune system process 0
biological process positive regulation of immune system
process
0
biological process positive regulation of leukocyte activa-
tion
0
biological process regulation of myeloid leukocyte medi-
ated immunity
0
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biological process defense response 0
biological process inflammatory response 0
biological process immune response 0
biological process response to wounding 0
biological process antigen processing and presentation 0
biological process antigen processing and presentation of
exogenous antigen
0
biological process antigen processing and presentation of
exogenous peptide antigen via MHC
class II
0
biological process neutrophil chemotaxis 0
biological process T cell activation 0
biological process defense response to bacterium 0
biological process innate immune response 0
biological process leukocyte activation 0
biological process lymphocyte activation 0
biological process antigen processing and presentation of
peptide antigen
0
biological process regulation of phagocytosis 0
biological process regulation of immune response 0
biological process response to stimulus 0
cellular component plasma membrane 0
cellular component external side of plasma membrane 0
cellular component cell surface 0
cellular component membrane 0
cellular component integral to membrane 0
cellular component intrinsic to membrane 0
cellular component MHC protein complex 0
cellular component MHC class II protein complex 0
cellular component membrane part 0
cellular component plasma membrane part 0
cellular component cell periphery 0
molecular function immunoglobulin receptor activity 0.001
molecular function cytokine binding 0.001
biological process phagocytosis 0.001
biological process mononuclear cell proliferation 0.001
biological process T cell proliferation 0.001
biological process positive regulation of T cell differentia-
tion
0.001
biological process lymphocyte proliferation 0.001
biological process positive regulation of cell activation 0.001
molecular function IgG binding 0.002
biological process type IIa hypersensitivity 0.002
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biological process regulation of type IIa hypersensitivity 0.002
biological process positive regulation of type IIa hyper-
sensitivity
0.002
biological process type II hypersensitivity 0.002
biological process leukocyte differentiation 0.002
biological process acute inflammatory response 0.002
biological process positive regulation of immune effector
process
0.002
biological process positive regulation of adaptive immune
response
0.002
biological process positive regulation of myeloid leukocyte
mediated immunity
0.002
biological process regulation of type II hypersensitivity 0.002
biological process positive regulation of type II hypersen-
sitivity
0.002
biological process Fc receptor signaling pathway 0.002
biological process neutrophil activation 0.002
biological process positive regulation of lymphocyte dif-
ferentiation
0.002
biological process positive regulation of phagocytosis 0.002
biological process leukocyte migration 0.002
biological process response to other organism 0.002
biological process leukocyte proliferation 0.002
molecular function signal transducer activity 0.003
molecular function molecular transducer activity 0.003
biological process regulation of leukocyte activation 0.003
biological process mast cell activation 0.003
biological process cytokine production 0.004
biological process regulation of acute inflammatory re-
sponse
0.004
biological process integrin-mediated signaling pathway 0.004
biological process antigen processing and presentation of
exogenous peptide antigen via MHC
class I
0.004
biological process positive regulation of T cell activation 0.004
biological process phagocytosis, engulfment 0.005
biological process response to biotic stimulus 0.005
biological process regulation of endocytosis 0.005
biological process regulation of T cell differentiation 0.005
biological process regulation of T cell activation 0.005
biological process regulation of cell activation 0.005
molecular function transmembrane signaling receptor ac-
tivity
0.007
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molecular function signaling receptor activity 0.007
biological process myeloid cell activation involved in im-
mune response
0.007
biological process positive regulation of hypersensitivity 0.007
biological process positive regulation of response to exter-
nal stimulus
0.007
molecular function immunoglobulin binding 0.008
biological process membrane invagination 0.008
biological process positive regulation of defense response 0.008
biological process positive regulation of immune response 0.008
biological process regulation of cytokine production 0.01
biological process serotonin secretion 0.01
biological process positive regulation of acute inflamma-
tory response to antigenic stimulus
0.01
biological process alpha-beta T cell activation 0.011
biological process positive regulation of adaptive immune
response based on somatic recombina-
tion of immune receptors built from im-
munoglobulin superfamily domains
0.012
biological process regulation of defense response 0.012
biological process positive regulation of inflammatory re-
sponse
0.012
biological process positive regulation of mast cell activa-
tion involved in immune response
0.016
biological process positive regulation of mast cell degran-
ulation
0.016
biological process lymphocyte mediated immunity 0.017
biological process response to bacterium 0.017
biological process regulation of adaptive immune re-
sponse
0.02
biological process response to stress 0.02
biological process leukocyte chemotaxis 0.02
biological process regulation of lymphocyte differentia-
tion
0.02
biological process positive regulation of transport 0.02
biological process regulation of leukocyte mediated im-
munity
0.023
biological process regulation of hypersensitivity 0.023
biological process positive regulation of leukocyte degran-
ulation
0.023
biological process positive regulation of lymphocyte acti-
vation
0.023
molecular function IgG receptor activity 0.026
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molecular function Rac GTPase activator activity 0.026
biological process regulation of homeostatic process 0.026
biological process positive regulation of alpha-beta T cell
differentiation
0.027
biological process cell killing 0.031
biological process hypersensitivity 0.031
biological process regulation of acute inflammatory re-
sponse to antigenic stimulus
0.031
biological process T cell differentiation 0.031
biological process positive regulation of mast cell activa-
tion
0.031
biological process positive regulation of B cell differentia-
tion
0.031
cellular component receptor complex 0.032
molecular function protein binding 0.033
biological process adaptive immune response based on so-
matic recombination of immune recep-
tors built from immunoglobulin super-
family domains
0.035
molecular function protein complex binding 0.036
biological process positive regulation of inflammatory re-
sponse to antigenic stimulus
0.037
biological process hemopoietic or lymphoid organ devel-
opment
0.038
biological process regulation of lymphocyte activation 0.038
Table A.2.: Table showing the enrichment of differentially expressed genes be-
tween food substrates and food preparations in the gene ontology
(GO). The significant categories their domain and the corresponding
FWER (< 0.05) are displayed. Table taken from Dannemann et al.
(2012b)
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Meat vs. Tuber (Cooked and Raw combined)
Metabolic pathways 1.3E-13
Ribosome 1.6E-09
Fatty acid metabolism 9.6E-09
Tryptophan metabolism 8.6E-07
Alanine, aspartate and glutamate metabolism 1.1E-06
Biosynthesis of unsaturated fatty acids 1.7E-06
Arginine and proline metabolism 2.4E-06
Valine, leucine and isoleucine degradation 3.4E-06
PPAR signaling pathway 5E-06
Steroid biosynthesis 1.6E-05
Glycine, serine and threonine metabolism 5E-05
Pyruvate metabolism 0.00021
Drug metabolism - cytochrome P450 0.00042
Fatty acid elongation in mitochondria 0.00051
Synthesis and degradation of ketone bodies 0.00051
Peroxisome 0.00056
Terpenoid backbone biosynthesis 0.00083
Butanoate metabolism 0.00084
Glycolysis / Gluconeogenesis 0.0013
Nitrogen metabolism 0.0028
Metabolism of xenobiotics by cytochrome P450 0.0039
Propanoate metabolism 0.0048
Lysine biosynthesis 0.005
Caffeine metabolism 0.0052
Bile secretion 0.0054
Retinol metabolism 0.006
Lysine degradation 0.0061
Phenylalanine metabolism 0.0063
Histidine metabolism 0.0079
beta-Alanine metabolism 0.01
Glutathione metabolism 0.011
Systemic lupus erythematosus 0.015
Arachidonic acid metabolism 0.021
Glycerolipid metabolism 0.022
Primary bile acid biosynthesis 0.031
Antigen processing and presentation 0.039
Cysteine and methionine metabolism 0.041
Renin-angiotensin system 0.043
Meat vs. Tuber (Cooked)
Metabolic pathways 6.6E-21
Fatty acid metabolism 2.2E-09
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PPAR signaling pathway 2.2E-09
Steroid biosynthesis 5E-08
Valine, leucine and isoleucine degradation 2.2E-07
Alanine, aspartate and glutamate metabolism 8.6E-07
Biosynthesis of unsaturated fatty acids 1.1E-06
Arginine and proline metabolism 1.7E-06
Tryptophan metabolism 1.2E-05
Terpenoid backbone biosynthesis 1.4E-05
Synthesis and degradation of ketone bodies 2E-05
Butanoate metabolism 2.1E-05
Systemic lupus erythematosus 3E-05
Peroxisome 5.7E-05
Glutathione metabolism 8.4E-05
Nitrogen metabolism 0.00018
Pyruvate metabolism 0.00037
Drug metabolism - cytochrome P450 0.00057
Bile secretion 0.00091
Retinol metabolism 0.002
Histidine metabolism 0.0025
Glycolysis / Gluconeogenesis 0.0038
Glycine, serine and threonine metabolism 0.0043
Phenylalanine metabolism 0.0056
Arachidonic acid metabolism 0.0058
Propanoate metabolism 0.01
Glycerolipid metabolism 0.014
Metabolism of xenobiotics by cytochrome P450 0.016
Phenylalanine, tyrosine and tryptophan biosynthesis 0.024
Lysine biosynthesis 0.027
Lysine degradation 0.027
Caffeine metabolism 0.036
Tyrosine metabolism 0.043
Meat vs. Tuber (Raw)
Retinol metabolism 7E-06
Fatty acid metabolism 1.9E-05
PPAR signaling pathway 3.5E-05
Metabolic pathways 5.1E-05
Synthesis and degradation of ketone bodies 8.3E-05
Ribosome 0.00014
Drug metabolism - cytochrome P450 0.00069
Metabolism of xenobiotics by cytochrome P450 0.0011
Butanoate metabolism 0.0019
Arachidonic acid metabolism 0.0019
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Alanine, aspartate and glutamate metabolism 0.0048
Prion diseases 0.0055
Biosynthesis of unsaturated fatty acids 0.0095
Arginine and proline metabolism 0.0097
Peroxisome 0.019
Phenylalanine, tyrosine and tryptophan biosynthesis 0.022
Phenylalanine metabolism 0.022
Valine, leucine and isoleucine degradation 0.023
Glycine, serine and threonine metabolism 0.027
Fat digestion and absorption 0.036
Nitrogen metabolism 0.042
Cooked vs. Raw (Meat and Tuber combined)
Nitrogen metabolism 0.0009
Osteoclast differentiation 0.0029
Leukocyte transendothelial migration 0.017
Biosynthesis of unsaturated fatty acids 0.019
Adipocytokine signaling pathway 0.019
PPAR signaling pathway 0.024
African trypanosomiasis 0.026
Pentose and glucuronate interconversions 0.028
Toll-like receptor signaling pathway 0.035
Carbohydrate digestion and absorption 0.041
Aldosterone-regulated sodium reabsorption 0.047
Pyruvate metabolism 0.047
Chagas disease (American trypanosomiasis) 0.049
Phagosome 0.049
Cyanoamino acid metabolism 0.05
Cooked vs. Raw (Tuber)
Retinol metabolism 3E-06
Drug metabolism - cytochrome P450 1.3E-05
PPAR signaling pathway 1.8E-05
Metabolism of xenobiotics by cytochrome P450 2.6E-05
Ribosome 4.1E-05
Pentose and glucuronate interconversions 0.00012
Steroid hormone biosynthesis 0.00031
Phenylalanine, tyrosine and tryptophan biosynthesis 0.00056
Linoleic acid metabolism 0.00068
Tryptophan metabolism 0.00099
Arachidonic acid metabolism 0.0013
Drug metabolism - other enzymes 0.0034
Ascorbate and aldarate metabolism 0.0036
Biosynthesis of unsaturated fatty acids 0.0036
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Pyruvate metabolism 0.0039
Butanoate metabolism 0.0049
Metabolic pathways 0.0055
Primary bile acid biosynthesis 0.0062
Phenylalanine metabolism 0.011
Prion diseases 0.011
Nitrogen metabolism 0.021
Fatty acid metabolism 0.031
African trypanosomiasis 0.042
Complement and coagulation cascades 0.047
Amoebiasis 0.047
Cooked vs. Raw (Meat)
Osteoclast differentiation 4E-14
Staphylococcus aureus infection 2.6E-12
Phagosome 1.1E-10
Leishmaniasis 1.7E-08
Autoimmune thyroid disease 3.3E-08
Antigen processing and presentation 3.9E-08
Cell adhesion molecules (CAMs) 2.1E-07
Allograft rejection 3.5E-07
Graft-versus-host disease 4.9E-07
Asthma 5.2E-07
Type I diabetes mellitus 8.8E-07
Natural killer cell mediated cytotoxicity 1.8E-06
Viral myocarditis 2.3E-06
Systemic lupus erythematosus 8E-06
Intestinal immune network for IgA production 8.1E-05
Chemokine signaling pathway 0.00011
Rheumatoid arthritis 0.00013
Toxoplasmosis 0.00032
Fc gamma R-mediated phagocytosis 0.0004
Hematopoietic cell lineage 0.0015
Endocytosis 0.0019
Chagas disease (American trypanosomiasis) 0.0039
Fc epsilon RI signaling pathway 0.0072
Cytokine-cytokine receptor interaction 0.0077
Leukocyte transendothelial migration 0.0085
African trypanosomiasis 0.042
Salivary secretion 0.045
Jak-STAT signaling pathway 0.048
B cell receptor signaling pathway 0.048
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Table A.3.: Table showing the enrichment of differentially expressed genes be-
tween food substrates and food preparations in KEGG pathways.
The significant pathways and the corresponding p values (< 0.05)
are displayed. Table taken from Dannemann et al. (2012b)
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Factors in this experiment van Erk et al.
Meat vs. Tuber (Cooked and Raw combined) OR=1.5, p=4.6e-17
Meat vs. Tuber (Cooked) OR=1.6, p=8.9e-14
Meat vs. Tuber (Raw) OR=1.8, p=2.3e-7
Table A.4.: Table showing enrichment of matching expression changes between
differentially expressed genes between food types and expression
changes with respect to high protein and high carbohydrate diets
reported by van Erk et al.(Erk et al., 2006). Odds ratios and their
respective p values are displayed. Table taken from Dannemann et al.
(2012b)
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Factors in this experiment Brawand et al.
Cooked vs. Raw (Meat and Tuber combined) OR=1.9, p=0.41
Cooked vs. Raw (Meat) OR=0, p=1
Cooked vs. Raw (Tuber) OR=0.6, p=0.80
Meat vs. Tuber (Cooked and Raw combined) OR=1.0, p=0.52
Meat vs. Tuber (Cooked) OR=0.9, p=0.68
Meat vs. Tuber (Raw) OR=2.2, p=0.11
Table A.5.: Table showing the enrichment of differentially expressed genes in sets
of genes with human-specific expression pattern in liver (Brawand
et al., 2011). The overlap is presented in form of an odds ratios, with
corresponding p value obtained by a Fisher exact test. Table taken
from Dannemann et al. (2012b)
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Human miRNA piRNA struct.
RNA
mRNA genome unknown total tissue
Human 1 29,7 25,7 11,2 0,4 7 26 17642208 Brain
Human 2 61 3,5 2,5 0,1 1,4 31,5 17042298 Brain
Human 3 69,4 3 3,9 0,1 4,6 19 22354371 Brain
Human 4 46,6 5,2 5,5 0,1 5,6 37 7823881 Brain
Human 5 47,9 2,8 3,6 0,5 5,2 40 9365394 Brain
Human 6 59,7 6,8 3,2 0,1 1,9 28,3 3926392 Liver
Human 7 61,9 1,4 1,1 0,4 2,1 33,1 8071014 Liver
Human 8 66,3 2,6 1,4 0,1 1,4 28,2 8457645 Liver
Human 9 56,3 2,4 2,1 0,1 1,9 37,2 9338200 Liver
Human 10 46,4 3,8 1,6 0,7 2 45,5 8519384 Liver
Human 11 15,6 25,4 1,4 2,1 36,4 19,2 5212242 Testis
Human 12 19,6 15 1,6 1,8 34,5 27,5 7837134 Testis
Human 13 20,8 13,8 1,9 1,8 32,9 28,8 8259096 Testis
Human 14 7,7 28,4 1,5 1,5 27,9 33 6917910 Testis
Human 15 7,5 24,1 1,2 1,3 26 39,9 8781842 Testis
Human 16 54,4 7,7 6,7 0,1 4 27,1 9204122 Kidney
Human 17 61 2,5 2,2 0,8 2 31,5 8728150 Kidney
Human 18 54,1 3,6 3 0,9 3,6 34,8 7949192 Kidney
Human 19 57,7 1,2 2,2 2 2,1 34,8 9010571 Kidney
Human 20 44,3 5,8 4,7 2,1 5,8 37,3 9500208 Kidney
Human 21 65,8 3,3 2,4 0 1,6 26,9 12112511 Heart
Human 22 60,1 6 2,7 0,1 4,1 27 11530585 Heart
Human 23 63,5 0,5 0,4 0,2 1,6 33,8 8736435 Heart
Human 24 65,9 0,4 0,4 0,1 1,3 31,9 8331963 Heart
Human 25 62,2 0,6 0,3 0,4 1,2 35,3 8757996 Heart
Chimpanzee miRNA piRNA struct.
RNA
mRNA genome unknown total tissue
Chimp 1 48,8 1,2 2,2 0,1 1,8 45,9 9256059 Brain
Chimp 2 61,8 0,8 1 0 1,6 34,8 9568220 Brain
Chimp 3 58,9 2,2 3,2 0,4 5,2 30,1 6260673 Brain
Chimp 4 57,4 1,4 2 0,2 3,7 35,3 9094360 Brain
Chimp 5 20,7 1,7 1,3 0,2 3,1 73 10925576 Brain
Chimp 1 65,6 0,7 0,5 0,4 1,6 31,2 8014456 Liver
Chimp 2 66 1,6 0,8 0,5 3,4 27,7 7783734 Liver
Chimp 3 63,3 2 0,9 0,2 3,4 30,2 8907119 Liver
Chimp 4 67,6 0,6 0,6 0,1 1,6 29,5 9134135 Liver
Chimp 5 26,4 7,4 3,6 1 6,7 54,9 12422816 Liver
Chimp 2 3,6 21,7 1,2 1,5 27,6 44,4 8562359 Testis
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Chimp 3 6 24,4 0,9 1,5 30 37,2 7032837 Testis
Chimp 4 6,4 13,6 0,6 1,4 25,9 52,1 8951138 Testis
Chimp 5 4,3 19,3 0,5 1,2 23,9 50,8 9187803 Testis
Chimp 6 6,7 18,1 1 1,6 28,2 44,4 9130739 Testis
Chimp 1 63,7 0,6 0,6 0,8 1,5 32,8 9542783 Kidney
Chimp 2 53,5 2,2 1,6 1,9 3,1 37,7 4555252 Kidney
Chimp 3 57,8 1,8 1,7 0,8 2,1 35,8 10097467 Kidney
Chimp 5 55,2 2,2 1,4 1,9 2 37,3 10147639 Kidney
Chimp 1 67,8 0,4 0,4 0,1 1,2 30,1 7151071 Heart
Chimp 2 67,9 0,3 0,3 0,1 1,2 30,2 8085902 Heart
Chimp 3 67,8 0,5 0,4 0,3 1,2 29,8 8998010 Heart
Chimp 4 59,9 2,1 1,1 0,3 3,4 33,2 8965970 Heart
Chimp 5 59,2 3,8 2,5 0,2 1,7 32,6 8492878 Heart
Rhesus
macaque
miRNA piRNA struct.
RNA
mRNA genome unknown total tissue
Rhesus 1 33,4 3 1,7 0,2 2,6 59,1 11283928 Brain
Rhesus 2 39,2 1,7 0,9 0,1 1,7 56,4 10838315 Brain
Rhesus 3 51,3 1,9 1,2 0,2 2,6 42,8 9800537 Brain
Rhesus 4 50,9 0,8 0,5 0 1,3 46,5 9841685 Brain
Rhesus 5 54,4 1,4 1 0,1 1,5 41,6 9235438 Brain
Rhesus 1 65,1 1,7 0,8 0,3 2,1 30 8244566 Liver
Rhesus 2 69,1 0,3 0,1 0,3 1,3 28,9 8330148 Liver
Rhesus 3 71,6 0,5 0,3 0 1,2 26,4 8407386 Liver
Rhesus 4 62,3 0,6 0,3 0,1 1,6 35,1 8877467 Liver
Rhesus 5 44,7 0,4 0,2 0,6 2,2 51,9 8591936 Liver
Rhesus 1 23,1 3,9 0,4 1,2 12,4 59 8965912 Testis
Rhesus 2 15,5 0,6 0,4 1 9,1 73,4 11833977 Testis
Rhesus 3 19,2 4,6 0,6 1,2 12,4 62 8978604 Testis
Rhesus 4 10 6,7 0,9 1,2 14,9 66,3 8742323 Testis
Rhesus 1 27,3 10,2 5,8 1,2 9,1 46,4 10602505 Kidney
Rhesus 2 53 0,8 0,5 0,7 1,8 43,2 12060903 Kidney
Rhesus 3 57,4 1,1 0,6 1,7 1,5 37,7 10512940 Kidney
Rhesus 4 50,5 3 1,3 1,7 2,9 40,6 10510840 Kidney
Rhesus 6 56,4 1,2 0,6 1,6 1,5 38,7 10387858 Kidney
Rhesus 1 61,5 0,8 0,6 0,1 1,7 35,3 7971698 Heart
Rhesus 2 17 4,4 4,1 0,5 5,8 68,2 15642226 Heart
Rhesus 3 64,2 0,4 0,2 0,1 1,4 33,7 8834241 Heart
Rhesus 4 58,7 1,4 0,7 0,3 1,9 37 9312495 Heart
Rhesus 5 69,6 0,5 0,3 0,2 1,3 28,1 8620073 Heart
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Table A.7.: Read composition for all individuals of human, chimpanzee and rhe-
sus macaque. Numbers in columns 2-6 are the percentage of reads
mapped to specific groups of RNAs. Column 7 is the percentage of
reads not assigned to other known RNAs. Table taken from Danne-
mann et al. (2012b)
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Human
mature sequence chr miRBase id
UGAGGGAGUGGGUGGGAGG 1
UGAGGGAGUGGGUGGGAGG 1
UGAGGGAGUAGGUGGUGAG 1
ACUGGAAUUGGAGUCAAAA 11
AAGGAGGAAAUAGGCAGGC 14 hsa-mir-3173
ACUGGAUUUGGAGCCAGAA 17
UGAGGGAGUUGGGUGUAUA 17
UGGCCGGAUGGGACAGGAG 18 hsa-mir-4743
UGAGGGAGUGGAUUGUAUG 21
CAGGGCUGGCAGUGACAUG 3 hsa-mir-4446
GGCUGGUCAGAUGGGAGUG 5
AGCAGGGCUGGGGAUUGCA 7
UGAGGGAGGAGGUUGGGUA 7
GGUGGGGCAAUGGGAUCAG 8 hsa-mir-3151
ACUGGGGAGCAGAAGGAGA 9 hsa-mir-4667
CAGAAGGGGAGUUGGGAGC 9 hsa-mir-3154
UGAGGUGGUAGGAUGUAGA X
CUGUCCUAAGGUUGUUGAG X hsa-mir-676
Chimpanzee
mature sequence chr miRBase id
UGAGGGAGUGGGUGGGAGG 1
UGAGGGAGUAGGUGGUGAG 1
ACUGGAAUUGGAGUCAAAA 11 GL 391837 random
AAAGGAGGAAAUAGGCAGG 14
ACUGGAUUUGGAGCCAGAA 17
UGAGGGAGUUGGGUGUAUA 17
UGGCCGGAUGGGACAGGAG 18
UGAGGGAGUGGAUUGUAUG 21
CAGGGCUGGCAGUGAGAUG 3
GGCUGGUCGGAUGGGAGUG 5
AGCAGGGCUGGGGAUUGCA 7
UGAGGGAGGAGGUUGGGUA 7
GGUGGGGCAAUGGGAUCAG 8
ACUGGGGAGCAGAAGGAGA 9
CAGAAGGGGAGUUGGGAGC 9
UGAGGUGGUAGGAUGUAGA X
119
CUGUCCUAAGGUUGUUGAG X
Rhesus macaque
mature sequence chr miRBase id
UGAGGGAGUGGGUGGGAGG 1
UGAGGGAGUAGGUGGUGAG 1
ACUGGAAUUGGAGUCAAAA 1
GAAGGAGGAAACAGGCAGG 7
ACUGGAUUUGGAGCCAGAA 16
UGAGGGAGUUGAGUGUAUA 16
UGGCCGGAUGGGACAGGAG 18
UGAGGGAGUGGAUUGUAUG 3
CAGGGCUGGCAGUGAGAUG 2
GGCUGGUUAGAUGGGAGUG 6
AGCAGGGCUGGGGAUUGCA 3
UGAGGGAGGAGGUUGGGUA 3
ACGGGUGGCGCAAUGGGAU 8
ACUGGGGAGCAGAAGGAGA 15
CAGAAGGGGAGUUGGGAGC 15
UGAGGUAGUAGGAUGUAGA X
CCGUCCUAAGGUUGUUGAG X
Table A.8.: Newly predicted miRNAs for human, chimpanzee and rhesus
macaque using miRDeep. Table taken from Dannemann et al.
(2012b)
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Novel
miRNAs
species miRBase
id
mature sequence chr score
chimpanzee ptr-mir-
4423
AUAGGCACCAAAAAGCAACAA 1 24.7
chimpanzee ptr-mir-
3121
UAAAUAGAGUAGGCAAAGGACA 1 25919
chimpanzee ptr-mir-
3117
AUAGGACUCAUAUAGUGCCAGG 1 4.2
chimpanzee ptr-mir-
4742
UCAGGCAAAGGGAUAUUUACAGA 1 4.7
chimpanzee ptr-mir-
4428
CAAGGAGACGGGAACAUGGAGCC 1 5.2
chimpanzee ptr-mir-
4654
UGUGGGAUCUGGAGGCAUCUGGG 1 5.7
chimpanzee ptr-mir-
92b
UAUUGCACUCGUCCCGGCCUCC 1 9795.4
chimpanzee ptr-mir-
3127
AUCAGGGCUUGUGGAAUGGGAAG 2A 103.7
chimpanzee ptr-mir-
3132
UGGGUAGAGAAGGAGCUCAGA 2B 5.5
chimpanzee ptr-mir-
3129
GCAGUAGUGUAGAGAUUGGU 2B 92.4
chimpanzee ptr-mir-
378b
ACUGGACUUGGAGGCAGAAA 3 5.2
chimpanzee ptr-mir-
4446
CAGGGCUGGCAGUGAGAUGGG 3 5.3
chimpanzee ptr-mir-
3136
CUGACUGAAUAGGUAGGGUCA 3 5.5
chimpanzee ptr-mir-
3138
ACAGUGAGGUAGAGGGAGUG 4 148.4
chimpanzee ptr-mir-
3660
ACUGACAGGAGAGCGUUUUGA 5 120.4
chimpanzee ptr-mir-
378e
ACUGGACUUGGAGUCAGG 5 5
chimpanzee ptr-mir-
449c
AGGCAGUGUAUUGCUAGCGGCUGU 5 5.4
chimpanzee ptr-mir-
3943
UAGCCCCCAGGCUUCACUUGGCG 7 47.7
121
chimpanzee ptr-mir-
4660
UGCAGCUCUGGUGGAAAAUGGA 8 45124
chimpanzee ptr-mir-
3151
GGUGGGGCAAUGGGAUCAGGUG 8 500.7
chimpanzee ptr-mir-
3149
UUUGUAUGGAUAUGUGUGUGUA 8 5.3
chimpanzee ptr-mir-
4667
ACUGGGGAGCAGAAGGAGAACC 9 5.5
chimpanzee ptr-mir-
548e
AAAAACUGCGACUACUUUUG 10 5.4
chimpanzee ptr-mir-
3664
UCAGGAGUAAAGACAGAGU 11 5.6
chimpanzee ptr-mir-
1260b
AUCCCACCACUGCCACCAU 11 5.8
chimpanzee ptr-mir-
3165
AGGUGGAUGCAAUGUGACCUCA 11 5.9
chimpanzee ptr-mir-
1252
AGAAGGAAGUUGAAUUCAUU 12 4.6
chimpanzee ptr-mir-
200c
UAAUACUGCCGGGUAAUGAUGGA 12 5.8
chimpanzee ptr-mir-
655
AUAAUACAUGGUUAACCUCUU 14 246.1
chimpanzee ptr-mir-
3173
AAAGGAGGAAAUAGGCAGGCCA 14 344.5
chimpanzee ptr-mir-
2392
UAGGAUGGGGGUGAGAGGUG 14 5
chimpanzee ptr-mir-
4504
UGUGACAAUAGAGAUGAACAUGG 14 5.8
chimpanzee ptr-mir-
4510
UGAGGGAGUAGGAUGUAUGGU 15 4.2
chimpanzee ptr-mir-
4524a
UGAGACAGGCUUAUGCUGCUA 17 195.8
chimpanzee ptr-mir-
4743
UGGCCGGAUGGGACAGGAGGCA 18 5.4
chimpanzee ptr-mir-
320e
AAAAGCUGGGUUGAGAAGGUGA 19 4.5
chimpanzee ptr-mir-
548o
AAAAGUAAUUGCGGUUUUUGCC 20 105.8
chimpanzee ptr-mir-
3193
CUCCUGCGUAGGAUCUGAGGAG 20 4.7
chimpanzee ptr-mir-
3192
UCUGGGAGGUUGUAGCAGUGGA 20 5
122
chimpanzee ptr-mir-
3200
CACCUUGCGCUACUCAGGUCUG 22 270.9
chimpanzee ptr-mir-
23c
AUCACAUUGCCAGUGAUUACCC X 4.4
chimpanzee ptr-mir-
2114
CGAGCCUCAAGCAAGGGACUUCA X 50.6
chimpanzee ptr-mir-
767
UGCACCAUGGUUGUCUGAGCA X 5.3
chimpanzee ptr-mir-
4536
UGUGGUAGAUAUAUGCACGA X 5.3
chimpanzee ptr-mir-
222
AGCUACAUCUGGCUACUGGGUC X 5.6
chimpanzee ptr-mir-
3937
ACAGGCGGCUGUAGCAAUGGGGGG X 6.1
chimpanzee ptr-mir-
676
CUGUCCUAAGGUUGUUGAGU X 79.5
gorilla ggo-mir-
135b
UAUGGCUUUUCAUUCCUAUGUGA 1 10.3
gorilla ggo-mir-
3605
GAUGAGGAUGGAUAGCAAGGAAG 1 1.1
gorilla ggo-mir-
29c
UAGCACCAUUUGAAAUCGGUUA 1 11813.8
gorilla ggo-mir-
197
UUCACCACCUUCUCCACCCAGC 1 119.9
gorilla ggo-mir-
92b
UAUUACACUCGUCCCGGCCUCC 1 1589.6
gorilla ggo-mir-
30e
UGUAAACAUCCUUGACUGGAAGC 1 3114.3
gorilla ggo-mir-
556
AUAUUACCAUUAGCUCAUCU 1 36.8
gorilla ggo-mir-
488
CCCAGAUAAUGGCACUCUCAA 1 4.7
gorilla ggo-mir-
320b
AGAAGCUGGGUUGAGAGGGCAA 1 5
gorilla ggo-mir-
190b
UGAUAUGUUUGAUAUUGGGUUG 1 5.1
gorilla ggo-mir-
429
UAAUACUGUCUGGUAAAACCG 1 5.3
gorilla ggo-mir-
760
CGGCUCUGGGUCUGUGGGGAG 1 5.4
123
gorilla ggo-mir-
1278
UAGUACUGUGCAUAUCAUCUA 1 5.6
gorilla ggo-mir-
551a
GCGACCCACUCUUGGUUUCCA 1 83
gorilla ggo-mir-
200b
UAAUACUGCCUGGUAAUGAUGAC 1 86.9
gorilla ggo-mir-
200a
UAACACUGUCUGGUAACGAUGU 1 99.7
gorilla ggo-mir-
4429
AAAAGCUGGGCUGAGAGGCGA 2A 1
gorilla ggo-mir-
3126
UGAGGGACAGAUGCCAGAAGCA 2A 5.3
gorilla ggo-mir-
1301
UUGCAGCUGCCUGGGAGUGACU 2A 5.5
gorilla ggo-mir-
3127
AUCAGGGCUUGUGGAAUGGGA 2A 5.6
gorilla ggo-mir-
26b
UUCAAGUAAUUCAGGAUAGGU 2B 15749.2
gorilla ggo-mir-
375
UUUGUUCGUUCGGCUCGCGUGA 2B 1.7
gorilla ggo-mir-
128
UCACAGUGAACCGGUCUCUU 2B 22571.1
gorilla ggo-mir-
149
UCUGGCUCCGUGUCUUCACUCCC 2B 357.8
gorilla ggo-mir-
3129
GCAGUAGUGUAGAGAUUGGU 2B 4
gorilla ggo-mir-
191
CAACGGAAUCCCAAAAGCAGC 3 13047.6
gorilla ggo-let-7g UGAGGUAGUAGUUUGUACAGU 3 134084.7
gorilla ggo-mir-
3923
AACUAGUAAUGUUGGAUUAGGGC 3 1.5
gorilla ggo-mir-
28
CACUAGAUUGUGAGCUCCUGGA 3 -4.8
gorilla ggo-mir-
4446
CAGGGCUGGCAGUGAGAUGGG 3 5.2
gorilla ggo-mir-
378b
ACUGGACUUGGAGGCAGAAAG 3 5.2
gorilla ggo-mir-
885
AGGCAGCGGGGUGUAGUGGA 3 5.7
gorilla ggo-mir-
551b
GCGACCCAUACUUGGUUUCAG 3 74.8
gorilla ggo-mir-
1255a
AGGAUGAGCAAAGAAAGUAGAU 4 122.2
124
gorilla ggo-mir-
548d
CAAAAACUGCAGUUACUUUUG 4 17.8
gorilla ggo-mir-
577
AUAGAUAAAAUAUUGGUACCUG 4 1.8
gorilla ggo-mir-
3138
ACAGUGAGGUAGAGGGAGUG 4 2.3
gorilla ggo-mir-
574
CACGCUCAUGCACACACCCACA 4 510.5
gorilla ggo-mir-
378e
ACUGGACUUGGAGUCAGGAC 5 0.5
gorilla ggo-mir-
3615
UCUCUCCGCUCCUCGCGGCUCGC 5 11.9
gorilla ggo-mir-
423
UGAGGGGCAGAGAGCGAGACUU 5 12767.2
gorilla ggo-mir-
4524a
UGAGACAGGCUUAUGCUGCUA 5 150
gorilla ggo-mir-
338
UCCAGCAUCAGUGAUUUUGUUGA 5 1509.7
gorilla ggo-mir-
193a
AACUGGCCUACAAAGUCCCAG 5 1740.8
gorilla ggo-mir-
1180
UUUCCGGCUCGCGUGGGUGUG 5 1.9
gorilla ggo-mir-
144
GGAUAUCAUCAUAUACUGUAAG 5 245.3
gorilla ggo-mir-
454
UAGUGCAAUAUUGCUUAUAGGGUU 5 4.9
gorilla ggo-mir-
152
UCAGUGCAUGACAGAACUUGG 5 5070.4
gorilla ggo-mir-
146a
UGAGAACUGAAUUCCAUGGGU 5 5.2
gorilla ggo-mir-
874
CUGCCCUGGCCCGAGGGACCGA 5 526.7
gorilla ggo-mir-
142
CCCAUAAAGUAGAAAGCACUA 5 5.3
gorilla ggo-mir-
1250
ACGGUGCUGGAUGUGGCCUU 5 5.4
gorilla ggo-mir-
4738
UGAAACUGGAGCGCCUGGAG 5 5.5
gorilla ggo-mir-
584
UUAUGGUUUGCCUGGGACUGA 5 5.8
gorilla ggo-mir-
1271
CUUGGCACCUAGCAAGCACUCA 5 58.5
125
gorilla ggo-mir-
378
ACUGGACUUGGAGUCAGAAGGCC 5 7592.3
gorilla ggo-mir-
340
UUAUAAAGCAAUGAGACUGAU 5 8919.2
gorilla ggo-mir-
877
GUAGAGGAGAUGGCGCAGGGGACA 6 1.5
gorilla ggo-mir-
30c
UGUAAACAUCCUACACUCUCAGC 6 1740.7
gorilla ggo-mir-
548b
CAAAAACCUCAGUUGCUUUUG 6 17.9
gorilla ggo-mir-
548a
AAAAGUAAUUGUGGUUUUUGC 6 30.4
gorilla ggo-mir-
133b
UUUGGUCCCCUUCAACCAGC 6 4
gorilla ggo-mir-
206
UGGAAUGUAAGGAAGUGUGUGG 6 5.4
gorilla ggo-mir-
1273c
GGCGACAAAACGAGACCCUG 6 8.4
gorilla ggo-mir-
671
UCCGGUUCUCAGGGCUCCACC 7 24.5
gorilla ggo-mir-
3943
UAGCCCCCAGGCUUCACUUGGCG 7 34
gorilla ggo-mir-
148a
UCAGUGCACUACAGAACUUUG 7 3957.5
gorilla ggo-mir-
339
UGAGCGCCUCGACGACAGAGCCG 7 429.6
gorilla ggo-mir-
592
UUGUGUCAAUAUGCGAUGAUG 7 45.6
gorilla ggo-mir-
548f
CAAAAGUGAUCGUGGUUUUUG 7 4.6
gorilla ggo-mir-
589
UGAGAACCACGUCUGCUCUGA 7 5.3
gorilla ggo-mir-
182
UUUGGCAAUGGUAGAACUCACA 7 5.4
gorilla ggo-mir-
590
GAGCUUAUUCAUAAAAGUGCAG 7 57.4
gorilla ggo-mir-
490
CAACCUGGAGGACUCCAUGCUG 7 73.8
gorilla ggo-mir-
335
UCAAGAGCAAUAACGAAAAAUG 7 785.9
gorilla ggo-mir-
486
UCCUGUACUGAGCUGCCCCGAG 8 1100
126
gorilla ggo-mir-
383
AGAUCAGAAGGUGAUUGUGGC 8 1642.2
gorilla ggo-mir-
3151
GGUGGGGCAAUGGGAUCAGGUG 8 18.3
gorilla ggo-mir-
598
UACGUCAUCGUUGUCAUCGUCA 8 5151.1
gorilla ggo-mir-
4660
UGCAGCUCUGGUGGAAAAUGGA 8 5.2
gorilla ggo-mir-
320a
AAAAGCUGGGUUGAGAGGGCGA 8 5.5
gorilla ggo-mir-
151a
UCGAGGAGCUCACAGUCUAG 8 5.6
gorilla ggo-mir-
455
GCAGUCCAUGGGCAUAUACAC 9 1166.5
gorilla ggo-let-7f UGAGGUAGUAGAUUGUAUAGU 9 1167727.6
gorilla ggo-mir-
873
GCAGGAACUUGUGAGUCUCC 9 197.5
gorilla ggo-mir-
27b
UUCACAGUGGCUAAGUUCUGC 9 2594.1
gorilla ggo-mir-
23b
AUCACAUUGCCAGGGAUUACCA 9 5
gorilla ggo-mir-
3927
CAGGUAGAUAUUUGAUAGGCA 9 6
gorilla ggo-mir-
491
AGUGGGGAACCCUUCCAUGAGGA 9 92.5
gorilla ggo-mir-
1287
UGCUGGAUCAGUGGUUCGAG 10 0.8
gorilla ggo-mir-
146b
UGAGAACUGAAUUCCAUAGGCUGU 10 10004.3
gorilla ggo-mir-
2110
UUGGGGAAGCGGCCGCUGAGUGA 10 1.4
gorilla ggo-mir-
346
UGUCUGCCCGCAUGCCUGCCUC 10 1.8
gorilla ggo-mir-
4484
GAAAAAGGCGGGAGAAGCCCCA 10 -2.5
gorilla ggo-mir-
202
AAGAGGUAUAGGGCAUGGGAAA 10 4.3
gorilla ggo-mir-
609
AGGGUGUUUCUCUCAUCUCUGG 10 4.3
gorilla ggo-mir-
548e
AAAAACUGCGACUACUUUUG 10 5.4
gorilla ggo-mir-
1296
UUAGGGCCCUGGCUCCAUCUCC 10 5.6
127
gorilla ggo-mir-
548c
AAAAGUACUUGCGGAUUUUG 11 12.7
gorilla ggo-mir-
34c
AGGCAGUGUAGUUAGCUGAUUG 11 1287.5
gorilla ggo-mir-
483
AAGACGGGAGGAAAGAAGGGAG 11 1967.6
gorilla ggo-mir-
4488
UAGGGGGCGGGCUCCGGCG 11 2
gorilla ggo-mir-
192
CUGACCUAUGAAUUGACAGCC 11 243338.1
gorilla ggo-mir-
34b
AGGCAGUGUCAUUAGCUGAUUG 11 28.3
gorilla ggo-mir-
210
CUGUGCGUGUGACAGCGGCUGA 11 323
gorilla ggo-mir-
675b
UGGUGCGGAGAGGGCCCACAGUG 11 41.1
gorilla ggo-mir-
139
UCUACAGUGCACGUGUCUCCAG 11 4363.3
gorilla ggo-mir-
1260b
AUCCCACCACUGCCACCA 11 5.6
gorilla ggo-mir-
326
CCUCUGGGCCCUUCCUCCAG 11 5.7
gorilla ggo-mir-
129
AAGCCCUUACCCCAAAAAGCA 11 7084.6
gorilla ggo-mir-
331
GCCCCUGGGCCUAUCCUAGAAC 12 1050.8
gorilla ggo-mir-
3612
AGGAGGCAUCUUGAGAAAUGG 12 12.5
gorilla ggo-mir-
1252
AGAAGGAAGUUGAAUUCAUU 12 16
gorilla ggo-mir-
148b
UCAGUGCAUCACAGAACUUUG 12 2086.5
gorilla ggo-let-7i UGAGGUAGUAGUUUGUGCUGU 12 25708.1
gorilla ggo-mir-
1228
GUGGGCGGGGGCAGGUGUGUGG 12 30.4
gorilla ggo-mir-
1291
GUGGCCCUGACUGAAGACCAGCA 12 5.3
gorilla ggo-mir-
1197
UAGGACACAUGGUCUACUUC 14 -0.3
gorilla ggo-mir-
370
GCCUGCUGGGGUGGAACCUGGUC 14 0.6
gorilla ggo-mir-
431
UGCAGGUCGUCUUGCAGGGCU 14 1
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gorilla ggo-mir-
380
UAUGUAAUAUGGUCCACAUC 14 106
gorilla ggo-mir-
3545
UUGAACUGUUAAGAACCACUGG 14 12.6
gorilla ggo-mir-
433
AUCAUGAUGGGCUCCUCGGUG 14 1331
gorilla ggo-mir-
376a
AUCAUAGAGGAAAAUCCACG 14 156.3
gorilla ggo-mir-
655
AUAAUACAUGGUUAACCUCUU 14 158.8
gorilla ggo-mir-
379
UGGUAGACUAUGGAACGUAGG 14 1946
gorilla ggo-mir-
624
UAGUACCAGUACCUUGUGUUCA 14 2
gorilla ggo-mir-
409
AGGUUACCCGAGCAACUUUGCA 14 233
gorilla ggo-mir-
487a
AAUCAUACAGGGACAUCCAGU 14 245.1
gorilla ggo-mir-
495
AAACAAACAUGGUGCACUUCU 14 2528.9
gorilla ggo-mir-
543
AAACAUUCGCGGUGCACUUCU 14 260.4
gorilla ggo-mir-
432
UCUUGGAGUAGGUCAUUGGGUG 14 2631.8
gorilla no id1 AGGGGGAAAGUUCUAUAG 14 3.4
gorilla ggo-mir-
493
UUGUACAUGGUAGGCUUUCAU 14 38.4
gorilla ggo-mir-
889
UUAAUAUCGGACAACCAUUG 14 3.9
gorilla ggo-mir-
485
AGAGGCUGGCCGUGAUGAAU 14 3983.2
gorilla ggo-mir-
299
UGGUUUACCGUCCCACAUACA 14 446.3
gorilla ggo-mir-
494
UGAAACAUACACGGGAAACCUC 14 4.7
gorilla ggo-mir-
329b
AACACACCUGGUUAACCUCU 14 4.7
gorilla ggo-mir-
1185
AGAGGAUACCCUUUGUAUGU 14 5
gorilla ggo-mir-
496
UGAGUAUUACAUGGCCAAUC 14 5
1miRBase did not provide names due to ambiguous N bases in the hairpin sequence
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gorilla ggo-mir-
487b
AAUCGUACAGGGUCAUCCACU 14 5.1
gorilla ggo-mir-
127
UCGGAUCCGUCUGAGCUUGGC 14 5.2
gorilla ggo-mir-
323b
CCCAAUACACGGUCGACCUC 14 5.3
gorilla ggo-mir-
337
GAACGGCUUCAUACAGGAG 14 5.3
gorilla ggo-mir-
668
AUGUCACUCGGCUCGGCCCAC 14 5.3
gorilla ggo-mir-
342
UCUCACACAGAAAUCGCACCCG 14 5.4
gorilla ggo-mir-
1193
GGGAUGGUAGACCGGUGACGUGC 14 5.4
gorilla ggo-mir-
376c
AACAUAGAGGAAAUUCCACG 14 558
gorilla ggo-mir-
3173
AAAGGAGGAAAUAGGCAGGCCAG 14 5.7
gorilla ggo-mir-
654
UGGUGGGCCGCAGAACAUGUGC 14 58.5
gorilla ggo-mir-
411
AUAGUAGACCGUAUAGCGUACG 14 587.6
gorilla ggo-mir-
656
AAUAUUAUACAGUCAACCUC 14 59.4
gorilla ggo-mir-
410
AAUAUAACACAGAUGGCCUG 14 644.2
gorilla ggo-mir-
376b
AUCAUAGAGGAAAAUCCAUG 14 71.1
gorilla ggo-mir-
377
AUCACACAAAGGCAACUUUUG 14 83.6
gorilla ggo-mir-
381
UAUACAAGGGCAAGCUCUCUG 14 86.1
gorilla ggo-mir-
345
GCUGACUCCUAGUCCAGGGCUCG 14 88.9
gorilla ggo-mir-
323a
CACAUUACACGGUCGACCUC 14 894
gorilla ggo-mir-
628
AUGCUGACAUAUUUACUAGAGG 15 141.7
gorilla ggo-mir-
1179
AAGCAUUCUUUCAUUGGUUGG 15 27.1
gorilla ggo-mir-
4510
UGAGGGAGUAGGAUGUAUGGU 15 4.7
130
gorilla ggo-mir-
1266
CCUCAGGGCUGUAGAACAGGGCUG 15 5.9
gorilla ggo-mir-
629
UGGGUUUAUGUUGGGAGAACU 15 78.2
gorilla ggo-mir-
1343
CUCCUGGGGCCCGCACUC 16 1
gorilla ggo-mir-
484
UCAGGCUCAGUCCCCUCCCGA 16 1.1
gorilla ggo-mir-
328
CUGGCCCUCUCUGCCCUUCCG 16 116.1
gorilla ggo-mir-
193b
CGGGGUUUUGAGGGCGAGAUGA 16 1197.1
gorilla ggo-mir-
940
AAGGCAGGGCCCCCGCUCCCC 16 1.9
gorilla ggo-mir-
138
AGCUGGUGUUGUGAAUCAGGCCG 16 3411
gorilla ggo-mir-
365a
UAAUGCCCCUAAAAAUCCUUA 16 698
gorilla ggo-mir-
140
ACCACAGGGUAGAACCACGGAC 16 97632.3
gorilla ggo-mir-
324
CGCAUCCCCUAGGGCAUUGGUG 17 550.3
gorilla ggo-mir-
497
CAGCAGCACACUGUGGUUUG 17 5.6
gorilla ggo-mir-
4520b
UUUGGACAGAAAACACGCAGG 17 5.6
gorilla ggo-mir-
887
GUGAACGGGCGCCAUCCCGAGGCU 17 81.3
gorilla ggo-mir-
22
AAGCUGCCAGUUGAAGAACUG 17 8262.6
gorilla ggo-mir-
582
UUACAGUUGUUCAACCAGUUAC 17 86.1
gorilla ggo-mir-
4529
UCAUUGGACUGCUGAUGGCCUG 18 0.8
gorilla ggo-mir-
122
UGGAGUGUGACAAUGGUGUUUG 18 2545110.2
gorilla ggo-mir-
4743
UGGCCGGAUGGGACAGGAGGCA 18 5.4
gorilla ggo-mir-1 UGGAAUGUAAAGAAGUAUGUA 18 54001.2
gorilla ggo-mir-
517c
AUCGUGCAUCCCUUUAGAGUG 19 3
gorilla ggo-mir-
516b
AUCUGGAGGUAAGAAGCACUU 19 3.9
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gorilla ggo-mir-
371b
ACUCAAAAGAUGGCGGCACUU 19 5.3
gorilla ggo-mir-
330
GCAAAGCACACGGCCUGCAGAGA 19 5.4
gorilla ggo-mir-
769
UGAGACCUCUGGGUUCUGAGC 19 545.2
gorilla ggo-mir-
125a
UCCCUGAGACCCUUUAACCUG 19 5.5
gorilla ggo-mir-
641
AAAGACAUAGGAUAGAGUCACC 19 6
gorilla ggo-mir-
181d
AACAUUCAUUGUUGUCGGUGGGU 19 6323.7
gorilla ggo-mir-
150
UCUCCCAACCCUUGUACCAGUG 19 64.7
gorilla ggo-let-7e UGAGGUAGGAGGUUGUAUAGU 19 86198.3
gorilla ggo-mir-
1289
UGGAAUCCAGGAAUCUGCAUUU 20 5.2
gorilla ggo-mir-
499a
UUAAGACUUGCAGUGAUGUU 20 5.5
gorilla ggo-mir-
296
AGGGUUGGGUGGAGGCUCUCC 20 6.2
gorilla ggo-let-7c UGAGGUAGUAGGUUGUAUGGU 21 270515.7
gorilla ggo-mir-
155
UUAAUGCUAAUCGUGAUAGGGG 21 5.3
gorilla ggo-mir-
1306
ACGUUGGCUCUGGUGGUGAUG 22 1.1
gorilla ggo-mir-
1286
UGCAGGACCAAGAUGAGCCCU 22 1.3
gorilla ggo-let-7b UGAGGUAGUAGGUUGUGUGGU 22 224101.1
gorilla ggo-mir-
1249
ACGCCCUUCCCCCCCUUCUUCA 22 29.3
gorilla ggo-let-7a UGAGGUAGUAGGUUGUAUAGU 22 523694.4
gorilla ggo-mir-
130b
CAGUGCAAUGAUGAAAGGGCA 22 548.3
gorilla ggo-mir-
185
UGGAGAGAAAGGCAGUUCCUGA 22 9137.4
gorilla ggo-mir-
18b
UAAGGUGCAUCUAGUGCAGU X -0.1
gorilla ggo-mir-
4536
UAUCGUGCAUAUAUCUACCACA X 0.4
gorilla ggo-mir-
508
ACUGUAGCCUUUCUGAGUAGA X 0.7
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gorilla ggo-mir-
374b
AUAUAAUACAACCUGCUAAGUG X 1006.8
gorilla ggo-mir-
532
CAUGCCUUGAGUGUAGGACCG X 1105.2
gorilla ggo-mir-
542
UGUGACAGAUUGAUAACUGAAA X 121
gorilla ggo-mir-
450b
UUUUGCAAUAUGUUCCUGAAUA X 16
gorilla ggo-mir-
502a
AAUGCACCUGGGCAAGGAUUCA X 164
gorilla ggo-mir-
503
UAGCAGCGGGAACAGUUCUGCAG X 180.3
gorilla ggo-mir-
504
GACCCUGGUCUGCACUCUA X 2
gorilla ggo-mir-
188
CAUCCCUUGCAUGGUGGAGGGUG X 20.1
gorilla ggo-mir-
424
CAGCAGCAAUUCAUGUUUUGA X 2017.9
gorilla ggo-mir-
509
UACUGCAGACGUGGCAAUCAUG X 20.9
gorilla ggo-mir-
660
UACCCAUUGCAUAUCGGAGUUG X 247.5
gorilla ggo-mir-
652
AAUGGCGCCACUAGGGUUGUG X 291.5
gorilla ggo-mir-
363
AAUUGCACGGUAUCCAUCUGUAA X 362.8
gorilla ggo-mir-
676
CUGUCCUAAGGUUGUUGAGUUG X 4
gorilla ggo-mir-
374a
CUUAUCAGAUUGUAUUGUAAU X 414.8
gorilla ggo-mir-
105
CCACGGAUGUUUGAGCAUGUG X -4.4
gorilla ggo-mir-
23c
AUCACAUUGCCAGUGAUUACCC X 4.4
gorilla ggo-mir-
421
AUCAACAGACAUUAAUUGGGCG X 5
gorilla ggo-mir-
20b
CAAAGUGCUCAUAGUGCAGGUAG X 5
gorilla ggo-mir-
651
UUUAGGAUAAGCUUGACUUUUG X 5
gorilla ggo-mir-
452
AACUGUUUGCAGAGGAAACUGA X 5.2
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gorilla ggo-mir-
767
UGCACCAUGGUUGUCUGAGCA X 5.3
gorilla ggo-mir-
502b
AUGCACCUGGGCAAGGAUUCUGA X 5.3
gorilla ggo-mir-
505
GUCAACACUUGCUGGUUUCC X 5.4
gorilla ggo-mir-
1298
UUCAUUCGGCUGUCCAGAUG X 5.4
gorilla ggo-mir-
222
AGCUACAUCUGGCUACUGGGUC X 5.6
gorilla ggo-mir-
361
UUAUCAGAAUCUCCAGGGGUAC X 615.7
gorilla ggo-mir-
450a
UUUUGCGAUGUGUUCCUAAUA X 69.1
gorilla ggo-mir-
448
UUGCAUAUGUAGGAUGUCCCA X 70
gorilla ggo-mir-
362
AACACACCUAUUCAAGGAUUCA X 70.8
gorilla ggo-mir-
766
ACUCCAGCCCCACAGCCUCAGC X 72.8
gorilla ggo-mir-
1264
ACAAGUCUUAUUUGAGCACCUG X 7.8
gorilla ggo-mir-
1277
UACGUAGAUAUAUAUGUAUUU X 93.5
orangutan ppy-mir-
4427
UCUGAAUAGAGUCUGAAGAG 1 0.2
orangutan ppy-mir-
3121
UAAAUAGAGUAGGCAAAGGACA 1 1.2
orangutan ppy-mir-
1976
CUCCUGCCCUCCUUGCUGUAG 1 3.8
orangutan ppy-mir-
4774
UCUGGUAUGUAGUAGGUAAUAA 2B 2.1
orangutan ppy-mir-
4782
UUCUGGAUAUGAAGACAAUCA 2B 3.2
orangutan ppy-mir-
4791
UGGAUAUGAUGACUGAAA 3 0.8
orangutan ppy-mir-
4446
CAGGGCUGGCAGUGAGAUGGG 3 2829
orangutan ppy-mir-
4796
UAAAGUGGCAGAGUAUAGACACA 3 3.3
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orangutan ppy-mir-
378b
ACUGGACUUGGAGGCAGAAAG 3 5.3
orangutan ppy-mir-
4788
ACGGACCAGCUAAGGGAGGCAU 3 5.9
orangutan ppy-mir-
3938
AAUUCCCUUGUAGAUAACCUGG 3 8.5
orangutan ppy-mir-
4798
UUCGGUAUACUUUGUGAAUUGG 4 11.1
orangutan ppy-mir-
4451
UGGUAGAGCUGAGGACAG 4 4.6
orangutan ppy-mir-
3661
UGACCUGGGACUCGGAUAGCUGC 5 1.5
orangutan ppy-mir-
548h
AAAAGUAAUUGCGGUUUUUG 5 23.7
orangutan ppy-mir-
4637
UACUAACUGCAGAUUCAAGUGA 5 3
orangutan ppy-mir-
378e
ACUGGACUUGGAGUCAGG 5 4.1
orangutan ppy-mir-
3912
UAACGCAUAAUAUGGACAUG 5 4.5
orangutan ppy-mir-
548f
CAAAAACUGUAAUUACUUUUG 5 5.1
orangutan ppy-mir-
3660
CACUGACAGGAGAGCAUUUUGA 5 5.3
orangutan ppy-mir-
548a
AAAAGUAAUUGUGGUUUUUG 6 4.9
orangutan ppy-mir-
1273e
GAGGCAGGAGAAUCGCUUG 6 5
orangutan ppy-mir-
3934
UCAGGUGUGGAAUCUGAGGCA 6 5.3
orangutan ppy-mir-
3145
AACUCCAAGCAUUCAAAACUCA 6 5.4
orangutan ppy-mir-
3943
UAGCCCCCAGGCUUCACUUGGCG 7 22.2
orangutan ppy-mir-
4667
UGACUGGGGAGCAGAAGGAGA 9 1.6
orangutan ppy-mir-
3154
CAGAAGGGGAGUUGGGAGCAG 9 1.9
orangutan ppy-mir-
4672
ACACAGCUGGACAGAGGGACGA 9 4.8
orangutan ppy-mir-
2861
GGCGGCGGGCGUCGGGCG 9 6
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orangutan ppy-mir-
2278
GAGGGCAGUGUGUGUUGUGUGG 9 8.8
orangutan ppy-mir-
4484
AAAAAGGCGGGAGAAGCCCCG 10 3.9
orangutan ppy-mir-
548e
AAAACGGUGACUACUUUUGCA 10 4.8
orangutan ppy-mir-
202
UUCCUAUGCAUAUACUUCUU 10 49.7
orangutan ppy-mir-
3155a
CAGGCUCUGCAGUGGGAACGGA 10 6.1
orangutan ppy-mir-
548c
AAAAGUACUUGCGGAUUUUG 11 5
orangutan ppy-mir-
1260b
AUCCCACCACUGCCACCA 11 5.5
orangutan ppy-mir-
3170
CUGGGGUUCUGAGACAGACAG 13 2.4
orangutan ppy-mir-
151b
UCCAGGAGCUCACAGUCUAG 14 2.6
orangutan ppy-mir-
1193
GGGAUGGUAGACCGGUGACGUGC 14 5
orangutan ppy-mir-
3173
AAGGAGGAAAUAGGCAGGCCAG 14 5.8
orangutan ppy-mir-
3174
UAGUGAGUUAGAGAUGCAGAGC 15 1.7
orangutan ppy-mir-
4515
AGGACUGGACUCCCGGCGGC 15 2.9
orangutan ppy-mir-
10a
UACCCUGUAGAUCCGAAUUUG 17 4.3
orangutan ppy-mir-
454
UAGUGCAAUAUUGCUUAUAGGG 17 5
orangutan ppy-mir-
4520a
UGGACAGAAAACACGCAGGAAG 17 5.2
orangutan ppy-mir-
152
UCAGUGCAUGACAGAACUUGG 17 8232.8
orangutan ppy-mir-
4526
GCUGACAGCAGGGCCGGCCAC 18 2.8
orangutan ppy-mir-
4529
AUUGGACUGCUGAUGGCCUG 18 3.6
orangutan ppy-mir-
4743
UGGCCGGAUGGGACAGGAGGCA 18 5.4
orangutan ppy-mir-
3188
AGAGGCUUUGUGCGGACUCGG 19 1.1
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orangutan ppy-mir-
3940
CAGCCCGGAUCCCAGCCCACUCA 19 1.5
orangutan ppy-mir-
320e
AAAAGCUGGGUUGAGAAGGUGA 19 4.6
orangutan ppy-mir-
3617
AAAGACAUAGUUGCAAGAUGGG 20 1.6
orangutan ppy-mir-
378d
ACUGGACUUGGAGUCAGA X 4.3
orangutan ppy-mir-
676
CCGUCCUAAGGUUGUUGAGUUG X 5.1
rhesus
macaque
mml-mir-
1255b
UACGGAUAAGCAAAGAAAGUGG 1 2.1
rhesus
macaque
mml-mir-
320b
AAAAGCUGGGUUGAGAGGGCAA 1 5.1
rhesus
macaque
mml-mir-
3122
GUUGGGACAAGAGAACGGUCU 1 5.5
rhesus
macaque
mml-mir-
1262
UGAUGGGUGAAUUUGUAGAAGG 1 647.1
rhesus
macaque
mml-mir-
4446
CAGGGCUGGCAGUGAGAUGGG 2 26007.7
rhesus
macaque
mml-mir-
1284
UCUGUACAGACCCUGGCUUU 2 4.5
rhesus
macaque
mml-mir-
4796
AAGUGGCAGAGUGUAGACACAA 2 5.9
rhesus
macaque
mml-mir-
3146
CAUGCUAGAACAGAAAGAAUGGG 3 5
rhesus
macaque
mml-mir-
4650
UGGAAGGUAGAAUGAGGCCUGAU 3 5.8
rhesus
macaque
mml-mir-
3145
UAUUUUGAGUGUUUGGAAUUGA 4 4.8
rhesus
macaque
mml-mir-
1243
AAACUGGAUCAAUUAUAGGAG 5 17.7
rhesus
macaque
mml-mir-
378d
ACUGGACUUGGAGUCAGAAGCA 5 4.8
rhesus
macaque
mml-mir-
3140
AAGAGCUUUUGGGAAUUCAGG 5 5.3
rhesus
macaque
mml-mir-
1255a
AGGAUGAGCAAAGGAAGUAGU 5 5.7
rhesus
macaque
mml-mir-
4803
UAACAUAAUAGUGUGGACUGA 6 5.6
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rhesus
macaque
mml-mir-
1271
CUUGGCACCUAGCAAGCACUCA 6 980.3
rhesus
macaque
mml-mir-
1179
AAGCAUUCUUUCAUUGGUUGG 7 16.9
rhesus
macaque
mml-mir-
1185
AGAGGAUACCCUUUGUAUGU 7 5.2
rhesus
macaque
mml-mir-
3173
GAAGGAGGAAACAGGCAGGCCAG 7 5.8
rhesus
macaque
mml-mir-
4716
AAGGGGGAAGGACACAUGGAGA 7 6.1
rhesus
macaque
mml-mir-
3151
ACGGGUGGCGCAAUGGGAUCAG 8 223.8
rhesus
macaque
mml-mir-
1296
UUAGGGCCCUGGCUCCAUCUCCU 9 5.5
rhesus
macaque
mml-mir-
1249
ACGCCCUUCCCCCCCUUCUUCA 10 118
rhesus
macaque
mml-mir-
3200
CACCUUGCGCUACUCAGGUCUG 10 202.6
rhesus
macaque
mml-mir-
1258
AGUUAGGAUUAGGUCGUGGAA 12 5.9
rhesus
macaque
mml-mir-
217b
UACUGCAUCAGGAACUGAUUGGA 13 4.3
rhesus
macaque
mml-mir-
1260b
AUCCCACCACUGCCACCA 14 5.6
rhesus
macaque
mml-mir-
1304
UUCGAGGCUACAAUGAGAUGUG 14 5.8
rhesus
macaque
no id2 CCAGGCUGGAGUGCAGUGG 15 4.1
rhesus
macaque
mml-mir-
873
GCAGGAACUUGUGAGUCUCC 15 4275.6
rhesus
macaque
mml-mir-
4667
ACUGGGGAGCAGAAGGAGAAC 15 5.5
rhesus
macaque
mml-mir-
3927
CAGGUAGAUAUUUGAUAGGCA 15 6.1
rhesus
macaque
mml-mir-
1250
ACGGUGCUGAAUGUGGCCUU 16 5.6
rhesus
macaque
mml-mir-
320c
AAAAGCUGGGUUGACAGGGUAA 18 3.8
rhesus
macaque
mml-mir-
4743
UGGCCGGAUGGGACAGGAGGCA 18 5.3
2miRBase did not provide names due to missing relationships to existing miRNAs in the
database
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rhesus
macaque
mml-mir-
518d
CUCUAGAGGAAAGCGCUUACUG 19 103
rhesus
macaque
mml-mir-
517c
AUCGUGCAGCCUUUUAGAGUG 19 106.7
rhesus
macaque
mml-mir-
519e
UUCUCCAAUGGGAAGCACCUUC 19 132.7
rhesus
macaque
mml-mir-
1283
CUACAAAGGAAAGCACUUUC 19 4.9
rhesus
macaque
mml-mir-
1323
UCAAAACUGAGGGGCAUUUUC 19 6232.9
rhesus
macaque
mml-mir-
1298
UUCAUUCGGCUGUCCAGAUGUA X 198.4
rhesus
macaque
mml-mir-
891b
UGCAACGAACUUGAGCCAUUGA X 24.7
rhesus
macaque
mml-mir-
2114
CGAGCCUCAAGCAAGGGACUUC X 25.3
rhesus
macaque
mml-mir-
4536
UGUGGUAGAUAUAUGCACGA X 4.2
rhesus
macaque
mml-mir-
1277
UACGUAGAUAUAUAUGUAUUU X 543.7
rhesus
macaque
mml-mir-
676
CCGUCCUAAGGUUGUUGAGU X 766.4
rhesus
macaque
mml-mir-
514b
AUUGACACCUCUGUGAGUAGA X 997.4
Table A.9.: Newly predicted miRNAs for four non primate species using miRD-
eep2. Table taken from Dannemann et al. (2012a)
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conservation variation
human chimpanzee rhesus macaque human
brain rho=0.40 rho=0.32 rho=0.41 rho=-0.22
P=1.6e-9 P=3.7e-6 P=7.0e-10 P=1.3e-3
heart rho=0.28 rho=0.26 rho=0.33 rho=-0.13
P=6.1e-5 P=2.1e-4 P=1.8e-6 P=0.06
kidney rho=0.26 rho=0.20 rho=0.35 rho=-0.07
P=1.4e-4 P=3.1e-3 P=2.8e-7 P=0.34
liver rho=0.30 rho=0.22 rho=0.34 rho=-0.11
P=1.1e-5 P=1.6e-3 P=4.0e-7 P=0.11
testis rho=0.18 rho=0.08 rho=0.15 rho=-0.04
P=7.8e-3 P=0.25 P=0.03 P=0.53
Table A.10.: Correlation between conservation/variation and miRNA expression
for human, chimpanzee and rhesus macaque in five tissues. Table
taken from Dannemann et al. (2012b)
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